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1.1 Anion Binding Catalysis 
Asymmetric catalysis is one of the most important tools in organic synthesis to achieve 
enantiopure compounds. Depending on the targeted reaction and nature of the reactants, all 
the different types of chemical interactions between the substrates and catalysts can be 
utilized. In this regard covalent bonding (e.g. via enamine catalysis, metal complexes, etc.) and 
different types of non-covalent interactions, such as hydrogen-bonding or ion-pairing, must 
be mentioned. The latter relies on charged intermediates and reagents, and depending on 
their activation modes the catalytic approaches based on it can be divided in four fields: 1) 
chiral cation-directed catalysis, 2) cation-binding catalysis, 3) chiral anion-directed catalysis 
and 4) anion-binding catalysis (Figure 1a).[1] In general, reactivity and enantioselectivity can be 
introduced by forming a charged intermediate during the reaction. Interaction of these ionic 
intermediates with chiral neutral or charged catalysts has emerged as a powerful tool for 
catalytic enantioselective synthesis. The most prominent type of catalysts in this research area 
consist of bi- or multi-H-bond donor compounds such as (thio)ureas,[2] squaramides,[3] 
(macrocyclic)amides[4] or calixarenes,[5] which can bind anions like halides, cyanides, 
carboxylates, sulfates or phosphates through H-bonding (Figure 1b).  
 
Figure 1 a) Charged and neutral ion-pairing activations, and b) molecular recognition of anions. 
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This thesis focuses on the so-called “anion-binding catalysis” approach that involves the non-
covalent binding to an ion pair by a chiral, neutral catalyst. For that reason, the principle of 
anion-binding catalysis will be described more closely.  
In general, anion-binding catalysis consists on the concept of ion pairs, which was described 
by Anslyn and Dougherty: “An ion pair is defined to exist when a cation and anion are close 
enough in space that the energy associated with their electrostatic attraction is larger than 
the thermal energy (RT) available to separate them. This means that the ions stay associated 
longer than the time required for Brownian motion to separate non-interacting species.”[6] 
Finally, having a look at the development of anion-binding catalysis, it can be concluded that 
it was born from the more classical hydrogen bond-donor asymmetric catalysis. Thus, the 
ability of thioureas as privileged H-donor organocatalysts to activate neutral electrophiles 
through hydrogen bonding has been extensively exploited. However, it may have led in some 
cases to the misinterpretation of the mechanism (neutral H-donor vs. anion-binding catalysis), 
since this type of catalysts can indeed activate an in situ formed electrophilic intermediate by 
binding to its counter-anion (Scheme 1).[7] 
 
Scheme 1 Activation modes of thiourea catalysts and anion-binding catalysis. 
In the following, key examples of anion-binding catalysis with various ionic species will be 
described. Since the field is huge, the examples of anion-binding catalysis implying 
heteroarenes as substrates will be emphasized. 
Chapter 1 
4 
1.1.1 Halide Binding 
In 2004, Jacobsen reported on a thiourea-catalyzed acyl-Pictet–Spengler reaction of 
tryptamine with different aldehydes to give tetrahydro-β-carbolines in good yields and 
enantioselectivities.[8] First, an activation by hydrogen bonding of the neutral carbonyl moiety 
was postulated, which later was refuted. They demonstrated that their acyl-Pictet–Spengler 
reaction does involve the formation of the chiral ion-pair intermediate between catalyst 1 and 
the formed ionic intermediate upon acylation of the neutral imine (Scheme 2a). Subsequently, 
the enantiodifferentiation of prochiral N-acyliminium ions by chiral thiourea 1 could be 
applied in a Mannich-type reaction of isoquinolines (Scheme 2b).[9] To get a better insight into 
the nature of the substrate-catalyst interactions, 1H NMR studies of the acyl-Pictet–Spengler 
type reaction with catalyst 2 were carried out. Therefore, N-acyl iminium ions were generated 
in situ by dehydration of hydroxylactams. In the presence of TMSCl as dehydrating reagent, 
the formation of the corresponding chlorolactam was fast and irreversible. A decrease of the 
conversion in the reaction was observed when the methyl substituent in alpha to the N-atom 
in the model substrate was replaced through a hydrogen atom. Due to this observation the 
possibility of an SN2 could be eliminated and a SN1 cyclization mechanism was postulated 
(Scheme 2c).[10] 
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Scheme 2 Enantioselective thiourea-catalyzed a) acyl-Pictet-Spengler reaction; b) acyl-Mannich reactions 
proceeding via N-acyliminium ions; c) Pictet–Spengler-type cyclization of hydroxylactams and the proposed 
anion-binding mechanism. 
Computational studies indicated that thiourea 2 was not bound to the carbonyl group due to 
the low Lewis basicity of the intermediates, but instead it is most plausible to be bound to the 
chlorine atom of the α-chloroamide. Furthermore, the thiourea catalyst 2 might assist the 
cleavage of the C-Cl bond with the formation of the resulting iminium ionic form. As it is 
depicted in Scheme 1, a close ion pair between the N-acyl iminium intermediate and the 
thiourea-chloride complex as chiral counteranion is formed, which is the responsible for the 
high chirality transfer of the reaction. The postulated anion-binding model found further 
support when the halide counterion and solvent effects were studied. Thus, a decrease in 
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enantioselectivity was observed with other halides (Br, 68% ee; I, < 5% ee) and polar solvents 
(MTBE, 97% ee; CH2Cl2, <5% ee). These experiments also agreed with a SN1 mechanism. NMR-
binding studies showed a 0.56 ppm downfield shift of the N-H protons of the thiourea when 
the catalyst was treated with a chloride source. This proofed a strong binding between the 
catalyst and the chloride anion. After these findings, intensive research directed to the 
exploration of new enantioselective transformations catalyzed by thioureas as anion-binders 
has been done.[11] Thus, the method has also been extended successfully to the regio- and 
enantioselective cyclization of pyrrole nucleophiles using the same thiourea catalyst 2.[12] A 
rate acceleration due to increased substitution at the electrophilic center was observed, which 
also confirmed a SN1 mechanism. 
In 2007, Takemoto reported on the first asymmetric Petatis reaction catalyzed by a chiral 
bifunctional thiourea catalyst, which promotes the enantioselective addition of vinyl boronic 
acids to in situ generated N-acylquinolinium salts 3 (Scheme 3).[13] Although an activation of 
the substrate by H-bonding of the catalyst to the carbamate carbonyl group of substrate salt 
was proposed, an anion-binding mechanism is more likely to take place. Consequently, during 
the reaction, the 1,2-amino alcohol moiety of the catalyst formed a reactive boron-“ate” 
complex by chelating the boronic acid, while the thiourea moiety interacted with the N-
acylquinolinium salt 3. 
 
Scheme 3 Thiourea-catalyzed enantioselective Petasis-type reaction of quinolines proceeding via N-
acylquinolinium ions. 
Later, Jacobsen and coworkers successfully applied the principle of asymmetric hydrogen-
bond catalysis by anion binding to various cationic species, aside from iminium ions.[14] For 
example, the addition of silyl ketene acetals 4 to 1-chloroisochromanes 5 proceeded smoothly 
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with moderate to excellent yields and enantioselectivities (Scheme 4).[14b] The products were 
isolated in more than 50% yield and moderate to high enantioselectivities, which remained 
constant during the reaction, indicating that a dynamic kinetic resolution took place. 
Therefore, racemization of the chloroether starting material by thiourea-assisted chloride 
dissociation was required. Interestingly, the addition of nBu4NCl led to the inhibition of the 
reaction, indicating the binding of the chloride anions to the catalyst. This observation 
supported the concept of chloride binding catalysis. Due to poor enantioselectivities obtained 
in this reaction with the established catalyst 1, the Jacobsen’s group developed a new catalyst 
6 with an additional aryl group at the amide unit. 
 
Scheme 4 Thiourea catalyzed additions to oxocarbenium ions. 
After a longstanding two-years re-optimization of the catalyst structure to the newly designed 
thiourea catalyst 7,[15] the same group was able to develop an intermolecular version of the 
reaction of acyloxylactams 8 with electron-rich and poor indoles 9 to form the corresponding 
substituted products with high enantioselectivities (Scheme 5).  
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Scheme 5 Intermolecular addition of indoles to cyclic N-acyliminium ions. 
From these examples, it is already visible that catalyst design is not trivial and the different 
available thioureas are not generally applicable for every kind of reaction. From there on, huge 
efforts have been done in designing new catalyst systems with the aim of developing a general 
catalyst structure. These efforts have also led to a new concept of catalysts, which consists of 
the combination of two distinct recognition sites for both cationic and anionic moieties of the 
ionic substrate. Catalyst 10 was designed not only to bind a chloride anion within the thiourea 
moiety, but also to engage stabilizing cation π-interactions as a second fundamental 
recognition element (Scheme 6). This new concept was successfully employed in the cationic 
bicyclization of hydroxylactams to generate highly enantioenriched tetracycles.[16]  
 
Scheme 6 Thiourea catalyst with two recognition sites. 
Despite the well-established (thio)urea-chloride binding for halogen anion acceptor catalysis, 
bromide anions can also be used. A primary aminothiourea 11 was found to catalyze the 
enantioselective α-alkylation of α-branched aldehydes 12 with symmetrical 
  Introduction 
9 
diarylbromomethanes 13 (Scheme 7).[14a] Since the thiourea catalyst 11 can also bind to the 
diarylbromomethane and promote a SN2 type reaction, various mechanistic studies had to be 
performed. A normal secondary kinetic isotope effect for the benzhydryl proton indicated that 
the electrophilic carbon undergoes a rehybridization from sp3 to sp2 in the rate-determining 
transition state. A Hammett study proved that during the reaction a positive charge at the 
benzhydryl carbon in the transition state (p= -1.95) was developed. As a third study a 
competition experiment was performed by adding an equimolar amount of benzyl bromide to 
the catalytic reaction. The reaction showed a complete selectivity, in which only the alkylation 
of the bromodiphenylmethane was observed. These experiments led to the assumption that 
the reaction proceeded through a SN1 mechanism as demonstrated in Scheme 6. 
 
Scheme 7 Enantioselective, catalytic SN1-type alkylation of aldehydes with benzhydryl cations. 
Asymmetric chloride-binding hydrogen-bond catalysis has been applied successfully to several 
different classes of electrophiles. Additionally, taking bromide- and fluoride-[17] binding 
systems into account, ion-pairing catalysis using halide counterions presents a broad potential 
in asymmetric synthesis. 
1.1.2 Sulfonate Anions 
Besides the well-studied halide anions, sulfonate anions have gained increased interest in 
anion binding catalysis. In 2010, the first anion-binding-catalyzed enantioselective Povarov 
reaction was described by Jacobsen and coworkers.[18] They introduced the sulfonic acid/chiral 
urea catalytic system 14, and an achiral sulfonic acid (TfOH) to promote the highly 
enantioselective [4+2]-cycloaddition of N-aryl imines 15 and electron rich olefins 16. After the 
initial protonation of the imine to form a protonated iminium intermediate 17, the urea 
catalyst 14 bind the sulfonate counter anion and a close ion pair between the formed catalyst-
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anion complex and the iminium substrate is formed (Scheme 8a). It was shown that both chiral 
moieties, the cyclohexyldiamino and the sulfonamide units, were crucial to obtain high 
enantioselectivities. Experimental and computational studies were carried out to get a better 
insight in the complex reaction system. With the bifunctional sulfonamide-urea catalyst 14, a 
higher solubility of the protio-iminium sulfate, as well as a substantial decrease in the reaction 
rate, were observed. Thus, the decrease in reactivity led to the possibility of a higher 
stereoinduction control. Since the plain Brønsted acid-catalyzed reaction is several times 
faster, for the enantioselective version it must be guaranteed that no free triflic acid is 
available to promote the racemic pathway. Various data demonstrated that the high 
enantioselectivities were achieved because of the strong binding between the protio-iminium 
triflate 17 and the sulfinamido urea catalyst 14. A large binding constant (K = 9 x 103 M-1) was 
observed for the catalyst-protio-iminium sulfate complex. A dynamic structure was 
considered, consisting of electrostatic and hydrogen bond interactions (Scheme 8b). As it is 
shown in the proposed transition structure, the kinetic isotopic effect suggested a partial 
rehybridization of the ortho-carbon of the aniline in the rate-limiting step. This indicated a 
concerted, but highly asynchronous [4+2]-cycloaddition, followed by re-aromatization 
(Scheme 8c). 
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Scheme 8 a) Urea/strong Brønsted acid co-catalyzed enantioselective Povarov reaction (NBSA = o-
nitrobenzenesulfonic acid); b) the ground state catalyst–substrate interactions; c) cycloaddition transition 
structure. 
Recently, in 2017 Banik and Jacobsen published on a Lewis acid enhancement by hydrogen-
bond donors for asymmetric catalysis.[19] A new mode of catalytic activation with chiral H-
bond donors, which enables enantioselective reactions of relatively unreactive electrophiles, 
was introduced. In general, ureas, thioureas, squaramides and guanidinium ions show weak 
acidity and therefore require highly reactive electrophilic substrates to be effective. They 
proved that squaramide 18 can interact with silyl triflates by binding the triflate counterion to 
form a stable, yet highly Lewis acidic, complex (Scheme 9a). The silyl triflate-chiral squaramide 
combination promoted then the generation of oxocarbenium intermediates from acetal 
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substrates. Non-covalent interactions between the squaramide catalyst 18 and the 
oxocarbenium triflate can hence control the enantioselective addition of nucleophiles. 
 
Scheme 9 a) Activation of silyl triflates via anion abstraction; b) Silyl triflate–promoted Mukaiyama aldol 
reaction of an acetal; c) [4+3]-Cycloaddition. 
This activation principle was successfully applied to the generation of oxocarbenium ions from 
stable acetals for the Mukaiyama aldol reaction (Scheme 9b) and for highly demanding [4+3]-
cycloadditions (Scheme 9c). Mechanistic studies for the [4+3]-cycloaddition were carried out 
to get a better insight in the catalytic mechanism. Kinetic data and titration experiments were 
consistent with a pre-equilibrium formation of a resting-state complex between the 
squaramide catalyst and TESOTf, displaying a 1:1 binding interaction between the catalyst and 
the anion. 
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Such type of detailed mechanistic studies[18-19] gave a better understanding of the 
stereochemical outcome of reactions controlled by non-covalent interaction between a 
catalyst and an ion pair intermediate. 
1.1.3 Cyanide and Carboxylate Anions 
The use of cyanides as counterions in anion-binding catalysis was discovered by coincidence 
during the development of a metal-catalyzed enantioselective Strecker reaction of imines. It 
was found out that the reaction also proceeded without any metal. The group of Jacobsen 
then developed a thiourea-catalyzed asymmetric Strecker reaction, followed by extensive 
studies of their behavior (Scheme 10).[20] 
 
Scheme 10 (Thio)urea-catalyzed asymmetric Strecker reaction. 
Like the sulfonate anions, carboxylates can also be efficiently bound by urea- and thiourea-
based compounds in a bidentate fashion. Jacobsen and coworkers reported various protocols 
in this field. The reported enantioselective Pictet-Spengler[21] and iso-Pictet-Spengler[22] 
reactions with carboxylates as a counterion has contributed essentially to the further 
development in this area. The formation of a benzoate-iminium ion salt was proposed to be 
facilitated by hydrogen bonding of the thiourea catalyst (Scheme 11). 
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Scheme 11 Thiourea-catalyzed enantioselective Pictet-Spengler reaction. 
In 2011, Seidel and his group developed an enantioselective version of the Steglich reaction 
by a rearrangement of O-acylated azalactones to the corresponding C-acylated compounds 
(Scheme 12a). Therefore, they employed a dual-catalysis approach by combining an achiral 
nucleophilic catalyst (DMAP) and a chiral anion-binding catalyst to provide α,α-disubstituted 
amino acid derivatives in a highly enantioselective fashion. By replacing the cocatalyst DMAP 
by isoquinoline they were able to synthesize highly functionalized enantioenriched α,β-diamio 
acid derivatives (Scheme 12b). The in situ formed acyl-isoquinolinium ion was attacked by the 
enolate at the 1-position of the isoquinoline ring yielding the desired products in high yield 
and enantioselectivities (up to 93% ee).[23] 
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Scheme 12 a) Steglich rearrangement of O-acylated azalactones b) Azlactone addition to isoquinolines. 
As it is demonstrated, the concept of anion-binding catalysis based on NH-bond donors 
represents an important field in organocatalysis and organic synthesis. Various publications 
and reviews can be found in literature,[3, 11, 24] whereby here only a few important works were 
presented.  
1.1.4 O-H Bond Donor Catalysts 
As it can be seen in the previous sections, the enantioselective anion-binding catalysis is 
mostly dominated using (thio)urea-based catalysts. Alternatively, to (thio)ureas, in 2013 
Mattson and co-workers found out that BINOL-based silanediols can not only act as hydrogen 
bond donors but could also be employed as catalysts in halide anion-binding catalysis. They 
applied a BINOL-based silanediol catalyst 19 in an enantioselective acyl-Mannich reaction with 
isoquinolines and obtained good yields and moderate enantioselectivities (up to 50% e.e., 
Scheme 13).[25] 
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Scheme 13 BINOL-based silanediol catalyst in an enantioselective acyl-Mannich reaction with isoquinolines. 
In 2016, the same group reported a silanediol-catalyzed functionalization of chromenones.[26] 
They obtained promising levels of enantiocontrol (up to 56% e.e.) in the addition of silyl ketene 
acetals to benzopyrylium triflates. As it is shown in Scheme 14, silanediol catalyst 20 or 21 can 
bind the triflate anion and build a chiral ion pair. But still, in terms of enantioselectivity they 
could not reach the levels as with the well-established NH-based catalysts (50’s vs. 90’s e.e.). 
 
Scheme 14 Silanediol-catalyzed chromenone functionalization. 
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The small amount of publications of alternative highly enantioselective anion-binding catalysts 
that are not NH-based demonstrates the difficulty in this field. The group of García Mancheño 
is dedicated to the development of a new class of anion binding catalysts based on the 
polarized C-H bonds of triazoles, aiming at opening a new field of C-H bonding. The earliest 
achievements reached in this field will be described in the following chapter. 
 
1.2 Triazoles as Anion-Acceptors  
1.2.1 From N-H to C-H 
As mentioned above, the most common structures in anion-binding catalysis are N-H-based 
catalysts such as e.g. (thio)ureas, squaramides or guanidines. This is because of the strong 
bond polarity, which relies in the great difference between their electronegativities (H: 2.20 
vs. N: 3.07). O-H-bonds also show potential as H-bond donors in anion-binding catalysis due 
to their even higher electronegativitiy difference (O: 3.50).[26-27] In contrast, the use of the less 
polarized C-H-bonds as hydrogen-donor moieties have been neglected, though they represent 
the most common bonds in organic molecules. Thus, some theoretical studies have shown 
that C-H bonds normally presents a binding strength of 50% of the N-H bonds.[28] However, in 
2008 the groups of Flood,[29] Craig[30] and Hecht[31] published at almost the same time different 
triazole-based anion receptors able to coordinate to different anions in their cavity, showing 
a high selectivity for the chloride anion (Figure 2). 
 
Figure 2 Triazole-acceptors developed by the groups of Flood, Craig, and Hecht. 
Flood and coworkers designed triazolophane macrocycles bearing tert-butyl substituents at 
the backbone, which show a very high chloride anion affinity (Ka (1,3±0,3)·105 M-1; G= -7.0 
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kcal·mol-1 in CH2Cl2), even superior to N-H-based anion acceptors. Craig and Hecht developed 
two different foldamers, which adopt a helical conformation by binding to a chloride anion. 
Anion-binding studies suggested a comparable high binding constant to the chloride anion of 
Ka = 1.7·104 M-1 in acetone. Interestingly, all three groups utilized 1,4-disubstituted 1,2,3-
triazoles as principal binding units in their systems. The triazole-moiety presents important 
characteristics such as a relative highly polarized C-H bond[32] and a large dipole moment (e.g. 
µ = 4.38 D) aligned with the C5-H bond,[33] which emphasizes the polarization and a high acidity 
of its C-H bond (e.g. pKa = 27.8 in DMSO for 1-methyl-1H-1,2,3-triazole).[34] Additionally, 
triazoles are easy to synthesize by the well-established “click”-chemistry protocols using a 
Cu(I)-catalyzed azide-alkyne cycloaddition reaction (CuAAC) (Figure 3 a)).[35] Its polarized C-H 
bond, bearing an electropositive hydrogen atom, enables the formation of complexes with 
electronegative species such as anions (C-H···X-) (Figure 3 b)). 
 
Figure 3 a) Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) and b) hydrogen bonding interaction. 
Furthermore, Flood and coworkers found out that intramolecular hydrogen bonds between 
hydroxyl groups and the N3-atom of the triazole led to a preorganized backbone, which 
enhance the affinities of the 1,2,3-triazole acceptors towards Cl- binding. Additionally, flexible 
aryl-triazole oligomers containing the same number or even more C-H bond donor units 
presented weaker binding constants compared to the rigid or rigidized structures (Figure 5).[36] 
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Figure 4 Chloride binding between preorganized and flexible 1,2,3-triazole structures. 
1.2.2 “Click” Bis-Triazoles as Neutral C-H···Anion-Acceptor Organocatalysts 
Considering the exceptional properties of triazoles, the unexplored function of the usually 
neglected 1,2,3-triazole as active group in organocatalysis was employed as a new valuable 
player to the field of anion-acceptor catalysis for the first time by our group.[37] 
Firstly, to determine the binding constants (K), NMR titration studies of various new 
bistriazoles BisTri containing a 1,3-bistriazoylbenzene moiety were carried out (Figure 5a). 
While aliphatic substituents (BisTri1) led to a low binding constant, other bistriazoles, which 
bear different electronically varied aromatic substituents, showed enhanced binding affinities. 
Derivative BisTri5, bearing a 3,5-bis(trifluoromethyl)phenyl group, was identified as the best 
bistriazole chloride anion acceptor (Ka(acetone) = 485 ± 56 M-1). Its binding affinity was improved 
when THF was used as solvent (Ka(THF) = 1417 ± 171 M-1), whereas the use of DCM led to a 
notably lower binding constant (Ka(DCM) = 108 ± 9 M-1). The lower binding affinity of the BisTri2 
bearing an electronpoor perfluorophenyl substituents is in accordance with previous NMR-
studies of thiourea catalysts by Schreiner et al., which showed that the ortho-hydrogens of 
the 3,5-bis(trifluoromethyl)phenyl ring also participate in the binding to a chloride.[38] 
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Figure 5 a) Chloride anion-binding constants: BisTri 1-5 b) Regioisomers influence on the chloride anion-binding 
constants. 
Interestingly, the regioisomer of BisTri5, BisTri6, showed a significantly lower binding 
constant, which indicated that a specific disposition of the triazoles in the structure is 
necessary for an effective chloride binding (Figure 5b). Next, the binding affinity of the best 
acceptor BisTri5 towards different anions was studied. Halide anions showed a decreasing 
binding from chloride to iodide: Cl- (KTHF = 1417±171 M-1) > Br- (KTHF = 438±11 M-1) > I- (KTHF = 
319±24 M-1). In contrast, the weakly coordinating TfO- and BF4- anions did not show any 
interaction with the acceptor. Due to a space limitation in the triazole cavity the binding 
affinity is obviously associated with the size and electronegativity of the anion. The bigger the 
anion, the weaker was the affinity to a halide. A clear anion selectivity of the BisTri5 for a 
chloride anion was obtained in this screening.  
The BisTri5 was then applied to the alkylation of benzylamine 22 with 4-dimethylamino-N-
triphenylmethyl-pyridinium chloride 23 as ionic electrophilic substrate (Scheme 15). This 
reaction was chosen as a model reaction to test the use of the new designed C-H bond-based 
neutral anion-acceptors as organocatalysts. The reaction was carried out with 10 mol% of 
BisTri5 and various amines, yielding the corresponding amine 24 in good yields. Later, by 
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applying BisTri1-5 to the reaction, the correlation of the binding affinity of the triazoles to 
their catalytic activity was confirmed: the higher the chloride binding affinity, the higher the 
yield. 
 
Scheme 15 N-alkylation reaction catalyzed by BisTri 1-5. 
1.2.3 From BisTriazoles to Chiral TetraTriazoles 
The studies of BisTriazoles proved that simple C-H bonds can be effectively used for anion-
binding catalysis.[37, 39] Nevertheless, the demand for the asymmetric version of C-H bond 
donors as anion-binding catalysts was still elusive. As a consequence, in 2014 our group was 
able to report for the first time on chiral helical oligotriazoles as a new class of anion-binding 
catalysts.[40] Based on the results with the BisTri catalysts, they designed extended, flexible 
structures with four triazole units (TetraTri) (Figure 6 a)). Under normal conditions in solution, 
the structure present an equilibrium between the linear and helical conformations. However, 
upon complexation to a chloride anion, a reinforced defined helical system was envisioned 
(Figure 6 b)).  
 
Figure 6 a) Designed triazole-based catalysts b) Chiral helical reinforced conformation for asymmetric anion-
binding catalysis.  
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The fact of introducing another two triazole units into the system gave a few advantages. First, 
the binding affinities are much higher than the ones of the BisTriazoles and second, by 
enhancing the size of the catalyst, the system cannot adopt a fully planar geometry during 
binding the anion like in the case of the BisTriazoles. Instead, a helical geometry is formed like 
it is represented in Figure 6. By introducing the chirality into the TetraTriazole through a chiral 
trans-diamine backbone, the resulting C2-symmetric TetraTriazole-anion complex during the 
reaction can then transfer its chirality information to a target molecule. The effective binding 
to a chloride anion was confirmed by CD (circular dicroism) titration of the tetrakistriazole 
catalyst 25 with tetrabutylammonium chloride (TBACl) as chloride anion source. A strong CD 
effect was observed when increasing the amount of TBACl. This led to the suggestion that 
various possible flexible open-chain conformers might be present in solution. However, upon 
addition and binding to a chloride anion a more rigid chiral helical catalyst-anion complex 
structure is formed, enhancing the population of the less thermodynamically stable catalyst’s 
helical conformation.[31, 41]  
This interesting catalyst system was then introduced in various enantioselective 
dearomatization reactions of heteroarenes. The progress and outcome of these studies will 
be described in the following sections. 
1.3 Preliminary Work on Enantioselective Dearomatization of N-Heteroarenes 
by Anion Binding Catalysis  
Since enantioselective dearomatization reactions of heteroarenes represent a powerful tool 
for the synthesis of bioactive and synthetically valuable chiral heterocycles, there is a great 
interest on the development of new catalytic systems to obtain the desired structures. There 
are various approaches reported in literature for achieving enantioselective dearomatization 
reactions. Those depend on transition metal catalysis,[42] hydration methods,[43] cycloaddition 
reactions,[44] nucleophilic dearomatization[45] and the organocatalyzed dearomatization of 
heterocycles. Since our investigation interest relies on the organocatalytic dearomatization of 
nitrogen and oxygen containing heterocycles, this section should give an overview of the 
state-of-the-art in this field. An interesting dearomatization approach consists in the 
activation of an N-heteroarene employing an acylating agent to generate the corresponding 
N-acyl iminium species.[46] This intermediate could then react with a nucleophile, generating 
a new stereocenter (Scheme 16). 
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Scheme 16 Reissert-type reaction of isoquinolines. 
Pioneer work was done by Shibasaki et al., in which a chiral BINOL-derived aluminium catalyst 
28 was employed in the Reissert reaction of quinolines and isoquinolines, leading to the 
corresponding nitrile products in moderate to good enantioselectivities (66-91% e.e.) (Scheme 
17a).[45b, 45c] This metal-catalyzed method was followed by the already mentioned work of 
Jacobsen and coworkers (Scheme 17b), which implied the thiourea organocatalyst 1 for the 
N-acyl-Mannich reaction of isoquinolines.[9] As shown before, the same N-acyl Mannich 
reaction was later carried out by Mattson et al., employing silandioles 29 and 21 as anion-
binding catalysts, leading to the desired products in moderate yields and 
enantioselectivities.[25] As a further example, the addition of azolactones to isoquinolines 
catalyzed by a thiourea catalyst 30 by Seidel et al. must be mentioned. The dearomatized 
isoquinoline derivatives were obtained in high yields and enantioselectivities (Scheme 17c).[23] 
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Scheme 17 Enantioselective dearomatization by a) Reissert reaction and b) N-acyl Mannich reaction c) 
Azolacton addition to isoquinolines 
New entries for this type of catalytic dearomatization reactions were achieved with our novel 
chiral triazole-based catalysts, which allowed the extension different N-heteroarenes 
including the highly demanding pyridines. These methodologies are presented in more 
detailed the following sections.  
1.3.1 Dearomatization of Quinolines with Chiral Triazole Catalysts 
1,2-Dihydroquinolines are important synthetic intermediates in the preparation of biological 
active compounds.[47] Therefore, and inspired by the seminal work of Jacobsen, the addition 
of silyl ketene acetals 31 to N-acyl iminium quinoline substrates 32 in the presence of catalytic 
amounts of chiral TetraTriazoles was carried out to obtain synthetically valuable 2-substituted 
chiral 1,2-dihydroquinolines 33 (Scheme 18).[40]  
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Scheme 18 Enantioselective dearomatization of quinolines by triazole-based anion-binding catalysis. 
A catalyst screening of different triazole-based catalysts identified 25a as the best catalyst in 
terms of enantioselecivity (96:4 e.r.) (Scheme 19).  
 
Scheme 19 Screening of various triazole catalysts. 
After an initial optimization of the reaction conditions this transformation was applied for a 
wide number of substituted substrates (>16 examples), leading to high enantioselectivities up 
to 98:2 e.r. in the final chiral product. 
1H-NMR titration and Circular dichroism (CD) titration of the catalyst (R,R)-25 with either 
preformed quinolinium chloride or Bu4NCl was carried out to get a better understanding of 
the activity of the TetraTri catalyst. 1H-NMR titration consisted a clear downfield shift of the 
proton signals of the C−H bonds of the triazoles and therefore a cooperative H-bond to the 
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chloride anion can be suggested. By CD spectroscopy conformational changes of structures 
can be observed. The titration curve of a chloride anion to (R,R)-25 (from Bu4NCl) led to the 
assumption of a reinforced catalyst helical structure upon the coordination to a Cl- anion.[40] 
1.3.2 Dearomatization of Isoquinolines 
The triazole-based catalysts 25 could be also applied successfully to the enantioselective 
dearomatization reaction of isoquinolines 34, providing the desired products 35 in good yields 
and moderate to good enantioselectivities (Scheme 20).[48]  
  
Scheme 20 Enantioselective N-acyl Mannich reaction of isoquinolines by triazole-based anion-binding catalysis. 
First, the focus was placed on a detailed catalyst screening. Different BisTriazoles and 
TetraTriazoles with chirality at the centered backbone, and TetraTriazoles and HexaTriazoles 
with chirality at the end-chain were tested. The catalysts bearing the chirality at the central 
backbone were clearly superior to the ones with chirality at the end-chain. Consequently, the 
highest enantioselectivities were induced by the catalysts 25a and 25b presenting four triazole 
and the chiral trans-(R,R)-1,2-diaminocyclohexane unit (aprox. 70:30 e.r., Scheme 21). After 
an optimization of the reaction conditions, various isoquinolines and silyl ketene acetal 
nucleophiles were successfully applied (14 examples, up to 86:14 e.r.). 
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Scheme 21 Family of chiral triazole-based catalysts, with chiral moiety at a) the backbone and b) the end-chain. 
To sum up, a straightforward and enantioselective method for the dearomatization of 
isoquinoline substrates employing triazole-based chiral catalysts was developed. 
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1.3.3. Dearomatization of Pyridines 
Partially hydrogenated pyridines and piperidine derivatives constitute an important class of 
compounds widely present in naturally occurring and synthetic substances with a broad 
bioactive spectrum.[49] Important characteristics of pyridines include their intrinsic 
electrophilic reactivity at both the C2 and the C4 position, which causes an important 
regioselectivity issue. Furthermore, upon nucleophilic attack, the aromaticity of the system 
will be completely broken due to the fact that no other aromatic ring is present like in the 
(iso)quinoline structures. For that reason, reports on this field are still rare and effective and 
selective catalytic processes are still challenging. The direct dearomatization of pyridines via 
the formation of their pyridinium salts represents the most efficient method for the synthesis 
of these kind of enantioenriched products.[45d, 50]  
After the promising results with quinolines and isoquinolines, the dearomatization reaction of 
a more fascinating but also more challenging substrate: the pyridine was studied with the C-
H-bond donor triazole catalyst developed in our group. Thus, we were able to report on a 
highly nucleophilic dearomatization reaction of pyridines with silyl ketene acetals. An effective 
chiral transfer to the final dihydropyridine product was achieved from the in situ formed chiral 
contact ion-pair 39 between the ionic intermediate 38 and the catalyst–anion complex 
(Scheme 22).[51] 
 
Scheme 22 Asymmetric dearomatization of pyridines by triazole-based anion-binding catalysis. 
After an initial optimization of the reaction using 2-picoline 40 as a model substrate, an 
excellent 94:6 regioselectivity towards the C2-addition product 41 was obtained. Moreover, 
the dearomatized product 41 presented an excellent enantiomeric ratio of 98:2. It was shown 
that our C-H-bond donor catalyst 25a was superior to the more common N-H-donor catalysts 
such as thioureas (43a/b) or squaramides (43c), which led to lower regioselectivities in favor 
for the 1,4-addition product 42 and hardly no enantiomeric induction for both regioisomers 
(Scheme 23).  
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Scheme 23 Hydrogen donor catalysts tested in this study. 
Interestingly, the regioisomeric outcome showed a high dependence on the substitution of 
the pyridine substrate. 2- and 4-substituted pyridines showed a preference for the formation 
of the 1,2-addition products, whereby a C3-substitution mainly gave the 1,4-addition product 
or a mixture of the 1,4- and the most crowded 1,2-addition products. 
These reports showed the high potential of the C-H bonds of 1,2,3-triazoles for promoting 
highly enantioselective catalytic reactions. Therefore, the triazole-based anion-binding 
catalysts developed in our research group constitute alternative H-donor structures. The main 
part of this thesis deals with the discovery of new enantioselective transformations employing 
these triazole-based catalysts and it will be extensively discussed in the following chapters 2-
4. 
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Chapter 2 
2. Enantioselective Dearomatization of Diazarenes by Anion-
Binding Catalysis 
 
Abstract: The first anion-binding organocatalyzed enantioselective Reissert-type 
dearomatization of diazarenes has been developed. This reaction represents a synthetic 
challenge since diazarenes have various reactive sites. The use of a chiral tetrakistriazole as a 
C–H-based hydrogen-donor catalyst allowed the straightforward highly regio- and 
enantioselective synthesis of a variety of chiral diazaheterocycles 
 
 
 
 
Parts of this chapter are reprinted with permission from Theresa Fischer, Julia Bamberger, and Olga 
García Mancheño, Org. Biomol. Chem., 2016, 14, 5794 – 5802.[1] Copyright The Royal Society of 
Chemistry 2016; schemes, tables, figures and text may differ from published version. 
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Preliminary work for the dearomatization of diazarenes was already performed: Theresa Fischer, 
Master Thesis, University of Regensburg 2015. 
 
Author contribution: 
Theresa Fischer:   80% of reproduced part: Initial optimization, catalyst screening, screening of 
the acylating agent and silyl ketene acetal, scope of the reaction with various 
diazarenes, 50% of the derivatization of 5a 
Julia Bamberger:  20% of the screening of the acylating agent (Table 3); 50% of the 
derivatization of 5a (Scheme 6) 
Olga García Mancheño: corresponding author  
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2.1 Introduction  
Chiral diazaheterocycles and their partial unsaturated derivatives are important naturally 
occurring substances and building blocks for the synthesis of bioactive compounds with a 
broad activity spectrum.[2] A few examples of relevant natural and synthetic bioactive di-
nitrogen-containing chiral hetero- cycles are shown in Fig. 1.  
 
Figure 1 Representative dugs and bioactive pyridine-derived or di-N-heterocycles. 
Among some interesting quinazoline derivatives, letermovir[3] is one of the top-selling antiviral 
drugs developed for the treatment of Cytomegalovirus infections and the alkaloid vasicine[4] 
is a cardiac-depressant. Moreover, based on a pyrazine moiety, matlystain B shows 
collagenase inhibitor properties.[5] Other di- or tetrahydrostructures based on diazarenes such 
as quinoxaline, naphthyridine or phthalazine present relevant biological activities such as CETP 
inhibition against atherosclerosis,[6] anti-dyslipidemia[7] or dihydrofolate reductase inhibition 
towards antibiotic-resistant Gram-positive bacteria.[8] Despite the great diversity of 
applications of chiral diazaheterocycles, there is still a demand of simple, mild and direct 
synthesis methods. Most of the common routes to chiral diazaheterocycles require long and 
tedious synthesis from chiral starting materials and normally involve the generation of at least 
one of the N-heterocyclic rings.[2] A more appealing and straightforward approach consists of 
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the enantioselective dearomatization of readily available diazarenes.[9] In this regard, the main 
method for inducing chirality relies on catalyzed asymmetric hydrogenation reactions of 
substituted azarenes,[10] for which several transition metal-catalyst systems consisting of 
rhodium, iridium or ruthenium complexes have been developed in the last past decades 
(Scheme 1).[10] A breakthrough in asymmetric hydrogenation of aromatics was done by 
Bianchini and his group in 1998. They reported on a hydrogenation of 2-methyl-quinoxaline 
catalyzed by a ortho-metalated dihydride iridium complex (Scheme 1). Later a lot of work was 
done in this field, yielding the dearomatized products in good enantioselectivities.[10] 
 
Scheme 1 Transition metal – catalyzed asymmetric hydrogenation of quinoxalines. 
More recently, many efforts have been set to overcome the need of transition metals. 
Consequently, in 2010 Rueping et al. first developed an organocatalytic transfer 
hydrogenation approach to the synthesis of tetrahydroquinoxalines.[11] 2-Arylquinoxalines 
were hence reacted with Hantzsch esters upon activation with catalytic amounts of a chiral 
BINOL-phosphate as catalyst to provide the corresponding tetrahydroquinoxalines in good 
yields (73-98%) and excellent enantioselectivities (80-98% ee) (Scheme 2). However, applying 
these reaction conditions to alkyl-substituted quinoxalines resulted in lower 
enantioselectivities (up to 64% ee). 
 
Scheme 2 Organocatalyzed asymmetric transfer hydrogenation of quinoxalines. 
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Besides asymmetric hydrogenation, the enantioselective nucleophilic addition to N-
heteroarenes represents a powerful tool towards the dearomatization of such systems. 
Several methods based on this approach have been developed for mono N-heteroarenes,[9c, 
12] however, to the best of our knowledge only one example for diazarenes has been described 
to date. The group of You reported an iridium-catalyzed intramolecular asymmetric allylic 
dearomatization reaction of pyrazines. 6,7-dihydropyrrolo[1,2-a]pyrazine derivatives were 
obtained with excellent yields (up to 95%) and enantioselectivity (up to 97% ee) (Scheme 3).[13] 
 
Scheme 3 Asymmetric allylic dearomatization. 
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2.2 Objectives 
In this chapter, we aimed at developing an efficient, highly regio- and enantioselective 
dearomatization methodology for diazarenes based on an anion-binding catalysis. 
The fact that there are only scarce both metal- and organocatalytic enantioselective 
examples in this field could be explained due to the presence of a larger number of reactive 
sites of diazarenes and therefore the possible generation of a complex mixture of products, 
which makes the dearomatization of this type of compounds highly challenging (Figure 2).  
 
Figure 2 Reactive sites of diazarenes. 
Recently, we have described the use of a family of triazole- based H-bond donors[14] as efficient 
anion-binding catalysts[14c, 15] for the asymmetric nucleophilic dearomatization of N-
heteroarenes, such as isoquinolines, quinolines and pyridines.[16] Therefore, in order to 
accomplish our envisioned catalytic asymmetric synthesis of chiral diaza-heterocycles, we 
decided to explore these H-donor catalysts for the related dearomatization of various types 
of 6-membered ring-containing diazarenes (Scheme 4).  
 
Scheme 4 Asymmetric dearomatization of diazarenes by anion-binding catalysis. 
To achieve the main goal of this chapter, the following points will be addressed: 
- Optimization of the reaction conditions: Screening of various chiral H-donor catalysts, acylating 
agents and the silyl ketene acetals  
- Study of the scope of the reaction with various diazarenes 
- Further derivatization reactions of the obtained chiral diaza-heterocycles  
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2.3 Results and Discussion 
2.3.1 Initial Optimization Experiments  
Our studies started with the optimization of the reaction of quinazoline (3a) as model 
substrate and with silyl ketene acetal 4a as nucleophile (Table 1). Various chiral H-donor 
catalysts such as tetrakistriazole 1a,[14] Jacobsen’s thiourea 2a,[16] squaramide 2b[17] and 
bifunctional thiourea-cinchona alkaloid 2c[18] were initially explored (entries 2-5). Following 
previously reported procedures,[14,16] the required ionic substrate, quinazolinium chloride salt, 
was generate in situ by acylating 3a with 2,2,2-trichloroethyl chloroformate (TrocCl) in MTBE 
at 0 °C for 30 min. Subsequent addition of the H-donor catalyst 1 or 2 and 4a at −78 °C (allowing 
the reaction mixture to warm up to room temperature overnight) delivered the dearomatized 
products 5-7. 
It is worth mentioning that there was an appreciable background reaction in the absence 
of a catalyst (entry 1, 56%). Fortunately, the heterocycle 5a was formed regioselectively along 
with small amounts of 6a (91:9, 5a:6a) and not observing the formation of the other possible 
isomer 7a. The catalytic reactions also showed a similar excellent regioselectivity towards 5a. 
From the catalysts tested in this study (entries 2–5), the triazole-based H-donor 1a proved to 
be the most efficient in terms of both reactivity and enantioselectivity. Thus, 5a was obtained 
in 65% yield and 96:4 er (entry 2), whereas the other catalysts delivered the dearomatized 
product in significantly low yields (13–34%) and low to moderate enantiomeric inductions 
(45:55–61:39 er).  
The change to other ethereal solvents such as Et2O was not beneficial, hampering the 
enantioselectivity (84:16 er, entry 6). When the reaction was carried out at a continuous 
temperature of −78 °C, the same enantiomeric ratio (96:4 er, entry 7) was obtained. A similar 
procedure at −40 °C led to 5a in a lower 86:14 er (entry 8). Lastly, the use of 5 mol% of catalyst 
1a provided an inferior chiral induction (91:9 er, entry 9). Therefore, 10 mol% of catalyst 
loading and a slow temperature gradient (from −78 °C to r.t.) were employed as optimal 
conditions for further studies. 
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Table 1 Optimization of the reaction with 3a as a model substrate.[a] 
 
Entry  Catalyst  Solvent  T. (°C) Yield (%)[b] 5a:6a:7a[c] 5a, e.r.[d] 
1 -- MTBE -78 - rt 56 91:9:--[e] -- 
2 1a MTBE -78 - rt 65 92:8:--[e] 96:4  
3 2a MTBE -78 - rt 34 92:8:--[e] 61:39  
4 2b MTBE -78 - rt 21 92:8:--[e] 46:54  
5 2c MTBE -78 - rt 13 92:8:--[e] 45:55  
6 1a Et2O -78 - rt 61 91:9:--[e] 84:16  
7 1a MTBE -78 88 92:8:--[e] 96:4 
8 1a MTBE -40 54 92:8:--[e] 86:14  
9 1a MTBE -78 - rt 66 92:8:--[e] 91:9[f]   
[a] Conditions: i) 3a (1 eq.) and TrocCl (1 eq.) were stirred in the appropriate dry solvent at 0 °C for 30 min; then 
ii) catalyst 1 or 2 (10 mol%) and 4a (2 eq.) were added at -78 °C and stirred for 18 h while allowing to reach slowly 
rt. [b] Isolated yield. [c] Isomeric ratios determined by 1H-NMR of the crude reaction. [d] Enantiomeric ratios 
determined by chiral HPLC. [e] Isomer 7a was not detected by NMR. [f] Reaction using 5 mol% of catalyst 1a. 
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2.3.2 Screening of the Acylating Agent  
The screening of the acylation reagents was next carried out (Table 2). Besides TrocCl (entry 
1), benzylchloroformate (CbzCl) was successfully employed in the reaction. However higher 
yields could be obtained with this acylating agent (65% vs.71%) a significant drop from 
96:4 e.r. with TrocCl to 60: 40 e.r. with CbzCl, in the enantioinduction was observed (entry 2). 
Methoxycarboxylic chloride could also be employed as acylating reagents (entry 3) but, an 
inseparable mixture of 5ac, 6ac and starting material 3a was obtained which made analyzation 
of the yield and enantiomeric ratio impossible. Additionally, in terms of regioselectivitiy TrocCl 
was superior compared to methoxycarboxylic chloride (98:2 vs 84:16) and was therefore used 
as the acylating agent of choice in further studies. 
Table 2 Screening of the acylating agent[a] 
 
Entry  R1COCl Product 5 Yield (%)[b] 5a:6a [c] 5a, e.r.[d] 
1 TrocCl 
 
65 98:2 96 :4  
2 CbzCl 
 
71 n.d. 60:40  
3 MeOCOCl 
 
n.d.[e] 84:16 n.d. [e] 
[a] Conditions: (i) 3a (1 eq.) and R1COCl (1 eq.) were stirred in dry MTBE at 0 °C for 30 min; then (ii) catalyst 1a 
(10 mol%) and 4 (2 eq.) were added at −78 °C and stirred for 18 h while allowing to reach slowly rt. [b] Isolated 
yield. [c] Isomeric ratios 5:6 determined by 1H–NMR of the crude reaction. [d] Enantiomeric ratios determined 
by chiral HPLC. [e] An inseparable mixture of 5ac, 6ac and staring material 3a. n.d. = not determined 
2.3.3 Screening of the Nucleophile Silyl Ketene Acetal  
Having identified TrocCl as optimal acylating agent, the effect of the substitution at the silyl 
ketene acetals 4 on the reactivity and enantioselectivity of the reaction was investigated 
(Table 3). Silyl ketene acetals 4 derived from acetic acid presenting different substitution such 
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as the less hindered MeO (4b, entry 2) or the bulkier tBuO (4c, entry 3) groups, as well as a 
propionic acid derivative (4d, entry 4) were then explored. Moderate to good 
enantioselectivities were achieved (72:28 to 88:12 er), where the initial iPrO-substituted 
ketene acetal 4a remained the most efficient nucleophile (entry 1). 
Table 3 Screening of the silyl ketene acetal 4[a] 
 
Entry  4, R2/R3 Product 5 Yield(%)[b] 5a:6a [c] 5a, e.r.[d] 
1 iPr/H 
 
65 98:2 96 :4 
2 Me/H 
 
72 94:6 72 :28 (94:6)[e] 
3 tBu/H 
 
62 95:5 83 :17 (95:5)[e] 
4 Et/Me 
 
91 
>95:5 
[5:1 dr][e] 
88 :12 (major) 
73 :27 (minor) 
[a] Conditions: (i) 3a (1 equiv.) and R1COCl (1 equiv.) were stirred in dry MTBE at 0 °C for 30 min; then (ii) catalyst 
1a (10 mol%) and 4 (2 equiv.) were added at −78 °C and stirred for 18 h while allowing to reach slowly rt. [b] 
Isolated yield. [c] Isomeric ratios 5:6 determined by 1H–NMR of the crude reaction. [d] Enantiomeric ratios 
determined by chiral HPLC. [e] Reaction with a 1:0.8 isomeric mixture of silyl ketene acetal 4d. The 
diastereomeric ratio of 5af was determined by 1H-NMR of the crude reaction.  
2.3.4 Scope of the Reaction with Various Diazarenes 
Based on these results, the screening of the substrate scope was next carried out with catalyst 
1a, TrocCl, silyl ketene acetal 4a and several representative, readily available mono- and 
bicyclic diazarenes in MTBE (Table 3). The study continued with the dearomatization of the 
analogous diazarene quinoxaline (3b), which also presents both nitrogen atoms in the same 
aromatic unit (entry 1). Although this substrate reminds of the structure of quinoline, only a 
complex mixture was obtained, in which the double addition of the TrocCl to both nitrogen 
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atoms could also be observed. The dearomatization of the highly symmetric phthalazine (3c), 
exhibiting only one equivalent reactive α-position, yielded compound 5c in a good 93% yield 
and 76:24 enantiomeric ratio (entry 2).  
Table 4. Scope of the reaction with various diazarenes[a] 
 
Entry Diazarene 3 Products 5 / 6  yield (%)[b] [5:6][c] 5, e.r.[d] 6, e.r.[d] 
1 
  
5b, Decomp. -- -- 
2 
 
 
5c, 93% (45%)[e] 
76:24 
(79:21)e 
-- 
3 
 
 
5d, 86%  
6d, 5% 
[95:5] 
83:17 62:38 
4 
  
5e, 56%[f] 80:20 -- 
5 
  
5f, 74% (38%)[e] 
63:37 
(61:39)[e] 
-- 
6 
 
 
5g, 87% 
6g, 6%  
 [94:6] 
73:27 52:48 
7 
  
5h, 72%, 66:34 -- 
[a] Conditions: (i) 3 (1 eq.) and TrocCl (1 eq.) were stirred in dry MTBE at 0 °C for 30 min; (ii) catalyst 1a (10 mol%) 
and 4 (2 eq.) were added at −78 °C and stirred for 18 h while allowing to reach slowly rt. [b] Isolated yield. [c] 
Isomeric ratios determined by 1H NMR. [d] Enantiomeric ratios determined by chiral HPLC. [e] Reaction at −78 °C 
in brackets. [f] Other possible isomers were not detected by NMR.  
Chapter 2 
44 
In the case of 1,5-naphthyridine (3d), which has one nitrogen atom in each ring, the 
challenge was again the control of the regioselectivity since both the C4 and C2 positions of 
each heteroaromatic ring are prone to nucleophilic addition (entry 3). A good regioselectivity 
of 95:5 was obtained in favor of the desired C2-addition product 5d. After the separation from 
the minor 4-addition product 6d, compound 5d was obtained in an 86% yield and a good 83:17 
enantiomeric ratio.  
Next, 1,6-naphthyridine (3e) was explored as a substrate (entry 4). Since this compound 
contains both the quinoline and the isoquinoline unit, it was interesting to get a deeper 
understanding about the reactivity, regioselectivity and enantioselectivity of this type of 
mixed structure. Due to the higher intrinsic reactivity of the benzylic position within the 
isoquinoline core, a high regioselectivity could be expected. Consequently, 5e was obtained 
as a single isomer and with high enantioselectivity (80:20 er).  
The reaction with methyl-substituted 1,8-naphthyridine (3f) proceeded smoothly, 
providing exclusively compound 5f in a good 74% yield and a significantly lower 
enantioselectivity (63:37 er, entry 5). This unexpected result compared to other 
naphthyridines cannot be easily rationalized, since in the previous work the related 
monoazarene quinolines provided very high enantioselectivities for this type of reaction 
(typically >95:5 er).[15a]  
As the dearomatization of the bicyclic diazarenes showed a good performance and a 
moderate to excellent enantioselectivity, a more challenging six-membered monocyclic 
heteroarene was next explored. Pyridazine (3g) was again nicely enrolled in the catalytic 
dearomatization reaction, providing a good 93% overall yield and a 94:6 mixture of the 2- (5g) 
and 4-addition (6g) products (entry 6). Remarkably, an acceptable 73:27 enantiomeric ratio 
was obtained for the more interesting 2-addition product 5g, whereas for the minor 
regioisomer 6g an almost racemic compound was formed. This can be explained by the greater 
distance of the newly introduced stereocenter at the C4 with respect to the C2 position to the 
positive nitrogen present in the key ionic intermediate. Consequently, the catalyst-chloride 
anion complex should stay near the nitrogen atom and therefore, the chirality transfer might 
be more efficient in the adjacent C2-position.  
Lastly, the reaction with a five membered diazarene was carried out. Thus, N-methyl 
benzimidazole provided the desired dearomatized heterocycle 5h in a good yield and 
moderate enantioselectivity (72%, 66:34 er; entry 7). 
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The reaction with other diazarenes such as 6-membered ring pyrazine and 5-
bromopyrimidine, or five-membered derivatives N-methyl imidazole and N-methyl pyrazole 
also proceeded. Unfortunately, the products showed a high instability and they could not be 
isolated pure, leading to a complex mixture of decomposition products (Table 5). 
Table 5 Reaction with various 5- and 6-membered diazarenes. 
 
Entry Diazarene 3 Products 5 / 6  yield (%)[b] [5:6][c] 5, e.r.[d] 6, e.r.[d] 
1 
  
5i, Decomp. -- -- 
2 
  
5j, Decomp. -- -- 
3 
 
 
5k, Decomp. -- -- 
4 
  
5l, Decomp. -- -- 
[a] Conditions: (i) 3 (1 eq.) and TrocCl (1 eq.) were stirred in dry MTBE at 0 °C for 30 min; (ii) catalyst 1a (10 mol%) 
and 4 (2 eq.) were added at −78 °C and stirred for 18 h while allowing to reach slowly rt. [b] Isolated yield. [c] 
Isomeric ratios determined by 1H NMR. [d] Enantiomeric ratios determined by chiral HPLC.  
2.3.5 Absolute Configuration 
Succeeding the reaction scope’s study, we were interested in determining the absolute 
configuration of the obtained new C-stereocenters. Unfortunately, most of the products 
resulted oils, hampering obtaining crystals for their X-ray structural analysis. However, we 
could assume the same behavior of the catalyst (R,R)-1a as in the reactions of the related 
mono-azarenes. Thus, the absolute configuration (R) was assigned for the products 5 and 6 by 
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comparison with the one previously obtained for quinolines, pyridines and isoquinolines as 
substrates (Figure 3).[16] 
 
Figure 3 Absolute configuration of diazarenes, quinolines, pyridines and isoquinolines obtained with catalyst 
(R,R)-1a. 
2.3.6 Scale-up Reaction and Catalyst Recycling  
The developed methodology proved to be very robust, allowing the scaling up of the reactions. 
Consequently, the enantioselective dearomatization of the model substrate 3a could be 
scaled-up to approximately 40 times (0.5 g scale) without any significant detriment of the 
enantioselectivity of the reaction (92:8 er vs. 96:4 er, 3.9 vs. 0.1 mmol scale; respectively). 
Moreover, the catalyst could be re-isolated in a good 74% yield and reused, delivering the 
same reactivity and stereochemical results (Scheme 5). 
 
Scheme 5 Reaction scale-up and catalyst recycling. 
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2.3.7 Derivatization of Diazarene Compounds 
Finally, the synthetic utility of this method was demonstrated by the derivatization of 5a. 
These reactions were carried out in cooperation with Julia Bamberger. Thus, the 
corresponding tetrahydroderivative 8 was synthesized by reduction with NaBH4 in the 
presence of B(OH)3.[17] The reduction of 5a with common reduction procedures like Et3SiH/TFA 
or the H2–Pd/C system under various conditions did not occur or lead to decomposition 
products. The dimethyl derivative 9 by trans-esterification with in situ generated KOMe with 
K2CO3 in MeOH (Scheme 6). Moreover, the Troc protecting group could easily be removed 
from 5a using Zn and NH4OAc at room temperature, providing the corresponding N-
deprotected product 10 in 97% yield. 
  
Scheme 6 Derivatization of the quinazoline derivative 5a. 
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2.4 Conclusion  
In conclusion, the first enantioselective nucleophilic dearomatization of diazarenes under mild 
and metal free conditions, using an anion-binding organocatalysis approach has been 
developed. Tetrakistriazole-based H-bond donor catalysts were superior to the more common 
N-H-based hydrogen-bond donors, providing the corresponding products in high 
enantioselectivities up to 96:4 e.r. Furthermore, we overcame the regioselectivity problems, 
which are present in the diazarenes due to a larger number of reactive sites. By formation of 
a close chiral anion pair between the catalyst and the in situ generated N-acyldiazarene highly 
regioselective dearomatization products were obtained. The great substrate scope 
demonstrated that the reaction could be nicely enrolled into almost every kind of diazarene 
accepting various positions of the two nitrogen heteroatoms in the ring. 
 
The absolute configuration was determined as (R) for the products 5 and 6 by comparison with 
the one previously reported dearomatized products of quinolines, pyridines and isoquinolines 
as substrates. Finally, the utility of the method was demonstrated by derivatizing the obtained 
dearomatized products. The rapid access to substituted chiral di- or tetrahydro 
diazaheterocycles by the new class of tetrakistriazole-based H-bond donor catalysts was 
clearly constituted. 
This work encouraged us to further investigate this kind of C-H-based chiral catalysts in 
reactions with other substrates or different nucleophiles such as the interesting phosphorous- 
or sulfur-nucleophiles.  
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2.5 Experimental Part 
2.5.1 General Information and Analytical Techniques 
1H- and 13C-NMR spectra were recorded in CDCl3 (reference signals: 1H = 7.26 ppm, 13C = 77.16 
ppm) on a Bruker ARX-300 and a Varian AV-300, 400 or 600 MHz. Chemical shifts (δ) are given 
in ppm and spin–spin coupling constants (J) are given in Hz. Analytical thin layer 
chromatography was performed using silica gel 60 F254 and a solution of KMnO4 served as 
the staining agent. Column chromatography was performed on silica gel 60 (0.040–0.063 mm). 
Exact masses (HRMS) were recorded on an Agilent Q-TOF 6540 UHD spectrometer using 
electro- spray (ES) or chemical (CI) ionization techniques. Chiral High-Pressure Liquid 
Chromatography (HPLC) analyses were per- formed on an Agilent 1200 series instrument. 
MTBE and Et2O were distilled and dried over Na. The catalysts 1a[16] and 2a–c,[17,18] and the 
silyl ketene acetals 4,[16a,17] were prepared following the known literature procedures. The 
starting materials and other commercially available reagents were used without further 
purification. 
2.5.2 General Organocatalytic Procedure 
 
The diazarene 3 (0.10 mmol, 1.0 eq.) was dissolved in freshly distilled anhydrous MTBE (1 mL, 
0.1 M) and cooled to 0 °C. After the addition of 2,2,2-trichloroethyl chloroformate (14 µL, 0.10 
mmol, 1.0 eq.), the reaction was stirred for 30 min at 0 °C and then cooled to −78 °C. Isopropyl 
TBS-ketene acetal 4a (51 µL, 0.20 mmol, 2.0 eq.) and the catalyst 1a (11.2 mg, 0.01 mmol, 10 
mol%) were added and the reaction mixture was stirred overnight, which was allowed to 
warm slowly to room temperature during that time. The crude mixture was purified by flash 
column chromatography (petrol ether/EtOAc 10:1) to obtain the desired addition product. 
2.5.3 Analytical Data for Compounds 5 and 6 
2,2,2-Trichloroethyl (R)-2-(2-isopropoxy-2-oxoethyl)quinazoline-1(2H)-carboxylate (5a). 
Quinazoline (3a) (13.0 mg, 0.100 mmol, 1.0 eq.), TrocCl, catalysts 1a and 
4a were added according to the general procedure, leading to a 98:2 
mixture of 5a and 6a. The main product 5a (26.5 mg, 0.065 mmol, 65%) 
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was isolated by column chromatography. The enantiomeric ratio was determined as 96:4 er 
by chiral HPLC [Chiralcel OJ-H, hexane/iPrOH (98:2), 1.0 mL min−1, λ =300 nm: tr (minor): 14.0 
min, tr (major): 22.2 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : −91.5 (c 0.1, CHCl3). 1H NMR (400 MHz, CDCl3): δ 8.08 (s, 
1H), 7.36–7.31 (m, 2H), 7.25–7.15 (m, 2H), 5.77–5.60 (m, 1H), 5.14–4.75 (m, 3H), 2.81–2.70 
(m, 1H), 2.70–2.58 (m, 1H), 1.16 (d, J = 6.3 Hz, 3H), 1.13 (d, J = 6.3 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 168.9, 150.8, 140.7, 138.7, 129.2, 127.7, 126.1, 126.2, 124.8, 94.3, 75.7, 68.6, 50.7, 
41.8, 21.7, 21.6; HRMS (ESI): m/z calculated for [C16H18Cl3N2O4]+: 407.0327; found 407.0333. 
 
Benzyl (R)-2-(2-isopropoxy-2-oxoethyl)quinazoline-1(2H)-carboxylate (5ab).  
Quinazoline (3a) (13.0 mg, 0.100 mmol, 1.0 eq.), benzylchloroformate 
(14.2 µL, 0.100 mmol, 1.0 eq.), catalyst 1a and 4a were added according to 
the general procedure, leading to the desired product 5ab (26.1 mg, 0.071 mmol, 71%). The 
enantiomeric ratio was determined as 60:40 er by chiral HPLC [Chiralcel OJ-H, hexane/iPrOH 
(98:2), 1.0 mL min−1, λ = 300 nm: tr (minor): 26.6 min, tr (major):  38.2 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : −13.2 (c 
0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 8.07 (s, 1H), 7.44–7.35 (m, 5H), 7.32–7.28 (m, 2H), 
7.19 (m, 2H), 5.66 (t, J = 6.3 Hz, 1H), 5.32 (d, J = 3.5 Hz, 2H), 4.97–4.84 (m, 1H), 2.63 (m, 2H), 
1.14 (d, J = 5.9 Hz, 3H), 1.12 (d, J = 6.3 Hz, H); 13C NMR (100 MHz, CDCl3): 169.1, 145.6, 141.8, 
134.8, 129.1, 128.9, 128.8, 128.4, 127.4, 126.1, 125.9, 125.0, 69.0, 68.5, 50.5, 42.0, 29.7, 21.6; 
HRMS (ESI): m/z calculated for [C21H23N2O4]+: 367.1652; found 367.1658. 
 
Methyl (R)-2-(2-isopropoxy-2-oxoethyl)quinazoline-1(2H)-carboxylate (5ac).  
Quinazoline (3a) (13.0 mg, 0.100 mmol, 1.0 eq.), MeOCOCl (7.7 µL, 0.100 
mmol, 1.0 eq.), catalyst 1a and 4a were added according to the general 
procedure, leading to an inseparable mixture of the desired product 5ac, 
the 4-addition by-product 6ac and the starting material.  
 
2,2,2-Trichloroethyl (R)-2-(2-methoxy-2-oxoethyl)quinazoline-1(2H)-carboxylate (5ad). 
Quinazoline (3a) (13.0 mg, 0.100 mmol, 1.0 eq.), TrocCl, catalyst 1a and 
the silyl ketene acetal 4b (45.0 µL, 0.200 mmol, 2.0 eq.) were added 
according to the general procedure, leading to the desired product 5ad (27.2 mg, 0.072 mmol, 
72%). The enantiomeric ratio was determined as 72:28 er by chiral HPLC [Chiralcel OJ-H, 
hexane/iPrOH (98:2), 1.0 mL min−1, λ = 300 nm: tr (minor): 28.0 min, tr (major): 36.7 min]. 
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[𝛂]𝟓𝟖𝟗
𝟐𝟎 : −39.6 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 8.03 (s, 1H), 7.29 (m, 2H), 7.20–7.08 
(m, 2H), 5.65 (t, J = 6.2 Hz, 1H), 4.87 (s, 2H), 3.58 (s, 3H), 2.68 (s, 2H); 13C NMR (100 MHz, 
CDCl3): δ 169.8, 147.1, 138.7, 129.3, 127.8, 126.4, 126.1, 124.8, 94.3, 75.7, 52.1, 50.7, 29.7; 
HRMS (ESI): m/z calculated for [C14H14Cl3N2O4]+: 379.0014; found 379.0019. 
 
2,2,2-Trichloroethyl (R)-2-(2-(tert-butoxy)-2-oxoethyl)quinazoline-1(2H)-carboxylate (5ae). 
Quinazoline (3a) (13.0 mg, 0.100 mmol, 1.0 eq.), TrocCl, catalyst 1a and 
the silyl ketene acetal 4c (54.0 µL, 0.200 mmol, 2.0 eq.) were added 
according to the general procedure, leading to the desired product 5ae 
(26.2 mg, 0.062 mmol, 62%). The enantiomeric ratio was determined as 83:17 er by chiral 
HPLC [Chiralcel OJ-H, hexane/iPrOH (98:2), 1.0 mL min−1, λ = 300 nm: tr (minor): 13.90 min, tr 
(major): 21.4 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : −1.7 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 8.09 (s, 1H), 7.36–
7.30 (m, 2H), 7.24–7.16 (m, 2H), 5.62 (t, J = 11.8, 1H), 4.91 (s, 2H), 2.80–2.53 (m, 2H), 1.35 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ 168.6, 150.9, 138.7, 129.2, 127.7, 126.3, 124.9, 94.4, 81.5, 
75.7, 50.8, 40.9, 27.9; HRMS (ESI): m/z calculated for [C17H20Cl3N2O4]+: 421.0483; found 
421.0487. 
 
2,2,2-Trichloroethyl (R)-2-(1-ethoxy-1-oxopropan-2-yl)quinazoline-1(2H)-carboxylate (5af). 
Quinazoline (3a) (26.0 mg, 0.20 mmol, 1.0 eq.), TrocCl, catalyst 1a and 
the silyl ketene acetal 4d (150.0 µL, 0.20 mmol, 2.0 equiv.; 1:0.8 E/Z 
mixture) were added according to the general procedure, leading to the desired product 5af 
(74.5 mg, 0.18 mmol, 91%) as a 5:1 mixture of diastereomers. The enantiomeric ratio was 
determined as 88:12 er for the major diastereoisomer and 73:27 for the minor 
diastereoisomer by chiral HPLC [Chiralcel OD-H, hexane/iPrOH (95:5), 1.0 mL min−1, λ = 290 
nm: major isomer: tr (minor): 9.23 min, tr (major): 16.54 min; minor: tr (minor): 7.78 min, tr 
(major): 11.76 min]. 1H NMR (300 MHz, CDCl3) (major): δ 8.13 (s, 1H), 7.33 (d, J = 3.9 Hz, 2H), 
7.21 (m, 1H), 7.02 (d, J = 7.3 Hz, 1H), 5.70 (bs, 1H), 5.03–4.79 (m, 2H), 4.15 (q, J = 7.1 Hz, 2H), 
2.89 (bs, 1H), 1.27 (t, J = 7.2 Hz, 3H), 0.99 (d, J = 7.1 Hz, 3H); 1H NMR (300 MHz, CDCl3) (minor): 
δ 8.11 (s, 1H), 7.33 (d, J = 3.9 Hz, 2H), 7.21 (m, 1H), 7.12 (d, J =7.5 Hz, 1H), 5.54 (bs, 1H), 5.03–
4.77 (m, 2H), 4.07–3.95 (m, 2H), 2.80–2.69 (m, 1H), 1.15 (t, J = 4.5 Hz, 3H), 0.89 (d, J = 6.8 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ 172.8, 172.2, 172.1, 151.4, 141.3, 139.4, 129.3, 129.2, 127.6, 
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126.6, 126.5, 126.2, 126.1, 94.3, 75.8, 75.7, 61.1, 55.3, 46.6, 24.0, 14.2, 14.0; HRMS (ESI): m/z 
calculated for [C16H18Cl3N2O4]+: 407.0327; found 407.0329. 
 
2,2,2-Trichloroethyl (R)-1-(2-isopropoxy-2-oxoethyl)phthalazine-2(1H)-carboxylate (5c) 
Phthalazine (3c) (13.0 mg, 0.100 mmol, 1.0 eq.), TrocCl, catalysts 1a and 4a 
were added according to the general procedure, leading to the desired 
product 5c (38 mg, 0.093 mmol, 93%). The enantiomeric ratio was determined 
as 76:24 er by chiral HPLC [Chiralcel OD-H, hexane/iPrOH (99 :1), 1.0 mL min−1, λ = 290 nm: tr 
(minor): 44.4 min, tr (major): 46.8 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : −145.0 (c 0.1, CHCl3). 1H NMR (300 MHz, 
CDCl3): δ 7.81 (bs, 1H), 7.56–7.38 (m, 2H), 7.36–7.29 (m, 2H), 5.97 (t, J = 7.1 Hz, 1H), 5.12–5.00 
(m, 1H), 4.94 (sept, J = 6.3 Hz, 1H), 4.90–4.81 (m, 1H), 2.83–2.50 (m, 2H), 1.20 (d, J = 6.2 Hz, 
3H), 1.11 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 168.9, 145.1, 144.2, 132.4, 132.0, 
128.9, 126.5, 126.3, 123.2, 95.0, 75.6, 68.5, 50.7, 39.5, 21.7, 21.7; HRMS (ESI): m/z calculated 
for [C16H18Cl3N2O4]+: 407.0327; found 407.0333. 
 
2,2,2-Trichloroethyl (R)-2-(2-isopropoxy-2-oxoethyl)-1,5-naphthyridine-1(2H)-carboxylate 
(5d) and 2,2,2-trichloroethyl 4-(2-isopropoxy-2-oxoethyl)-1,5-naphthyridine-1(4H)-
carboxylate (6d) 
1,5-Naphthyridine (3d) (13.0 mg, 0.100 mmol, 1.0 eq.), TrocCl (13.8 µL, 0.100 mmol, 1.0 eq.), 
1a (11.2 mg, 0.010 mmol, 10 mol%) and the silyl ketene acetal 4 (51.0 µL, 0.200 mmol, 
2.0 equiv.) were added according to the general procedure, leading to a 6:1 mixture of 5d and 
6d. The mixture of isomers were separated and isolated by flash column chromatography 
(petrol ether/EtOAc 10:1) to yield the 2-addition product 5d (35.6 mg, 0.087 mmol, 87%) and 
the 4-addition 6d (2.0 mg, 0.005 mmol, 5%).  
5d: The enantiomeric ratio of was detemined as 83:17 e.r. by chiral HPLC 
[Chiralcel OD-H, hexane/iPrOH (98:2), 1.0 mL min−1, = 280 nm: tr (minor): 
13.8 min, tr (major): 29.7 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -147.2 (c 0.1, CHCl3); 1H NMR (300 MHz, CDCl3): δ 8.33 
(d, J = 4.6 Hz, 1H), 8.01 (bs, 1H), 7.19 (dd, J = 8.3, 4.8 Hz, 1H), 6.75 (d, J = 9.9 Hz, 1H), 6.43 (dd, 
J = 9.8, 5.8 Hz, 1H), 5.53 (dd, J = 13.4, 6.9 Hz, 1H), 5.01 (bs, 1H), 4.97 (sept, J = 6.3 Hz, 1H), 4.72 
(bs, 1H), 2.60-2.40 (m, 2H), 1.17 (d, J = 8.9 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 169.1, 152.0, 
145.7, 132.3, 127.3, 122.5, 94.8, 75.6, 68.5, 50.2, 38.9, 21.8, 21.7; HRMS (ESI): m/z calculated 
for [C16H18Cl3N2O4]+: 407.0327; found 407.0332. 
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6d: The enantiomeric ratio of was detemined as 62:38 e.r. by chiral HPLC 
[Chiralcel OD-H, hexane/iPrOH (98:2), 1.0 mL/min, = 230 nm: tr (minor): 8.9 
min, tr (major): 9.7 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : +4.8 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): 
δ 8.43 (d, J = 8.5 Hz, 1H), 8.37 (dd, J = 4.7, 1.4 Hz, 1H), 7.21 (dd, J = 8.4, 4.6 Hz, 
1H), 7.07 (dd, J = 8.0, 0.9 Hz, 1H), 5.50 (dd, J = 8.0, 4.5 Hz, 1H), 5.03 (sept., J = 6.3 Hz, 1H), 4.94 
(d, J = 11.9 Hz (AB system), 1H), 4.80 (d, J = 11.9 Hz (AB system), 1H), 4.04 (dt, J = 9.2, 4.6 Hz, 
1H), 2.92 (dd, J = 15.7, 5.1 Hz, 1H), 2.64 (dd, J = 15.7, 8.9 Hz, 1H), 1.21 (d, J = 6.3 Hz, 6H); 13C 
NMR (100 MHz, CDCl3): δ 171.0, 150.6, 150.5, 148.6, 146.0, 128.5, 124.7, 121.8, 113.1, 94.7, 
75.6, 67.9, 40.9, 36.7, 21.8; HRMS (ESI): m/z calculated for [C16H18Cl3N2O4]+: 407.0327; found 
407.0331. 
 
2,2,2-Trichloroethyl (R)-5-(2-isopropoxy-2-oxoethyl)-1,6-naphthyridine-6(5H)-carboxylate 
(5e) 
1,6-Naphthyridine (3e) (13.0 mg, 0.100 mmol, 1.0 eq.), TrocCl (13.8 µL, 
0.100 mmol, 1.0 eq.), 1a (11.2 mg, 0.010 mmol, 10 mol%) and the silyl ketene 
acetal 4 (51.0 µL, 0.200 mmol, 2.0 eq.) were added according to the general 
procedure, leading to a 1:1.6 mixture of rotamers of the titled product (23.0 mg, 0.056 mmol, 
56%). The enantiomeric ratio was detemined as 80:20 e.r. by chiral HPLC [Chiralcel OJ-H, 
hexane/iPrOH (98:2), 1.0 mL/min, = 290 nm: tr (minor): 15.8 min, tr (major): 23.2 min].  
[𝛂]𝟓𝟖𝟗
𝟐𝟎 : -65.0 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 8.45 (dd, J = 4.9, 1.5 Hz, 1H), 7.53 (d, 
J = 7.7 Hz, 1H), 7.21 – 7.14 (m, 1H), 7.13 – 7.04(m, 1H), 6.21 (d, J = 8.1 Hz, 1H, minor rotamer), 
6.16 (d, J = 8.0 Hz, 1H, major rotamer), 5.86 (dd, J = 7.5, 6.3 Hz, 1H), 5.07 – 4.86 (m, 2H), 4.78 
(bd, J = 15.2, 1H), 2.94 – 2.58 (m, 2H), 1.22 – 1.07 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 169.2, 
150.8, 149.3, 134.4, 129.3, 129.2, 128.2, 126.5, 126.4, 122.03, 121.8, 111.0, 94.9, 75.8, 68.6, 
52.9, 40.4, 39.6, 21.8; HRMS (ESI): m/z calculated for [C16H18Cl3N2O4]+: 407.0327; found 
407.0334.  
 
2,2,2-Trichloroethyl (R)-2-(2-isopropoxy-2-oxoethyl)-7-methyl-1,8-naphthyridine-1(2H)-
carboxylate (5f) 
2-Methyl-1,8-naphthyridine (3f) (14.4 mg, 0.100 mmol, 1.0 eq.), TrocCl 
(13.8 µL, 0.100 mmol, 1.0 eq.), 1a (11.2 mg, 0.010 mmol, 10 mol%) and 
the silyl ketene acetal 4 (51.0 µL, 0.200 mmol, 2.0 eq.) were added according to the general 
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procedure, leading to the desired product (31.0 mg, 0.074 mmol, 74%). The enantiomeric ratio 
was determined as 63:37 e.r. by chiral HPLC [Chiralcel OD-H, hexane/iPrOH (98:2), 1.0 mL 
min−1, = 290 nm: tr (minor): 13.4 min, tr (major): 22.1 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : +4.0 (c 0.1, CHCl3). 1H 
NMR (300 MHz, CDCl3): δ 7.31 (d, J = 7.6 Hz, 1H), 6.94 (dd, J = 7.7, 0.4 Hz, 1H), 6.47 (d, J = 9.5 
Hz, 1H), 6.16 (dd, J = 9.5, 5.8 Hz, 1H), 5.51 (dt, J = 10.0, 5.5 Hz, 1H), 5.05 – 4.92 (m, 1H), 4.99 
(d, J = 11.9 Hz, 1H), 4.72 (d, J = 11.9 Hz, 1H), 2.64 (dd, J = 15.3, 5.3 Hz, 1H), 2.51 (s, 3H), 2.48 
(dd, J = 15.3, 9.7 Hz, 1H), 1.22 (d, J = 6.7 Hz, 3H), 1.19 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 169.3, 156.7, 152.1, 146.6, 134.4, 128.3, 124.1, 120.4, 119.2, 94.9, 75.7, 68.3, 51.2, 
39.3, 24.3, 21.8; HRMS (ESI): m/z calculated for [C17H20Cl3N2O4]+: 421.0483; found 421.0486. 
 
2,2,2-Trichloroethyl (R)-6-(2-isopropoxy-2-oxoethyl)pyridazine-1(6H)-carboxylate (5g) and 
2,2,2-trichloroethyl 4-(2-isopropoxy-2-oxoethyl)pyridazine-1(4H)-carboxylate (6g) 
Pyridazine (3g) (7.3 mg, 0.100 mmol, 1.0 eq.), TrocCl (13.8 µL, 0.100 mmol, 1.0 eq.), 1a 
(11.2 mg, 0.010 mmol, 10 mol%) and the silyl ketene acetal 4 (51.0 µL, 0.200 mmol, 2.0 eq.) 
were added according to the general procedure, leading to the 2-addition product 5g (31.0 
mg, 0.087 mmol, 87%) and the 4-addition product 6g (4.0 mg, 0.011 mmol, 11%).  
5g: The enantiomeric ratio of the main product was detemined as 73:27 e.r. 
by chiral HPLC [Chiralcel OJ-H, hexane/iPrOH (98:2), 1.0 mL min−1, = 300 nm: 
tr (minor): 15.3 min, tr (major): 18.2 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -245.0 (c 0.1, CHCl3). 1H NMR (300 MHz, 
CDCl3): δ 7.24 (bs, 1H), 6.39 (ddd, J = 9.6, 6.1, 1.7 Hz, 1H), 5.97 (dd, J = 9.7, 3.2 Hz, 1H), 5.43 – 
5.23 (m, 1H), 5.16 – 4.61 (m, 3H), 2.83 – 2.30 (m, 2H), 1.22 (d, J = 6.3 Hz, 6H); 13C NMR (75 
MHz, acetone-D6): δ 168.9, 152.7, 141.4, 132.0, 117.4, 95.0, 75.5, 68.5, 47.8, 38.1, 21.8; HRMS 
(ESI): m/z calculated for [C12H16Cl3N2O4]+: 357.0175; found 357.0175. 
 
6g: The enantiomeric ratio was determined as 52:48 e.r. by chiral HPLC [Chiralcel 
OJ-H, hexane/iPrOH (98:2), 1.0 mL min−1, = 230 nm: tr (minor): 17.8 min, tr 
(major): 19.9 min]. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -2.0 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.06 (d, 
J = 8.4 Hz, 1H), 7.02 (bs, 1H), 5.18 – 4.95 (m, 2H), 4.92 (s, 2H), 3.46 – 3.27 (m, 1H), 
2.53 (dd, J = 16.1, 6.9 Hz, 1H), 2.43 (dd, J = 16.1, 7.3 Hz, 1H) 1.24 (d, J = 6.2 Hz, 6H); 13C NMR 
(75 MHz, CDCl3): δ 169.9, 154.0, 142.7, 123.2, 94.7, 75.5, 68.6, 39.7, 28.8, 21.8; HRMS (ESI): 
m/z calculated for [C12H16Cl3N2O4]+: 357.0175; found 357.0183. 
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2,2,2-Trichloroethy 2-(2-isopropoxy-2-oxoethyl)-3-methyl-2,3-dihydro-(1H)-benzo[d] 
imidazole-1-carboxylate (5f) 
1-Methylbenzimidazole (3f) (13.2 mg, 0.100 mmol, 1.0 eq.), TrocCl 
(13.8 µL, 0.100 mmol, 1.0 eq.), 1a (11.2 mg, 0.010 mmol, 10 mol%) and the 
silyl ketene acetal 4 (51.0 µL, 0.200 mmol, 2.0 eq.) were added according 
to the general procedure, leading to the desired product (29.4 mg, 0.072 mmol, 72%).The 
enantiomeric ratio was detemined as 66:34 e.r. by chiral HPLC [Chiralcel OJ-H, hexane/iPrOH 
(99:2), 1.0 mL min−1, = 300 nm: tr (minor): 10.5 min, tr (major): 12.0 min]. (Note: instable 
compound. Partial decomposition occurred during the structural analysis). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -12.7 (c 0.1, 
CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.62-7.39 (m, 1H), 6.94 (dd, J = 7.7, 6.9 Hz, 1H), 6.71 (bd, 
J = 7.0 Hz, 1H), 6.48 (d, J = 7.7 Hz, 1H), 5.79 (bd, J = 9.8 Hz, 1H), 5.15-4.68 (m, 3H), 2.92 (s, 5H), 
1.14 (d, J = 6.3 Hz, 3H), 1.08 (d, J = 6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3)  169.3, 149.2, 142.3, 
124.6, 118.9, 118.7, 114.1, 109.9, 107.3, 78.8, 78.3, 75.7, 75.0, 68.4, 40.3, 38.9, 34.7, 34.2, 
21.8, 21.7; HRMS (ESI): m/z calculated for [C16H20Cl3N2O4]+: 409.0483; found 409.0480. 
 
2.5.4 Derivatization of 5a 
2,2,2-Trichloroethyl(R)-2-(2-isopropoxy-2-oxoethyl)-3,4-dihydroquinazoline-1(2H)-
carboxylate (8) 
To a solution of 5a (0.1 mmol, 40 mg, 1 eq.) in anhydrous MeOH (1mL) at 
0 °C, B(OH)3 (0.2 mmol, 12.2 mg, 2 eq.) and NaBH4 (0.2 mmol, 7.2 mg, 2 
eq.) were added slowly and stirred for 1 h at room temperature. The 
reaction mixture was quenched with H2O (2 mL), filtered and washed with EtOAc (3 x3 mL). 
Purification by solid phase extraction (MeOH:Et3N 50:1) yielded the desired product 8 (26 mg, 
0.064 mmol, 64%). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -4.6 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.09 (t, J = 7.2 Hz, 
2H), 6.82 (t, J = 7.1 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 5.64 (t, J = 6.9 Hz, 1H), 5.22 (d, J = 12.1 Hz, 
1H), 5.00 (m, 1H), 4.77 (s, 1H), 4.43 (m, 1H), 2.84 (bs, 2H), 1.23 (d, J = 6.2 Hz, 6H); 13C NMR (75 
MHz, CDCl3): δ 169.7, 152.8, 141.8, 128.1, 127.6, 122.9, 120.0, 117.4, 95.3, 75.3, 68.4, 51.4, 
42.6, 29.7, 21.8; HRMS (ESI): m/z calculated for [C16H19Cl3N2Na O4]+: 431.0303; found 
431.0300. 
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Methyl (R)-2-(2-methoxy-2-oxoethyl)quinazoline-1(2H)-carboxylate (9) 
A mixture of 5a (20.0 mg, 0.05 mmol, 1 eq.) and K2CO3 (35.0 mg, 0.25 
mmol, 5 eq.) in anhydrous MeOH (1mL) was stirred for 1 h at room 
temperature. After that time H2O (1 mL) was added, the mixture extracted 
with CHCl3 (3 x 3 mL), washed with brine (3 x 3 mL) and the crude product was dried over 
NaSO4. Purification by column chromatography (petrol ether/EtOAc 5:1) yielded the desired 
product 9 (11.0 mg, 0.04 mmol, 84%). 1H NMR (300 MHz, CDCl3): δ 7.72 (bs, 1H), 7.45 (td, J = 
7.5, 1.4 Hz, 1H), 7.41 – 7.36 (td, J = 7.5, 1.2 Hz, 1H), 7.32 – 7.25 (m, 2H), 6.01 – 5.88 (bm, 1H), 
3.91 (s, 3H), 3.62 (s, 3H), 2.69 (dd, J = 14.5, 5.8 Hz, 1H), 2.63 (dd, J = 14.5, 8.2 Hz, 1H); 13C NMR 
(75 MHz, CDCl3): δ 170.1, 154.4, 143.1, 132.4, 131.9, 128.8, 126.3, 126.0, 123.5, 76.7, 54.0, 
51.9, 39.1; HRMS (ESI): m/z calculated for [C13H15N2O4]+: 263.1026; found 263.1021. [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -
18.8 (c 0.1, CHCl3). 
 
Isopropyl (R)-2-(1,2,3,4-tetrahydroquinazolin-2-yl)acetate (10) 
A mixture of 5a (20.0 mg, 0.05 mmol, 1 eq.) and Zn-powder (34.0 mg, 0.05 
mmol, 10 eq.) in NH4OAc (1.0 M)/THF (1/3; 1mL) was stirred for 16 h at 
room temperature. After that time sat. aq. K2CO3 solution (1 mL) was added, extracted with 
CHCl3 (3 x 3 mL) and dried over NaSO4 to yield the desired product 10 (11.0 mg, 0.04 mmol, 
84%).  
The enantiomeric ratio was determined as 90:10 er by chiral HPLC [Chiralpack AD, 
hexane/iPrOH (90:10), 1.0 mL min−1, λ = 280 nm: tr (major): 8.6 min, tr (minor): 9.7 min]. 
[𝛂]𝟓𝟖𝟗
𝟐𝟎 : +16.8 (c 0.1, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.25 – 7.12 (m, 2H), 7.04 (m, 2H), 
6.96 – 6.82 (m, 1H), 5.06 (s, 1H), 5.18 – 4.30 (m, 3H), 2.88 (dd, J = 16.8, 10.0 Hz, 1H), 2.59 (dd, 
J = 16.8, 3.2 Hz, 1H), 1.27 – 1.22 (d, J = 6.3, 6H); 13C NMR (75 MHz, CDCl3): δ 171.2, 146.7, 
140.5, 128.6, 125.7, 125.0, 123.4, 123.2, 68.6, 49.0, 44.1, 21.8; HRMS (APCI): m/z calculated 
for [C13H16N2O2]+: 233.1285, found. 233.1290. 
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2.5.5 Representative Spectra and HPLC Chromatograms of 5a  
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Chiral-phase HPLC: OJ-H; Hex/iPrOH 98:2 (λ = 300 nm)  
racemic: 
 
 
enantioselective: 
 
 
 
 
 
 
 
 
 
 
 
Enantioselective Dearomatization of Diazarenes 
59 
2.6 References 
[1] T. Fischer, J. Bamberger, O. García Mancheño, Org. Biomol. Chem. 2016, 14, 5794-5802. 
[2] a) P. M. a. P. Tapolcsányi, Asymmetric Synthesis of Nitrogen Heterocycles, Wiley-VCH, 
Weinheim, 2009; b) K. A. Rinderspacher, Progress in Heterocyclic Chemistry, Vol. 27, Elservier, 
Amsterdam, 2015. 
[3] S. Chou, Curr Opin Infect Dis 2015, 28, 293-299. 
[4] K. Nepali, S. Sharma, R. Ojha, K. L. Dhar, Med. Chem. Res. 2013, 22, 1-15. 
[5] K. Tamaki, K. Tanzawa, S. Kurihara, T. Oikawa, S. Monma, K. Shimada, Y. Sugimura, Chem. 
Pharm. Bull. 1995, 43, 1883-1893. 
[6] M.-C. Fernandez, A. Escribano, A. I. Mateo, S. Parthasarathy, E. M. Martin de la Nava, X. Wang, 
S. L. Cockerham, T. P. Beyer, R. J. Schmidt, G. Cao, Y. Zhang, T. M. Jones, A. Borel, S. A. 
Sweetana, E. A. Cannady, G. Stephenson, S. Frank, N. B. Mantlo, Bioorg. Med. Chem. Lett. 2012, 
22, 3056-3062. 
[7] G. C. M. Bell, A. Escribano, M. Fernandez, P. Lander, N. Mantlo, E. Martin de la Nava, A. Mateo 
Herranz, D. Mayhugh and X. Wang, Vol. US2007013526A120070726 (Ed.: U.S. Pat. Appl. Publ), 
US, 2007. 
[8] C. R. Bourne, E. W. Barrow, R. A. Bunce, P. C. Bourne, K. D. Berlin, W. W. Barrow, Antimicrob 
Agents Chemother 2010, 54, 3825-3833. 
[9] a) M. Ahamed, M. H. Todd, Eur. J. Org. Chem. 2010, 2010, 5935-5942; b) C. X. Zhuo, W. Zhang, 
S. L. You, Angew. Chem. Int. Ed. 2012, 51, 12662-12686; c) F. Berti, F. Malossi, F. Marchetti, M. 
Pineschi, Chem. Commun. 2015, 51, 13694-13697. 
[10] D. S. Wang, Q. A. Chen, S. M. Lu, Y. G. Zhou, Chem. Rev. 2012, 112, 2557-2590. 
[11] M. Rueping, F. Tato, F. R. Schoepke, Chemistry 2010, 16, 2688-2691. 
[12] L. Mengozzi, A. Gualandi, P. G. Cozzi, Chemical Science 2014, 5, 3915-3921. 
[13] a) Z. P. Yang, Q. F. Wu, S. L. You, Angew. Chem. Int. Ed. 2014, 53, 6986-6989; b) C. X. Zhuo, C. 
Zheng, S. L. You, Acc Chem Res 2014, 47, 2558-2573. 
[14] a) S. Beckendorf, S. Asmus, O. G. Mancheño, ChemCatChem 2012, 4, 926-936; b) S. Asmus, S. 
Beckendorf, M. Zurro, C. Muck-Lichtenfeld, R. Frohlich, O. Garcia Mancheno, Chem. Asian J. 
2014, 9, 2178-2186; c) M. Mahlau, B. List, Angew. Chem. Int. Ed. 2013, 52, 518-533. 
[15] a) T. J. Auvil, A. G. Schafer, A. E. Mattson, Eur. J. Org. Chem. 2014, 2014, 2633-2646; b) K. Brak, 
E. N. Jacobsen, Angew. Chem. Int. Ed. 2013, 52, 534-561. 
[16] a) M. Zurro, S. Asmus, S. Beckendorf, C. Mück-Lichtenfeld, O. García Mancheño, J. Am. Chem. 
Soc. 2014, 136, 13999-14002; b) O. García Mancheño, S. Asmus, M. Zurro, T. Fischer, Angew. 
Chem. Int. Ed. 2015, 54, 8823-8827; c) M. Zurro, S. Asmus, J. Bamberger, S. Beckendorf, O. 
García Mancheño, Chem. Eur. J. 2016, 22, 3785-3793. 
[17] B. T. Cho, S. K. Kang, Tetrahedron 2005, 61, 5725-5734. 
 
 Chapter 3 
3. Triazole-Based Anion-Binding Catalysis for the Enantioselective 
Dearomatization of N-Heteroarenes with Different Nucleophiles 
 
Abstract: The first enantioselective synthesis of chiral heterocyclic α-amino phosphonates by 
nucleophilic dearomatization of quinolines and pyridines using an anion-binding 
organocatalysis approach is described. Chiral tetrakistriazoles were employed as efficient 
hydrogen-bond donor catalysts by the formation of a chiral close ion-pair with the in situ 
formed N-acyl salts with Troc-chloride and subsequent treatment with various phosphorous 
nucleophiles, such as silyl protected dialkyl phosphites and trialkylphosphites. Thus, the 
corresponding products were obtained in complete or high regioselectivities and up to 97:3 
e.r. for quinolines or up to 87:13 e.r. for the more demanding pyridine substrates. This method 
allows the rapid access to substituted chiral cyclic α-amino phosphonates, which can easily 
further be transform into phosphonic acid derivatives. Introducing boron-nucleophiles in the 
same reaction was not successful and did not lead to any new discovery. 
 
Parts of this chapter are reprinted with permission from Theresa Fischer, Qui-Nhi Duong, and Olga 
García Mancheño Chem. Eur.J. 2017, 23,5983–5987 [1] Copyright 2017 Wiley-VCH Verlag GmbH&Co. 
KGaA, Weinheim; schemes, tables, figures and text may differ from the published version
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3.1 Triazole-Based Anion-Binding Catalysis for the Enantioselective 
Dearomatization of N-Heteroarenes with P-Nucleophiles 
 3.1.1 Introduction 
Chiral α-aminophosphonic acid derivatives are important bioactive structures in the 
pharmaceutical and medicinal industry, as well as valuable building blocks in organic 
synthesis.[2] Few examples of relevant bioactive chiral α-aminophosphonic acid derivatives are 
shown in Figure 1. Thus, surrogates of α-amino acids, (e.g. of L-ornithine or pipecolic acid), 
have been extendedly exploited as more robust units.[3] Moreover, several structures based 
on an α-aminophosphonic acid moiety such as dufulin,[4] show pesticide activity. Other 
interesting derivatives are cyclic α-aminophosphonates, which present a broad biological 
spectrum such as antiobiotics[5] or proteinases inhibitors.[6] 
 
Figure 1 Representative bioactive α-aminophosphonic acid derivatives. 
Several methods for the synthesis of α-aminophosphonic acid derivatives have been 
reported.[7] However, only scarce asymmetric approaches to cyclic α-aminophosphonic acids 
are available and most of them rely on metal catalysis. For example in 1998, a catalytic 
enantioselective hydrophosphonylation of cyclic imines catalyzed by chiral heterobimetallic 
lanthanoid complexes was reported by the group of Shikasaki (Scheme 1).[8] They 
demonstrated an asymmetric approach to cyclic R-aminophosphonates using thiazolines as 
the imine model component and a heterobimetallic (R)-LnPB-catalyst (Ln = lanthanoid metal, 
P = potassium, B = (R)-binaphthol) for the hydrophosphonylation of the C=N double bond with 
up to 98% enantiomeric excess and 98% yield. 
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Scheme 1 Enantioselective hydrophosphonylation catalyzed by (R)-LnPB or Ti(IV) complexes.  
More recently, in 2015 Kobayashi and his group described a catalytic asymmetric endo-
selective [3+2]-cycloaddition reaction of Schiff bases of α-aminophosphonates with olefins, 
obtaining cyclic α-aminophosphonic acids in high yields (up to 90%) and enantioselectivities 
(up to 99% ee) (Scheme 2).[9] They introduced a [Ag]- or [Cu]-amide catalyst bearing a chiral 
ligand to control the endo- and enantioselectivity. 
 
Scheme 2 Catalytic asymmetric endo-selective [3+2]-cycloaddition reaction between olefins and Schiff bases of 
α-aminophosphonates. 
A different interesting and highly straightforward approach for the formation of aza-
heterocyclic phosphonic acid derivatives consists in the dearomatization of readily available 
N-heteroarenes with phosphorous nucleophiles (Scheme 3).[10] However, besides few 
examples of the racemic addition of phosphites to the N-acyl salts,[11] most of the common 
metal-free routes to α-aminophosphonic acids from heteroarenes require harsh temperature 
and acidic conditions, hampering the development of selective and asymmetric versions 
(Scheme 3).[12]  
 
Scheme 3 Nucleophilic dearomatization of quinolines. 
In this regard, the Mukherjee’s group recently reported on a thiourea-based anion-binding-
catalyzed[13],[14] asymmetric dearomatization of isoquinolines by acylation and subsequent 
reaction with trimethylsilyl-substituted phosphites (Scheme 4 a).[15] They showed that by 
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anion-binding catalysis cyclic α-aminophosphonates could be synthesized in excellent yields 
with moderate to high enantioselectivities (up to 94% ee). Instead of the popular dialkyl- or 
trialkylphosphites, they used the less common silyl esters of dialkyl phosphonates (silyl 
phosphites) as nucleophiles which showed high reactivity (Scheme 4 b).[16] In 2015, the group 
of List introduced this class of nucleophiles in a catalytic enantioselective Abramov 
reaction.[10f] However, apart from these two examples, the use of silyl phosphites in 
asymmetric synthesis remains rare.  
 
Scheme 4 Thiourea-based anion-binding-catalyzed asymmetric dearomatization of isoquinolines.  
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3.1.2 Objectives 
Inspired by the work of Mukherjee and based on the observed superior performance of our 
recently developed triazole-based chiral H-donor catalyst[17] with the more challenging 
substrates quinolines and pyridines,[18] we decided to explore the enantioselective 
dearomatization of these heteroarenes with phosphorous nucleophiles (Scheme 5).  
 
Scheme 5 Triazole-based anion-binding catalysis for the enantioselective dearomatization of N-heteroarenes 
with P-nucleophiles. 
The key step is the formation of a chiral close ion-pair between an in situ generated N-acyl salt 
and the triazole catalyst-chloride anion complex, which is responsible for the chirality transfer 
to the product.  
To achieve high regio- and enantioselectivities and to get a deeper insight in the operating 
modes of our catalyst, the following steps will be performed: 
- Initial optimization of the reaction with quinoline and different P-nucleophiles 
- Scope of the reaction with various quinoline and pyridine derivatives 
- Study other phosphorous nucleophiles of different nature  
- Further derivatization reactions of the chiral aminophosphonates 
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3.1.3 Results and Discussion 
3.1.3.1 Initial Optimization 
For our first studies, the reaction of quinoline (2a) as substrate, TrocCl as acylating agent and 
diethyl(trimethylsilyl)phosphite (3a) as phosphorous nucleophile was chosen as model 
transformation (Table 1). The study was initially carried out in the presence of triazole-1a, 
which proofed to be the best catalyst in the dearomatization of quinolines and pyridines with 
silyl ketene acetals.[16] Several aprotic solvents such as ethers (MTBE, Et2O or THF, entries 1-3) 
and aromatics (toluene, ethylbenzene or cumene, entries 4-6) were tested at low 
temperatures (-90 to -80 °C). Although this type of triazole catalysts generally provides the 
best enantiomeric inductions in ethereal solvents, 1a showed a higher performance in 
aromatic solvents with this type of nucleophile (up to 92:8 e.r.). Consequently, toluene was 
chosen as solvent for further optimization studies. The effect of the substitution at the 
phosphite 3 was then evaluated (entries 7-12). While the substitution at the silyl group did not 
significantly affect to the reaction outcome, the nature of the alkoxy groups was determining. 
Thus, alkylic chains were well suitable, from which the n-butyl group provided the best 
enantioselectivity of 94:6 e.r. (entry 8). On the other hand, aromatic rests such as phenyl were 
not tolerated, being not reactive under the employed conditions (entry 10). Other triazole-
based chiral H-donor catalysts such as regioisomeric tetrakistriazoles 1a’, 1b and 1c, and 
bistriazole 1d were next explored (entries 13-16, Figure 2). As expected, the tetrakistriazoles 
1a-1c were superior to the chiral bistriazole 1d. Moreover, the same high enantioselectivity 
(94:6 e.r.) was observed with the catalysts 1a and 1c. However, due to the more simplicity in 
the synthesis of 1a, this catalyst was chosen as the ideal structure. Finally, no loss of catalyst 
efficiency was obtained by decreasing it’s loading to 5 or even 2.5 mol%, both resulting in the 
same high 95:5 e.r. (entries 17-18). The reaction could also be scaled up 10 times (to 1 mmol 
scale), maintaining the high levels of reactivity and enantioselectivity (entry 18, in brackets). 
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Figure 2 Catalysts tested in model reaction. 
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Table 1. Optimization of the reaction conditions with quinoline (2a).[a] 
 
Entry Cat. 1 (mol%) R3Si, R’ (3) Solvent  4, yield (%)[b] e.r. [c] 
1 1a (10) TMS, Et (3a) MTBE 4a, 98 85:15 
2 1a (10) TMS, Et (3a) Et2O 4a, 64 81:19 
3 1a (10) TMS, Et (3a) THF 4a, 99 63:37 
4 1a (10) TMS, Et (3a) toluene 4a, 99 90:10 
5 1a (10) TMS, Et (3a) EtC6H5 4a, 89 92:8 
6 1a (10) TMS, Et (3a) cumene 4a, 94 86:14 
7 1a (10) TMS, Me (3b) toluene 4b, 99 90:10 
8 1a (10) TMS, nBu (3c) toluene 4c, 94 94:6 
9 1a (10) TMS, iPr (3d) toluene 4d, 95 90:10 
10 1a (10) TMS, Ph (3e) toluene 4e, --- --- 
11 1a (10) TBS, nBu (3f) toluene 4c, 80 91:9 
12 1a (10) DMPS, nBu (3h) toluene 4c, 78 92:8 
13 1a’ (10) TMS, nBu (3c) toluene 4c, 92 92:8 
14 1b (10) TMS, nBu (3c) toluene 4c, 97 82:18 
15 1c (10) TMS, nBu (3c) toluene 4c, 92 94:6 
16 1d (10) TMS, nBu (3c) toluene 4c, 90 69:31 
17 1a (5.0) TMS, nBu (3c) toluene 4c, 85 95:5 
18 1a (2.5) TMS, nBu (3c) toluene 4c, 86(87) [d] 
95:5 
(92:8)[d] 
 
[a] Conditions: i) 2a (0.1 mmol, 1.0 eq.) and TrocCl (1.0 eq.) in the corresponding solvent at 0 °C, 30 min; then ii) 
at -90 °C, the catalyst 1 and nucleophile 3 (2.0 eq.) were added and stirred for 18 h (-90 to -80 °C overnight). [b] 
Isolated yields. [c] E.r. determined by chiral HPLC. [d] 1 mmol scale reaction in brackets. 
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3.1.3.2 Scope of the Reaction with Various Quinoline and Pyridine Derivatives 
The screening of the substrate scope with catalyst 1a was next carried out (Table 2). Together 
with Qui-Nhi Duong, a variety of substituted quinolines were explored using 2.5 or 5 mol% of 
1a. The method showed to be general, tolerating both electron donating and withdrawing 
groups, as well as substitution at nearly every position (4f – 4o) except for postion C8 of the 
quinoline core (4p). In all the cases, the products were obtained with good to excellent yields 
and enantioselectivities (up to 97:3 e.r.). Furthermore, polycyclic systems such as 
phenanthridine could be enrolled in the reaction, leading to the corresponding α-
aminophosphonate 4o in a high enantiomeric ratio of 94:6. In this case, although the same 
enantioselectivity was obtained, 5 mol% of 1a was employed to achieve a higher yield (4o, 
71% vs. 30% with 2.5 mol%). Moreover, it is worthy to mention that the reaction proceeded 
with complete regioselectivity towards the 2-addition products, with exception of 7-methyl 
(4f) and 6-chloroquinoline (4k), in which the formation of the 4-addition products was also 
observed. For those cases, moisture could be responsible for the formation of some 4-addition 
product. Generally, under incompletely dry conditions, a loss of reactivity and regioselectivity 
was observed.  
Table 2 Scope of various quinoline derivatives.[a] 
 
[a] Conditions: i) 2 (1.0 eq.) and TrocCl (1.0 eq.) in toluene or MTBE at -80 °C, 30 min; then ii) at -85 °C, the catalyst 
1a (10 mol%) and 3 (2.0 eq.) were added and stirred for 18 h (-85 to -80 °C overnight). Isolated yields are shown. 
E.r. determined by chiral HPLC. [b] Concomitant formation of the 4-addition product (see the experimental part 
for details). 
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Based on the good results obtained with quinolines, the more demanding pyridines were 
subsequently investigated. Since the pyridine structure acts different as the quinolines, due 
to full dearomatization of the ring, a re-optimization of the reaction conditions had to be 
carried out. 4-Methylpyridine (2k) and 10 mol% of catalyst 1a were used to test different 
solvents, phosphites and reaction times (Table 3). First, a solvent screening was carried out 
using 3a as a nucleophile (entries 1-6). Under various etheral and aromatic solvents, MTBE 
and toluene proofed to be the best yielding high yields (81%) and enantioselectivities around 
80:20 e.r. (entries 1-2). Later, a screening of nucleophiles was done, whereby both, MTBE and 
toluene was used as a solvent. Furthermore, the reaction time was extended to 36 h to 
improve the yield and the enantioselective outcome (entries 7-15). Under the tested 
nucleophiles, it was observed that greater steric hinderance lead to higher enantioinduction. 
Thus, alkylic chains were well suitable, from which the n-butyl group in MTBE provided the 
best enantioselectivity of 81:19 e.r. (entry 11). On the other hand, the methyl goup did not 
lead to any conversion of the product (entry 8; 12). Additionally, the extension of the reaction 
time did not really enhance the enantioselective outcome, but a drop in yield was observed.  
Since we did not get a clear information about the behavior of the pyridine derivatives under 
the reaction conditions, a short re-optimization for 3-methylpyridine (2j) was next carried out 
(Table 4).  
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Table 3 Re-optimization-screening for 4-methylpyridine (2k)[a] 
 
Entry R3Si, R’ (3) Solvent t [h] Yield [%][b] e.r.[c] 
1 TMS, Et (3a) MTBE 18 81 78:22 
2 TMS, Et (3a) toluene 18 81 82:18 
3 TMS, Et (3a) DCM 18 21 52:48 
4 TMS, Et (3a) Et2O 18 55 78:22 
5 TMS, Et (3a) cumene 18 49 58:42 
6 TMS, Et (3a) EtC6H5 18 30 62:38 
7 TMS, Et (3a) MTBE 36 52 77:23 
8 TMS, Me (3b) MTBE 36 - - 
10 TMS, iPr (3d) MTBE 36 94 76:24 
11 TMS, nBu (3c) MTBE 36 67 81:19 
12 TMS, Me (3b) toluene 36 - - 
13 TMS, Et (3a) toluene 36 36 69:31 
14 TMS, iPr (3d) toluene 36 66 75:25 
15 TMS, nBu (3c) toluene 36 15 65:35 
[a] Conditions: i) 4-Methylpyridine (2k) (0.1 mmol, 1.0 eq.) and TrocCl (1.0 eq.) in the corresponding solvent at 0 
°C, 30 min; then ii) at -90 °C, the catalyst 1a and nucleophile 3 (2.0 eq.) were added and stirred for 18 h at -90 to 
-80 °C. [b] Isolated yields. [c] E.r. determined by chiral HPLC. 
Since 3-methylpyridine (2j) consists of two reactive sites, the C2 and the C4 position we were 
interested to see if the reaction conditions have a great influence on regioselectivities. Testing 
various solvents (entries 1-6), once more, MTBE and toluene proofed to be the best solvents 
for this reaction yielding the same enantiomeric ratios (83:17 e.r.) of the 2-addition product 
5a (entries1-2). However, toluene was superior in terms of regioselectivity, only yielding the 
2-addition product 5a, whereas in MTBE the 4-addition product 5a´was formed in 11% yield 
and a moderate enantiomeric ratio (63:37 e.r.). Changing the ethyl group of the nucleophile 
to a n-butyl or a iso-propyl group (entries 7-10), similar enantiomeric ratios were obtained, 
whereby n-butyl phosphite in toluene gave 5b in high yield (84%), complete regioselectivity 
and good enantioselectivity (85:15 e.r.) (entry 8). 
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Table 4 Re-optimization-screening for 3-methylpyridine (2j)[a]  
 
Entry R3Si, R’ (3) Solvent 
Product [%] 
5 (5´)[b] 
e.r. [c] 
5 (5´) 
1 TMS, Et (3a) MTBE 5a 81 (11) 83:17 (63:37) 
2 TMS, Et (3a) toluene 5a 89 (-) 83:17 (-) 
3 TMS, Et (3a) DCM 5a 52 (19) 52:48 (51:49) 
4 TMS, Et (3a) Et2O 5a 37 (27) 61:39 
5 TMS, Et (3a) THF 5a 37 (22) 74:26 
6 TMS, Et (3a) hexane 5a 56 (19) 45:55 
7 TMS, n-Bu (3b) MTBE 5b 76 (-) 80:20 (-) 
8 TMS, n-Bu (3b) toluene 5b 84 (-) 85:15 (-) 
9 TMS, i-Pr (3c) MTBE 5c 26 (41) 77:23 (-) 
10 TMS, i-Pr (3c) toluene 5c 88 (7) 81:19 (73:27) 
 [a] Conditions: i) 3-Methylpyridine (2j) (0.1 mmol, 1.0 eq.) and TrocCl (1.0 eq.) in the corresponding solvent at 0 
°C, 30 min; then ii) at -90 °C, the catalyst 1a and nucleophile 3 (2.0 eq.) were added and stirred for 18 h at -90 to 
-80 °C. [b] Isolated yields. [c] E.r. determined by chiral HPLC. 
The scope of various pyridine derivatives was then carried out using toluene or MTBE as 
solvent and 10 mol% of 1a as catalyst (Table 5). The regioselectivities (mixtures of 2-/4-
addition) and the enantioselectivities were uniformly lower as for the quinoline substrates. 
However, considering the more challenging nature of pyridines, the obtained results are the 
state-of-the-art for this heteroarenes. In this regard, products 5a, 5b, 5c and 5h were obtained 
in good yields and enantioselectivities (up to 85:15 e.r.) but regioselectivity was not complete. 
On the other hand, with products 5d-g no 4-addition product, but good enantioselectivities 
(up to 82:18 e.r.) were observed. Furthermore, it was shown that substitution in every position 
of the pyridine was tolerated yielding the desired products in good regio- and 
enantioselectivities and moderate to high yields. 
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Table 5 Scope of various pyridine derivatives. [a] 
 
[a] Conditions: i) 2 (1.0 eq.) and TrocCl (1.0 eq.) in toluene or MTBE at -80 °C, 30 min; then ii) at -85 °C, the catalyst 
1a (10 mol%) and 3 (2.0 eq.) were added and stirred for 18 h at -85 to -80 °C. See the experimental part for the 
exact conditions for each substrate. Isolated yields are shown. E.r. determined by chiral HPLC. [b] Concomitant 
formation of the 4-addition product 5´ (see experimental part for details). 
3.1.3.3 Application of Other Phosphorous Nucleophiles 
The possibility of employing other phosphorous nucleophiles of different nature was next 
explored (Scheme 6). First, the reactivity of a trialkylphosphite and a non-protected 
dialkylphosphite was compared to the corresponding silylated phosphite 3. Triethylphosphite 
worked well, providing the product in good yield (72% vs. 99%) and same enantioselectivity 
(90:10 e.r.) (Scheme 6, iiA). On the other hand, the less nucleophilic dialkylphosphite[19] 
showed a lower reactivity and led to a racemic product (Scheme 6, iiC) a)). Moreover, when 
the corresponding phosphite anion was generated in situ under standard conditions using 
Et3N as base, no reaction was observed (Scheme 6, iiC) b)). The in situ formation and reaction 
of TMS-phosphite delivered the product in only 11% and a significant lower enantioselectivity 
(83:17 vs. 90:10 e.r.) (Scheme 6, iiC) c)).  
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Scheme 6 Application of other phosphorous nucleophiles. 
3.1.3.4 Derivatization of the Chiral Aminophosphonates 
Finally, the applicability of the method was illustrated by the derivatization of the formed 
chiral α-aminophosphonates 4 and 5 (Scheme 7). Thus, the corresponding phosphonic acid 7 
was easily obtained by treatment of 4c with TMSBr. This reaction preceded without loss of 
enantiopurity, which could be determined after re-esterification with ethyl orthoester. 
Moreover, 4c could also be hydrogenated to provide the tetrahydroquinoline derivative 8. 
 
Scheme 7 Derivatization of the chiral α- aminophosphonates. 
To assign the absolute configuration of the phosphonates 4/5, the reaction of pyridine with 
CbzCl was performed. Although a lower asymmetric induction was observed with this 
acylating agent (65:35 e.r.), it permitted the straightforward synthesis of pipecolic phosphonic 
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acid 9 by hydrogenation and phosphonate hydrolysis (Scheme 8). Consequently, the absolute 
configuration was determined to be (S) by comparison of the optical rotation with the 
reported literature (R)-9 [α] : −4.5 (c 1.0, (1 M NaOH)).[20] 
 
Scheme 8 Determination of the absolute configuration. 
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3.1.4 Conclusion 
In conclusion, the first enantioselective synthesis of chiral cyclic α-aminophosphonic acid 
derivatives by nucleophilic dearomatization of quinolines and pyridines using an anion-binding 
organocatalysis approach has been developed.  
 
Tetrakistriazole-based H-bond donor catalysts were highly effective with both silyl-protected 
dialkyl- and trialkylphosphites as nucleophiles, providing the corresponding products in 
complete or high regioselectivities, and up to 97:3 e.r. for quinolines or up to 89:11e.r. for the 
more demanding pyridine substrates. This method allows for easy access to substituted chiral 
cyclic α-amino phosphonates, which can be further transformed into other phosphonic acid 
derivatives. 
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3.2 Triazole-Based Anion-Binding Catalysis for the Enantioselective 
Dearomatization of N-Heteroarenes with Boron-Nucleophiles 
3.2.1 Introduction  
As we demonstrated in our group, dearomatization reactions have emerged as powerful tools 
to convert planar aromatic compounds into several of three dimensional, highly functionalized 
cyclic products.[1] Recently, dearomative borylation involving N-heteroarenes has gained 
increasing attention as it can provide saturated or partially saturated borylated N-heterocycles 
that present important building blocks for organic synthesis and bioactive products.[2] The 
development of an enantioselective C-B bond-forming dearomatization reaction would 
provide an attractive and complementary approach for the synthesis of complex, 
functionalized cyclic molecules in combination with the stereospecific transformation of a 
stereogenic C-B bond. In the last years, Cu-catalyzed hydroborations of unsaturated C-C bonds 
has gained of interest, leading to the development of a large number of reported methods in 
this field by famous groups like Tsuji,[3] Tortosa,[4] Feringa[5] or Hartwig.[6] Moreover, Ito et al. 
made an outstanding work on the hydroboration of N-heterocyclic substrates and published 
high enantioselective Cu-catalyzed hydroboration of indoles,[7] pyridines[8] and 
dihydroquinolines derivatives[9] via an strategy based on a sequential 
dearomatization/borylation reaction.  
However, due to their archetypal Lewis acid character, common routes to organoboranes rely 
on the reactivity of boron as an electrophile. Therefore, besides hydroborylation reactions 
with boranes, a main challenge in this field is the formation of the required boron-nucleophile 
for direct additions. Recently, the group of Zhang reported on a kinetic resolution of racemic 
2-substituted 1,2-dihydroquinolines 1 via asymmetric Cu-catalyzed borylation with kinetic 
selectivity factors of up to 569 (Scheme 1a).[2c] Under mild conditions, a variety of chiral 3-
boryl-1,2,3,4-tetrahydroquinolines 2 containing two vicinal stereogenic centers and the 
unreacted 2-substituted 1,2-dihydroquinolines 1 were afforded in high yields with up to 99% 
ee and dr > 99:1, and over 98% ee values, respectively. This year, the same group published 
an enantioselective synthesis of boryl tetrahydroquinolines via Cu-catalyzed hydroboration 
(Scheme 1b).[2d] They were also able to apply this strategy in the enantioselective synthesis of 
the potential agent sumanirole 3 for the treatment of Parkinson’s disease and of the positive 
inotropic agent (S)-903 4 (Scheme1). 
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Scheme1 Cu-catalyzed hydroboration of 1,2-dihydroquinolines. 
Recently, a few methods have been reported on the metal-free formation of boron-
nucleophiles. Hoveyda et al. postulated that a neutral, intermolecular Lewis base adduct of 
B2pin2 5 and a N-heterocycliccarbene (NHC) 6 can act as a boron-nucleophile in the NHC-
catalyzed β-borylation of α,β-unsaturated ketones 7 (Scheme 2).[10] This constitutes a novel 
organocatalytic process distinct from those previously reported involving Cu-catalysis.[11] Due 
to mechanistic studies, 10 mol% of carbene can activate the diboron reagent (B2pin2) 5 by 
nucleophilic attack at one of the boron atoms and formation of a boronate species. 
 
Scheme 2 NHC-catalyzed borylation reported by Hoveyda et al. 
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Almost simultaneously the group of Fernandez described a method for the synthesis of 𝛽-
borated carbonyl compounds by reacting B2pin2 5 with α,β-unsaturated esters 8 in the 
presence of a phosphine catalyst 9. The reaction is not only metal-free, but also only requires 
simple additives such as MeOH, an inorganic base and a phosphine like triphenylphosphine to 
create a nucleophilic boron-species (Scheme 3).[13]  
 
Scheme 3 Phosphine-mediated catalytic β-boration of α,β-unsaturated esters with B2pin2. 
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3.2.2 Objectives 
Inspired by the recent work of enantioselective hydroboration of 1,2-dihydroquinolines, the 
new approaches towards nucleophilic boron-reagents and our expertise in triazole-based 
anion-binding catalysis for enantioselective dearomatization of N-heteroarenes[1] we aimed 
at combining these stratgeties and developing a new methodology based on the 
enantioselective dearomatization of N-Heteroarenes by triazole-based anion-binding catalysis 
with boron-nucleophiles.  
The previous work in this field with N-heterocycles is limited to 1,2-dihydroquinolines 
substrates that must be first gained by reduction of the corresponding quinolines, Therefore, 
we envisioned to overcome this restraint by introducing the boron-nucleophile into a 
previously in situ generated N-acyl salt. Consequently, the triazole catalyst would bind the 
ionic substrate, forming a chiral close ion-pair that would be responsible for the chirality 
transfer to the final product (Scheme 4). 
 
Scheme 4 Triazole-based anion-binding catalyzed enantioselective dearomatization of N-heteroarenes with B-
nucleophiles. 
To achieve the main goal of this chapter, the following points will be addressed: 
- Optimization of the borylation reaction conditions under metal-free conditions  
- Optimization of the Cu-catalyzed borylation with quinoline as model substrate  
- Study of the scope of the reaction with different N-heteroarenes  
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3.2.3 Results and Discussion 
3.2.3.1 Metal-free Borylations 
To achieve a complete metal-free asymmetric dearomatization of N-heteroarenes with boron-
nucleophiles, initial attempts were carried out following the recently published reaction 
conditions from Hoveyda.[10a] Therefore, quinoline 10 was used as a model substrate and an 
acylating agent 12 was added at 0 °C to form the N-acyl salt.[12] N-Heterocyclic carbene 12 
served as catalysts to polarize the B-B bond of the bis(pinacolato)diboron 5. All steps were 
carried out in an Ar-filled glove box to avoid any decomposition of the in situ generated 
reactive boron reagent by moisture or oxygen. Unfortunately, neither by changing the 
acylating agent (entries 1-5), nor by adding additives like MeOH (entry 6) afforded any 
conversion. Pure quinoline starting material 10 was isolated, which pointed to the fact that 
the nucleophilic boron-species was not formed. 
Table 1 Initial Optimization of the dearomatization of quinoline promoted by N-heterocyclic 
carbenes.[a]  
 
Entry Acylating reagent 11 Additive  TetraTri 1a Conversion (%) 
1 
 
- - - 
2 
 
- 10 mol% - 
3 
 
- - - 
4 
 
- 10 mol% - 
5 
 
- - - 
6 
 
MeOH - - 
[a] Conditions: i) Quinoline 10 (1.0 eq.) and acylating agent (1.0 eq.) in THF at 0 °C, 30 min; then ii) the catalyst 
1a (10 mol%), NHC (10 mol%), NaOtBu (10 mol%) and B2pin2 (1.1 eq.) were added and stirred for 18 h. All steps 
were carried out in an Ar-filled glovebox. 
Chapter 3 
85 
In a next step, a phosphine-based catalytic system was used to form the nucleophilic boron-
species. Therefore, we followed the reported reaction conditions of the group of Fernandez 
using triphenyl phosphine, MeOH and the cesium carbonate base as additives (Table 2).[13] 
The acylating agent 11, additives and temperature were screened, but unfortunately without 
any success. No conversion of the quinoline starting material could be observed. 
Table 2 Initial optimization of the dearomatization of quinoline promoted by a phosphine-
based catalyst.[a] 
 
Entry Acylating reagent 11 P-catalyst Temp [°C] Conversion (%) 
1 
 
- 45 - 
2 
 
PPh3 45 - 
3 
 
PPh3 r.t. - 
4 
 
PPh3 r.t. - 
5 
 
PPh3 60 - 
6 
 
- 60 - 
7 
 
PPh3 60 - 
[a] Conditions: i) Quinoline 10 (1.0 eq.) and acylating agent (1.0 eq.) in THF at 0 °C, 30 min; then ii) the phosphine 
catalyst (10 mol%), Cs2CO3 (10 mol%), MeOH (2.5 eq.) and B2pin2 (1.1 eq.) were added and stirred for 18 h. All 
steps were carried out in an Ar-filled glovebox. 
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3.2.3.2 Cu(I)-Catalyzed Borylations 
Since all our attempts of a full metal-free dearomatization of quinolines did not gave any 
satisfactory result, we decided to change to a Cu(I)-catalyzed formation of the boron-
nucleophile. With the knowledge of our cooperation partner Mariola Tortosa (U.A.M., Spain) 
in boron chemistry, we introduced a catalytic Cu(I) species (CuCl) and screened various 
reaction conditions (Table 3).[4, 14] 
Table 3 Initial optimization of the Cu(I)-catalyzed dearomatization of quinoline and pyridine.[a] 
 
Entry substrate Acylating reagent 11 Ligand 14 Base  conversion (%) 
1 13 
 
xantphos NaOtBu decomp 
2 13 
 
xantphos NaOtBu decomp 
3 13 MeOTf PCy3 NaOtBu decomp 
4 13 MeOTf PCy3 MgOtBu decomp 
5 13 MeOTf PCy3 NaOMe decomp 
6 10 
 
xantphos NaOtBu decomp 
7 10 
 
xantphos NaOtBu decomp 
8 10 MeOTf PCy3 NaOMe - 
9 10 MeOTf PCy3 LiOtBu - 
10 10 MeOTf PCy3 NaOtBu - 
[a] Conditions: i) substrate (1.0 eq.) and acylating agent 11 (1.0 eq.) in THF at 0°C, 30 min; then ii) a solution of 
CuCl (10 mol%), ligand (11 mol%), base (1.0 eq.) and B2pin2 (1.1 eq.) was added to the N-acyl salt and stirred for 
18 h. All steps were carried out in an Ar-filled glovebox. 
A variety of parameters were tested, but none of the applied conditions led to the desired 
product. In the case of using pyridine as a substrate, only decomposition was observed (entries 
1-5), while quinoline gave either decomposition or no conversion (entries 6-10). Since the 
formation of the N-acyl salt was visible in all cases, we imagine a high intrinsic instability of 
the 2-addition product. Therefore, we tried to block the 2-position of the substrate to force a 
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4-addition of the boron-nucleophile. Unfortunately, the employed 2-substituted substrates 
did not give any conversion (entries 1-4, Table 4) 
Table 4 Initial optimization of the Cu(I)-catalyzed dearomatization of quinaldine and 2-
phenylpyridine.[a] 
 
Entry substrate Acylating reagent 11 conversion (%) 
1 15 
 
- 
2 15 
 
- 
3 16 
 
- 
4 16 
 
- 
[a] Conditions: i) substrate (1.0 eq.) and acylating agent (1.0 eq.) in THF at 0 °C, 30 min; then ii) a solution of CuCl 
(10 mol%), xantphos (11 mol%), NaOtBu (1.0 eq.) and B2pin2 (1.1 eq.) was added to the N-acyl salt and stirred for 
18 h. All steps were carried out in an Ar-filled glovebox. 
3.2.4 Conclusion 
To sum up the obtained results, all our efforts were not successful, and we could not achieve 
the addition of a boron-nucleophile to a N-heteroarene under different dearomatization 
reaction conditions. It turned out that our original idea was more complex than what we first 
thought, most probably due to the intrinsic unstable nature of the targeted N,B-products. 
Therefore, extensive studies will further be required in order to achieve the aims of this 
project.  
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3.3 Experimental part 
3.3.1 General Information 
1H, 13C and 31P NMR spectra were recorded in CDCl3 (reference signals:[1] 1H = 7.26 ppm, 13C = 
77.16 ppm, CDCl3) on a Bruker Advance 300 or 400 MHz. Chemical shifts (δ) are given in ppm 
and spin-spin coupling constants (J) are given in Hz. Analytical thin layer chromatography was 
performed using silica gel 60 F254 and a solution of KMnO4 or phosphomolybdic acid served as 
staining agent. Column chromatography was performed on silica gel 60 (0.040-0.063 mm). 
Exact masses (HRMS) were recorded on an Agilent Q-TOF 6540 UHD spectrometer (samples 
in CH3OH as solvent) using electrospray (ESI) or electron (EI) ionization techniques. Chiral High-
Pressure Liquid Chromatography (HPLC) analyses were performed on an Agilent 1200 series 
instrument. 
CH2Cl2 and Et3N were distilled over CaH2. THF, toluene, MTBE and Et2O were distilled and dried 
over Na. The different silyl-phosphites 3 were prepared following known literature 
procedures.[2] Other solvents and commercially available reagents were used without further 
purification. 
3.3.2 General Procedure for the Catalytic Dearomatization Reaction 
 
The quinoline or pyridine derivative 2 (0.1 mmol, 1.0 eq.) was dissolved in the corresponding 
anhydrous solvent (1 mL, 0.1 M) and cooled to 0 °C. After the addition of TrocCl (13.8 µL, 0.1 
mmol, 1.0 eq.), the reaction was stirred for 30 min at 0 °C and then cooled to - 85 °C. The 
phosphite 3 (0.2 mmol, 2 eq) and the catalyst 1a (2.5 to 10 mol%) were added and the resulting 
mixture was stirred overnight at – 80 °C. Purification by flash column chromatography 
(petroleum ether/EtOAc) yielded the crude product, which was stirred in NaOH (2 M, 1.0 mL) 
for 30 min. The organic phase was washed again with NaOH (2 M, 3 x 1 mL) to remove the 
remaining phosphite, dried over MgSO4, and concentrated in vacuo to obtain the desired 
product. 
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3.3.3 Analytical Data for Compounds 4 
2,2,2-Trichloroethyl 2-(di-ethoxyphosphoryl)quinoline-1(2H)-carboxylate (4a) 
Quinoline (2a) (11.8 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 
1.0 eq.), 1a (11.0 mg, 0.01 mmol, 10 mol%) and diethyl(trimethylsilyl) 
phosphite (3a) (44.4 µL, 0.2 mmol, 2.0 eq.) were reacted in 
ethylbenzene according to the general procedure. The desired product 4a (39.4 mg, 0.089 
mmol, 89%) was isolated by flash column chromatography (petroleum ether/ethyl acetate, 
7:3) as slight pale yellow oil. The enantiomeric ratio was found to be 92:8 by chiral HPLC 
(Chiralpak IA, Hex/iPrOH 95:5, 1.0 mL/min, λ=300 nm: tr (minor): 17.3 min, tr (major): 16.3 
min. 1H NMR (300 MHz, CDCl3): δ 7.56 (s, 1H), 7.17 (s, 1H), 7.04 (q, J = 7.3 Hz, 2H), 6.56 (dd, J 
= 9.4, 5.5 Hz, 1H), 6.05 (s, 1H), 5.59 (d, J = 20.1 Hz, 1H), 5.04 (d, J = 64.8 Hz, 1H), 4.60 (d, J = 
62.4 Hz, 1H), 3.78 (s, 4H), 1.13 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 152.7, 134.3, 129.3, 128.0, 
127.5, 126.5, 125.6, 123.1, 95.0, 76.0, 63.2 (d, J = 6.9 Hz), 62.9 (d, J = 6.9 Hz), 51.7 (d, J = 153.5 
Hz), 16.3 (d, J = 5.9 Hz), 16.1 (d, J = 5.9 Hz); 31P NMR (121 MHz, CDCl3): δ 19.06 (s, minor 
rotamer), 18.19 (s, major rotamer); HRMS (ESI): m/z calculated for [C16H20Cl3NO5P]+: 
442.0139, found 442.0147. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)quinoline-1(2H)-carboxylate (4c) 
Quinoline (2a) (11.8 µL, 0.1 mmol, 1.0 equ.), TrocCl (14.2 µL, 0.1 mmol, 
1.0 eq.), 1a (2.8 mg, 0.0025 mmol, 2.5 mol%) and dibutyl(trimethylsilyl) 
phosphite (3c) (44.4 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene 
according to the general procedure. The desired product 4c (42.8 mg, 0.086 mmol, 86%) was 
isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale 
yellow oil. The enantiomeric ratio was determined as 95:5 e.r. by chiral HPLC [Chiralpak IA, 
hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 14.6 min, tr (minor): 15.5 min]. Scale-
up reaction: Quinoline (118.2 µL, 1.0 mmol, 1.0 equiv.), TrocCl (142.0 µL, 1.0 mmol, 1.0 equiv.), 
1a (28.0 mg, 2.5 mol%) and phosphite 3c (440 µL, 2.0 mmol, 2.0 equiv.) were reacted in 
toluene for 26 h according to the general procedure. The desired product 4c (433.3 mg, 0,87 
mmol, 87%) was isolated by flash column chromatography (petroleum ether/ethyl acetate, 
7:3) as slight pale yellow oil. The enantiomeric ratio was detemined as 92:8 e.r. by chiral HPLC 
[Chiralpak IA, hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 14.6 min, tr (minor): 
15.5 min]. 
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1H NMR (300 MHz, CDCl3) δ 7.80- 7.55 (bs, 1H), 7.23 b(s, 1H), 7.17 – 7.04 (m, 2H), 6.61 (dd, J = 
9.5, 5.3 Hz, 1H), 6.12 (bs, 1H), 5.66 (bd, J = 17.6 Hz, 1H), 5.25 - 4.90 (m, 1H), 4.80 - 4.45 (m, 
1H), 4.08 – 3.82 (m, 3H), 3.76 (dq, J = 9.9, 6.5 Hz, 1H), 1.57 – 1.44 (m, 2H), 1.37 – 1.22 (m, 4H), 
1.17 – 1.00 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H), 0.78 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
151.6 (bs), 135.2, 133.1 (bs), 126.8 (bs), 126.4 (d, J = 4.1 Hz), 125.5 (d, J = 2.0 Hz), 125.3 (bs), 
124.4 (bs), 123.1 (bs), 122.1 (bs), 121.0 (bs), 93.9, 74.9 (bs), 65.7 (bs), 65.4 (d, J = 6.7 Hz), 50.6 
(d, J = 153.4 Hz), 31.4 (d, J = 6.0 Hz), 31.2 (d, J = 6.1 Hz), 17.5 (d, J = 12.6 Hz), 12.5 (d, J = 6.3 
Hz). 31P NMR (121 MHz, CDCl3) δ 18.40; HRMS (ESI): m/z calculated for [C20H28Cl3NO5P]+: 
498.0765; found 498.0773. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-7-methylquinoline-1(2H)-carboxylate (4f) 
7-Methylquinoline (2b) (13.4 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 
0.1 mmol, 1.0 eq.), 1a (5.6 mg, 0.005 mmol, 5.0 mol%) and phosphite 
3c (44.4 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene according to 
the general procedure leading to a mixture of 4f and regioisomer 4f’ (5:1). An inseparable 
mixture of 2-addition 4f and 4-addition 4f’ (36.0 mg, 0.070 mmol, 70%) was isolated by flash 
column chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The 
enantiomeric ratio was detemined as 97:3 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH 
(95:5), 1.0 mL/min, = 300 nm: tr (major): 15.6 min, tr (minor): 16.6 min]. 1H NMR (300 MHz, 
CDCl3) δ 7.40 (bs, 1H, 2-add + 1H, 4-add), 7.11 (t, J = 7.3 Hz, 1H, 4-add), 6.99 – 6.88 (q, J = 7.7 
Hz , 2H, 2-add + 1 H 4-add), 6.81 (dd, J = 9.7, 5.4 Hz, 1H, 4-add), 6.51 (dd, J = 9.5, 5.4 Hz, 1H, 2-
add), 6.16 (bs, 1H, 4-add), 6.04 (bs, 1H, 2-add), 5.57 (bd, J = 20.4 Hz, 1H, 2-add + 1H, 4-add), 
5.30 – 4.90 (m, 1H, 2-add + 1H, 4-add), 4.80 – 4.35 (m, 1H, 2-add + 1H, 4-add), 4.05 – 3.66 (m, 
5H, 2-add + 4 H, 4-add), 2.25 (d, J = 3.2 Hz, 3H, 2-add), 1.58 – 1.46 (m, 2H, 2-add), 1.35 – 1.22 
(m, 4H), 1.14 – 1.01 (m, 2H, 2-add), 0.81 (t, J = 7.3 Hz, 3H, 2-add),  0.71 (t, J = 7.3 Hz, 3H, 2-
add); 13C NMR (75 MHz, CDCl3) (major product of 2-add) δ 152.6, 138.0, 133.8, 127.7, 127.2, 
126.3, 126.1, 125.9, 124.8, 124.7, 121.7, 95.0, 76.0, 66.5 (dd, J = 18.9, 7.4 Hz), 51.5 (d, J = 153.2 
Hz), 32.3 (dd, J = 11.3, 6.1 Hz), 18.5 (d, J = 12.1 Hz), 13.5 (d, J = 6.1 Hz);  31P NMR (121 MHz, 
CDCl3) δ 18.62.; HRMS (ESI): m/z calculated for [C21H30Cl3NO5P]+: 512.0922; found 512.0926. 
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2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-4-methylquinoline-1(2H)-carboxylate (4g) 
4-Methylquinoline (2c) (13.2 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 
mmol, 1.0 eq.), 1a (2.8 mg, 0.0025 mmol, 2.5 mol%) and phosphite 3c 
(50.0 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene according to the 
general procedure. The desired product 4g (30.0 mg, 0.059 mmol, 59%) 
was isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as a 
colourless oil. The enantiomeric ratio was found to be 90:10 by chiral HPLC (Chiralpak OD-H, 
Hex/iPrOH 95:5, 1.0 mL/min, λ=300 nm: tr (minor): 7.9 min, tr (major): 7.4 min. 1H NMR (300 
MHz, CDCl3): δ 7.61 (bs, 1H), 7.25 (s, 1H), 7.24 – 7.12 (m, 2H), 5.92 (s, 1H), 5.58 (d, J = 18.0 Hz, 
1H), 5.11 (d, J = 55.5 Hz, 1H), 4.60 (d, J = 64.2 Hz, 1H), 4.02 – 3.64 (m, 4H), 2.11 (d, J = 5.5 Hz, 
3H), 1.61 – 1.43 (m, 2H), 1.35 – 1.20 (m, 4H), 1.14 – 0.97 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H), 0.77 
(t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 152.4, 134.9, 133.3, 130.3, 129.1, 127.8, 126.6, 
125.3, 123.3, 119.4, 95.0, 75.8, 66.4, 51.3 (d, J = 156.8 Hz), 32.5 (d, J = 6.0 Hz), 32.3 (d, J = 6.1 
Hz), 18.6 (d, J = 5.8 Hz), 18.5 (d, J = 5.5 Hz), 13.6 (d, J = 6.1 Hz).; 31P NMR (121 MHz, CDCl3): δ 
18.93; HRMS (ESI): m/z calculated for [C21H30Cl3NO6P]+: 512.0922, found 512.0922. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-3-methylquinoline-1(2H)-carboxylate (4h) 
3-Methylquinoline (2d) (13.4 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 
mmol, 1.0 eq.), 1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3c 
(50.0 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene according to the 
general procedure. The desired product 4h (48.6 mg, 0.094 mmol, 94%) was isolated by flash 
column chromatography (petroleum ether/ethyl acetate, 7:3) as a colourless oil. The 
enantiomeric ratio was found to be 89:11 by chiral HPLC (Chiralpak IA, Hex/iPrOH 95:5, 
1.0 mL/min,λ=300 nm: tr (minor): 10.5 min, tr (major): 11.4 min. 1H NMR (300 MHz, CDCl3): 
7.73 – 7.52 (m, 1H), 7.16 (s, 1H), 7.08 (td, J = 7.4, 1.2 Hz, 1H), 7.02 (d, J = 7.3 Hz, 1H), 6.35 (d, J 
= 4.7 Hz, 1H), 5.43 (d, J = 20.9 Hz, 1H), 5.15 (d, J = 58.9, 11.8 Hz, 1H), 4.60 (dd, J = 58.6, 10.8 
Hz, 1H), 4.06 – 3.61 (m, J = 13.1, 9.8, 6.3 Hz, 4H), 2.12 (s, 3H), 1.62 – 1.42 (m, 2H), 1.39 - 1.18 
(m, 4H), 1.15 – 0.99 (m, 2H), 0.87 (t, J = 7.3 Hz, 3H), 0.76 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 152.4, 133.2, 128.5 (d, J = 3.9 Hz), 126.8, 125.6, 125.4, 124.9, 123.5, 95.0, 75.9, 66.5, 
66.3, 55.4 (d, J = 148.6 Hz), 32.4 (d, J = 5.9 Hz), 32.2 (d, J = 6.2 Hz), 21.7, 18.5 (d, J = 17.3 Hz), 
13.5 (d, J = 8.9 Hz); 31P NMR (121 MHz, CDCl3): δ 18.92; HRMS (ESI): m/z calculated for 
[C21H30Cl3NO6P]+: 512.0922, found 512.0919. 
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2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-6-methylquinoline-1(2H)-carboxylate (4i) 
6-Methylquinoline (2e) (13.4 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 
0.1 mmol, 1.0 eq.), 1a (5.6 mg, 0.005 mmol, 5.0 mol%) and phosphite 
3c (44.4 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene according to 
the general procedure. The desired product 4i (43.6 mg, 0.085 mmol, 85%) was isolated by 
flash column chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. 
The enantiomeric ratio was determined as 94:6 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH 
(95:5), 1.0 mL/min, = 300 nm: tr (major): 13.8 min, tr (minor): 15.8 min. 1H NMR (300 MHz, 
CDCl3) δ 7.60 –  7.40 (m, 1H), 7.03 (bd, J = 7.3 Hz, 1H), 6.89 (s, 1H), 6.56 (dd, J = 9.5, 5.4 Hz, 
1H), 6.09 (bs, 1H), 5.64 (bd, J = 20.7 Hz, 1H), 5.25 – 4.90 (m, 1H), 4.80 – 4.40 (t, J = 36.2 Hz, 
1H), 4.11 – 3.68 (m, 4H), 1.67 – 1.41 (m, 2H), 1.41 – 1.19 (m, 4H), 1.16 – 1.00 (m, 2H), 0.87 (t, 
J = 7.3 Hz, 3H), 0.77 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 152.8, 135.1, 131.6, 128.5, 
128.0, 127.2 (d, J = 4.1 Hz), 127.0 (d, J = 2.0 Hz), 125.1, 123.0, 95.0, 75.8, 67.09 – 66.01 (m), 
51.6 (d, J = 153.2 Hz), 32.3 (dd, J = 10.1, 6.1 Hz), 20.8 (s), 18.5 (d, J = 10.8 Hz), 13.5 (d, J = 5.4 
Hz); 31P NMR (121 MHz, CDCl3) δ 18.53; HRMS (ESI): m/z calculated for [C21H30Cl3NO5P]+: 
512.0922; found 512.0917. 
 
2,2,2-Trichloroethyl 6-chloro-2-(dibutoxyphosphoryl)quinoline-1(2H)-carboxylate (4k) 
6-Chloroquinoline (2f) (16.3 mg, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 1a (5.6 
mg, 5.0 mol%) and phosphite 3c (44.4 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene according 
to the general procedure leading to a mixture of 2.6:1 of 4k and regioisomer 4k’. The desired 
product 4k (35.0 mg, 0.066 mmol, 66%) and the regioisomer 4k’ (14.0 mg, 0.026 mmol, 26%) 
were isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as slight 
pale yellow oil. 
4k: The enantiomeric ratio was determined as 95:5 e.r. by chiral 
HPLC [Chiralpak IA, hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr 
(major): 14.6 min, tr (minor): 15.5 min]. 1H NMR (300 MHz, CDCl3): 
δ 7.53 (bs, 1H), 7.34 (d, J = 7.8 Hz, 1H), 7.22 (d, J = 2.1 Hz, 1H), 6.54 (dd, J = 9.5, 5.4 Hz, 1H), 
6.16 (bs, 1H), 5.64 (d, J = 19.1 Hz, 1H), 5.09 (m, 1H), 4.60 (m, 1H), 4.12 – 3.77 (m, 4H), 1.60 – 
1.40 (m, 2H), 1.38 – 1.23 (m, 4H), 1.16 – 1.02 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H), 0.81 (t, J = 7.3 
Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 152.2, 133.2, 131.1 – 130.2 (m, J = 14.5, 10.0 Hz), 129.2 
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(dd, J = 16.5, 3.1 Hz), 128.0 – 126.5 (m, J = 8.3 Hz), 124.9 – 124.5 (m), 123.4, 118.7 – 118.3 (m), 
94.7, 75.9 (d, J = 5.1 Hz), 66.5 (d, J = 6.7 Hz), 65.5 (d, J = 5.9 Hz), 51.5 (d, J = 153.6 Hz), 32.3 (dd, 
J = 7.4, 6.3 Hz), 18.5 (d, J = 8.1 Hz), 13.6 (d, J = 4.1 Hz); 31P NMR (121 MHz, CDCl3): δ 18.07;  
HRMS (ESI): m/z calculated for [C20H27Cl4NO5P]+: 532.0375; found 532.0382. 
 
 4k’: The enantiomeric ratio was determined as 50:50 e.r. by chiral HPLC [Chiralpak IA, 
hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 10.5 min, tr 
(minor): 11.5 min]. 1H NMR (300 MHz, CDCl3): δ 7.63 (bs, 1H), 7.16 (bs, 
1H), 7.08 (t, J = 7.4 Hz, 1H), 7.02 (d, J = 7.4 Hz, 1H), 6.35 (d, J = 4.3 Hz, 
1H), 5.43 (d, J = 20.5 Hz, 1H), 5.15 (m, 1H), 4.57 (m, 1H), 4.00 – 3.64 (m, 
3H), 1.57 – 1.49 (m, 2H), 1.34 – 1.23 (m, 4H), 1.15 – 1.00 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H) 0.77 
(t, J = 7.2, 3H); 13C NMR (75 MHz, CDCl3): δ 152.6, 141.5, 128.5, 126.8, 125.5 (d, J = 25.8 Hz), 
124.8, 123.9 – 123.2 (m), 94.8, 76.0 – 75.4 (m), 65.5 (d, J = 6.0 Hz), 32.6 – 32.2 (m), 23.8, 21.7, 
18.6 (d, J = 8.7 Hz), 13.5 (d, J = 5.5 Hz); 31P NMR (121 MHz, CDCl3): δ 17.90 - 17.7 (m); HRMS 
(ESI): m/z calculated for [C20H27Cl4NO5P]+: 532.0375; found 532.0998. 
 
2,2,2-Trichloroethyl 6-bromo-2-(dibutoxyphosphoryl)quinoline-1(2H)-carboxylate (4l) 
6-Bromoquinoline (2g) (20.1 mg, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 
0.1 mmol, 1.0 eq.), 1a (2.8 mg, 2.5 mol%) and phosphite 3c (44.4 
µL, 0.2 mmol, 2.0 eq.) were reacted in toluene according to the 
general procedure. The desired product 4l (51.0 mg, 0.088 mmol, 88%) was isolated by flash 
column chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The 
enantiomeric ratio was determined as 88:12 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH 
(95:5), 1.0 mL/min, = 300 nm: tr (major): 15.4 min, tr (minor): 16.5 min]. 1H NMR (300 MHz, 
CDCl3): δ 7.53 (bs, 1H), 7.34 (d, J = 7.8 Hz, 1H), 7.22 (d, J = 2.1 Hz, 1H), 6.54 (dd, J = 9.5, 5.4 Hz, 
1H), 6.16 (bs, 1H), 5.64 (d, J = 19.1 Hz, 1H), 5.09 (m, 1H), 4.60 (m, 1H), 4.12 – 3.77 (m, 4H), 1.60 
– 1.40 (m, 2H), 1.38 – 1.23 (m, 4H), 1.16 – 1.02 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H), 0.81 (t, J = 7.3 
Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 152.2, 133.3 – 132.8 (m), 130.7 – 130.4 (m), 129.2 (dd, J 
= 16.5, 3.1 Hz), 128.0 – 126.5 (m), 124.9 – 124.5 (m), 123.4, 118.4, 94.7, 76.2 – 74.4 (m), 69.0 
– 66.1 (m), 65.5 (d, J = 5.9 Hz), 51.6 (d, J = 153.6 Hz), 32.4 (dd, J = 7.4, 6.3 Hz), 18.6 (d, J = 8.1 
Hz), 13.6 (d, J = 4.1 Hz); 31P NMR (121 MHz, CDCl3): δ 18.07;  HRMS (ESI): m/z calculated for 
[C20H27BrCl3NO5P]+: 575.9870; found 575.9870. 
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2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-6-methoxyquinoline-1(2H)-carboxylate (4m) 
6-Methoxyquinoline (2h) (13.8 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 
µL, 0.1 mmol, 1.0 eq.), 1a (5.6 mg, 0.005 mmol, 5.0 mol%) and 
phosphite 3c (50.0 µL, 0.2 mmol, 2.0 eq.) were reacted in toluene 
according to the general procedure. The desired product 4m (45.7 mg, 0.086 mmol, 86%) was 
isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as a colourless 
oil. The enantiomeric ratio was found to be 92:8 by chiral HPLC (Chiralpak IA, Hex/iPrOH 95:5, 
1.0 mL/min, λ=300 nm: tr (minor): 20.9 min, tr (major): 19.7 min. 1H NMR (300 MHz, CDCl3): 
δ 7.62-7.34 (m, 1H), 6.76 (d, J = 7.8 Hz, 1H), 6.62 (d, J = 2.8 Hz, 1H), 6.57 (dd, J = 9.5, 5.4 Hz, 
1H), 6.07 (s, 1H), 5.65 – 5.49 (m, 1H), 5.03 (dd, J = 61.1, 11.4 Hz, 1H), 4.55 (dd, J = 62.8, 11.1 
Hz, 1H), 4.06 – 3.73 (m, 4H), 3.72 (s, 3H), 1.53 – 1.36 (m, 2H), 1.32-1.16 (m, 4H), 1.03 (d, J = 6.8 
Hz, 2H), 0.81 (t, J = 7.2 Hz, 3H), 0.72 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 157.1 (d, 
J = 5.7 Hz), 152.4 (d, J = 5.7 Hz), 128.4, 127.8, 126.4, 123.8, 113.1, 110.3, 94.98, 75.9, 66.5-66.4 
(m), 55.4, 51.7 (d, J = 153.0 Hz), 32.4 (dd, J = 11.1, 6.1 Hz), 18.5 (d, J = 13.4 Hz), 13.5 (d, J = 8.2 
Hz); 31P NMR (121 MHz, CDCl3): δ 18.48; HRMS (ESI): m/z calculated for [C21H30Cl3NO6P]+: 
528.0864, found 528.0871.  
 
2,2,2-Trichloroethyl 5-bromo-2-(dibutoxyphosphoryl)quinoline-1(2H)-carboxylate (4n) 
5-Bromoquinoline (2i) (14.8 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 
mmol, 1.0 eq.), 1a (2.8 mg, 2.5 mol%) and phosphite 3c (44.4 µL, 0.2 
mmol, 2.0 eq.) were reacted in toluene according to the general 
procedure. The desired product 4n (44.0 mg, 0.076 mmol, 76%) was 
isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale 
yellow oil. The enantiomeric ratio was detemined as 97:3 e.r. by chiral HPLC [Chiralpak IA, 
hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 15.6 min, tr (minor): 16.6 min]. 1H 
NMR (300 MHz, CDCl3): δ 7.57 (bs, 1H), 7.37 (d, J = 8.1Hz, 1H), 7.09 (t, J = 7.9 Hz, 1H), 7.00 (dd, 
J = 9.8, 5.4 Hz, 1H), 6.25 (q, J = 4.7 Hz, 1H), 5.75 – 5.55 (d, J = 19.8 Hz 1H), 5.16 - 4.55 (m, 2H), 
4.12 – 3.72 (m, 4H), 1.58 – 1.44 (m, 2H), 1.35 – 1.29 (m, 4H), 1.20 – 1.00 (m, 2H), 0.88 (t, J = 
7.3 Hz, 3H), 0.80 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 152.3, 129.58 - 129.53 (m), 
128.5 - 128.3 (m), 127.1 (d, J = 4.2 Hz), 126.9 - 126.8 (m) , 121.3 (d, J = 2.7 Hz), 94.7, 75.97 - 
75.92 (m), 66.9 - 66.5 (m), 51.3 (d, J =153.3 Hz), 32.4 (dd, J = 14.6, 6.1 Hz), 18.6 (d, J = 15.0 Hz), 
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13.6 (d, J = 6.6 Hz); 31P NMR (121 MHz, CDCl3): δ 17.85;  HRMS (ESI): m/z calculated for 
[C20H27BrCl3NO5P]+: 575.9870; found 575.9865. 
 
Benzyl 2-(dibutoxyphosphoryl)quinoline-1(2H)-carboxylate (4p) 
Quinoline (2a) (11.8 µL, 0.1 mmol, 1.0 eq.), CbzCl (14.2 µL, 0.1 mmol, 
1.0 eq.), 1a (2.8 mg, 2.5 mol%) and phosphite 3c (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure. The 
desired product 4p (37.5 mg, 0.082 mmol, 82%) was isolated by flash column chromatography 
(petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The enantiomeric ratio was 
determined as 79:21 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH (95:5), 1.0 mL/min, = 
300 nm: tr (major): 25.8 min, tr (minor): 19.6 min]. 1H NMR (300 MHz, CDCl3): δ 7.43 – 7.31 
(m, 5H), 7.19 (bs, 1H), 7.10 – 7.01 (m, 2H), 6.58 (dd, J = 9.5, 5.5 Hz, 1H), 6.07 (bs, 1H), 5.65 (bs, 
1H), 5.25 (d, J = 24.9 Hz, 2H), 3.95 – 3.63 (m, 4H), 1.32 – 1.22 (m, 8H), 0.88 (t, J = 7.6 Hz, 6H); 
13C NMR (75 MHz, CDCl3): δ 157.3, 135.7, 128.5, 128.3, 128.1 (d, J = 1.8 Hz), 128.0 (d, J = 2.4 
Hz), 127.9, 127.3, 126.4 (d, J = 2.1 Hz), 124.8 (d, J = 6.2 Hz), 32.3 (dd, J = 10.1, 6.1 Hz), 31.6, 
25.4, 22.7, 18.5 (d, J = 10.1 Hz), 13.6 (d, J = 6.0 Hz); 31P NMR (121 MHz, CDCl3): δ 18.93. 
 
3.3.4 Analytical Data for Compounds 5 
2,2,2-Trichloroethyl 2-(diethoxyphosphoryl)-3-methylpyridine-1(2H)-carboxylate (5a) 
3-Picoline (2j) (10.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3a (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure. The desired 
product 5a (36.0 mg, 0.089 mmol, 89%) was isolated by flash column chromatography 
(petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The enantiomeric ratio was 
determined as 87:13 e.r. by chiral HPLC [Chiralpak IC, hexane/iPrOH (80:20), 1.0 mL/min, = 
300 nm: tr (major): 10.2 min, tr (minor): 9.5 min]. 1H NMR (300 MHz, CDCl3): δ 6.71 (t, J = 6.0 
Hz, 1H), 5.82 (t, J = 5.8 Hz, 1H), 5.53 – 5.35 (m, 1H), 5.14 (d, J = 16.8 Hz, 1H), 4.94 (dd, J = 34.1, 
11.9 Hz, 1H), 4.71 (dd, J = 34.8, 11.9 Hz, 1H), 4.20 – 4.04 (m, 4H), 1.97 (d, J = 3.4 Hz, 3H), 1.31 
– 1.26 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 151.8 (d, J = 1.0 Hz, minor), 151.4 (d, J = 1.8 Hz, 
major), 137.7, 130.7, 130.1, 128.5, 126.5 (d, J = 4.3 Hz, major), 126.0 (d, J = 4.3 Hz, minor), 
124.3, 123.3 (d, J = 1.5 Hz), 122.1 (d, J = 1.6 Hz), 120.2 (d, J = 9.5 Hz, minor), 119.7 (d, J = 9.6 
Hz, major), 94.8 (s, major), 94.7 (s, minor), 75.5, 63.0 (d, J = 7.1 Hz, major), 62.6 (d, J = 6.3 Hz, 
Chapter 3 
97 
minor), 55.6 (d, J = 74.2 Hz, minor), 54.8 (d, J = 148.7 Hz, major), 28.2, 21.65 (d, J = 2.7 Hz, 
minor), 21.5 (d, J = 2.6 Hz, major), 16.5 (d, J = 5.5 Hz, minor), 16.4 (d, J = 6.2 Hz, major); 31P 
NMR (121 MHz, CDCl3) δ 19.86; HRMS (ESI): m/z calculated for [C13H20Cl3NO5P + MeOH]+: 
438.0401; found 438.0032. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-3-methylpyridine-1(2H)-carboxylate (5b) 
3-Picoline (2j) (10.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3c (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure. The desired 
product 5b (39.0 mg, 0.084 mmol, 84%) was isolated by flash column chromatography 
(petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The enantiomeric ratio was 
determined as 85:15 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH (95:5), 1.0 mL/min, = 
300 nm: tr (major): 9.9 min, tr (minor): 9.3 min]. 1H NMR (300 MHz, CDCl3): δ 1H NMR (300 
MHz, CDCl3) δ 6.71 (m, 1H), 5.82 (m, 1H), 5.51 – 5.34 (m, 1H), 5.14 (d, J = 16.9 Hz, 1H), 5.06 – 
4.83 (dd, JP-H , JH-H = 52.6, 11.8 1H), 4.80 – 4.57 (dd JP-H , JH-H = 12.12, 1H), 4.15 – 3.95 (m, 4H), 
1.97 (d, J = 3.6 Hz, 3H), 1.65 – 1.55 (m, 4H), 1.43 – 1.31 (m, 4H), 0.91 (t, J = 7.4 Hz, 6H). 13C 
NMR (75 MHz, CDCl3): δ 151.4 (d, J = 1.7 Hz), 126.6 (d, J = 4.2 Hz), 122.1, 119.7 (d, J = 9.9 Hz), 
109.0 (d, J = 3.08 Hz), 94.8, 93.8, 75.6, 66.5 (d, J = 7.5 Hz), 66.2 (d, J = 6.6 Hz), 55.8, 53.8, 32.6 
- 32.5 (m), 23.8, 21.5, 18.6 (d, J = 1.2 Hz), 13.6 (d, J = 2.0 Hz); 31P NMR (121 MHz, CDCl3) δ 
20.00; HRMS (ESI): m/z calculated for [C17H28Cl3NO5P + MeOH ]+: 478.1078; found 478.0716. 
 
2,2,2-Trichloroethyl 2-(diisopropoxyphosphoryl)-3-methylpyridine-1(2H)-carboxylate (5c) 
3-Picoline (2j) (10.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3d (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure leading to a 
mixture of 12.5:1 of 5c and regioisomer 5c’. The desired product 5c (38.2 mg, 0.088 mmol, 
88%) was isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as 
slight pale yellow oil. The enantiomeric ratio was determined as 81:19 e.r. by chiral HPLC 
[Chiralpak IA, hexane/iPrOH (98:2), 1.0 mL/min, = 300 nm: tr (major): 14.7 min, tr (minor): 
13.8 min]. 1H NMR (300 MHz, CDCl3): δ 6.71 (t, J = 6.7 Hz, 1H), 5.82 (dd, J = 12.6, 6.4 Hz, 1H), 
5.49 – 5.32 (m, 1H), 5.16 – 5.04 (m, 1H), 4.87 – 4.75 (m, 2H), 4.74 – 4.56 (m, 2H), 1.96 (d, J = 
3.3 Hz, 3H), 1.34 – 1.25 (m, 12H); 13C NMR (100 MHz, CDCl3): δ 147.9, 146.0, 130.1, 128.6 (d, J 
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= 24.8 Hz), 124.1 (d, J = 55.7 Hz), 122.1 (s), 119.8 (d, J = 80.4), 118.0, 113.4, 94.8, 75.3, 70.8 (d, 
J = 5.7 Hz), 51.7, 28.2, 23.9 (dd, J = 20.0, 4.5 Hz); 31P NMR (121 MHz, CDCl3): δ 18.52-18.12 (m); 
HRMS (ESI): m/z calculated for [C15H24Cl3NO5P]+: 434.0433; found 434.0452. 
 
2,2,2-Trichloroethyl 2-(diethoxyphosphoryl)-4-methylpyridine-1(2H)-carboxylate (5d) 
4-Picoline (2k) (10.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3a (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure. The desired 
product 5d (33.0 mg, 0.081 mmol, 81%) was isolated by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The 
enantiomeric ratio was determined as 82:18 e.r. by chiral HPLC [Chiralpak IC, hexane/iPrOH 
(80:20), 1.0 mL/min, = 300 nm: tr (major): 11.5 min, tr (minor): 19.8 min]. 1H NMR (300 MHz, 
CDCl3): δ 6.78 (t, J = 8.9 Hz, 1H), 5.38 (d, J = 4.8 Hz, 1H), 5.36 – 5.20 (m, 2H), 4.96 (dd, J = 44.8, 
11.9 Hz, 1H), 4.68 (dd, J = 51.0, 11.9 Hz, 1H), 4.29 – 3.93 (m, 4H), 1.85 – 1.77 (m, 3H), 1.29 (t, 
J = 7.1 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 152.4, 151.2, 133.5, 131.5, 125.5, 124.3, 111.7 (d, 
J = 3.5 Hz), 111.0 (d, J = 5.5 Hz), 75.5, 63.2 - 62.7 (m), 51.0 (d, J = 151.6 Hz), 20.5, 16.5 (d, J = 
10.5 Hz); 31P NMR (121 MHz, CDCl3): δ 18.86 (d, J = 28.6 Hz); HRMS (ESI): m/z calculated for 
[C13H20Cl3NO5P]+: 406.0139; found 406.0108. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-4-methylpyridine-1(2H)-carboxylate (5e) 
4-Picoline (2k) (10.0 µL, 0.1 mmol, 1.0 e.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3c (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in MTBE according to the general procedure. The desired 
product x (31.0 mg, 0.067 mmol, 67%) was isolated by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The 
enantiomeric ratio was determined as 81:19 e.r. by chiral HPLC [Chiralpak IC, hexane/iPrOH 
(90:10), 1.0 mL/min, = 300 nm: tr (major): 14.1 min, tr (minor): 22.4 min]. 1H NMR (300 MHz, 
CDCl3) δ 6.88 – 6.63 (m, 1H), 5.37 (s, 1H), 5.29 (dd, J = 14.5, 7.5 Hz, 1H), 5.08 – 4.54 (m, 3H), 
4.20 – 3.89 (m, 4H), 1.80 (d, J = 5.8 Hz, 3H), 1.70 – 1.50 (m, 4H), 1.43 – 1.30 (m, 4H), 0.91 (t, J 
= 7.3 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 151.2, 133.1, 132.6 (d, J = 9.7 Hz), 125.9 – 125.5 (m), 
125.4, 124.2, 111.6 (d, J = 3.6 Hz), 111.1 (d, J = 5.4 Hz), 94.8, 75.5, 66.4 (dd, J = 25.8, 7.2 Hz), 
65.4 (d, J = 6.0 Hz), 50.9 (d, J = 153.8 Hz), 32.9 – 31.9 (m), 20.5 (d, J = 3.2 Hz), 18.6 (d, J = 3.6 
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Hz), 13.5 (d, J = 4.9 Hz); 31P NMR (121 MHz, CDCl3): δ 19.33 (m) HRMS (ESI): m/z calculated for 
[C17H28Cl3NO5P + MeOH - O]+: 478.1078; found 478.0715. 
 
2,2,2-Trichloroethyl 2-(diisopropoxyphosphoryl)-4-methylpyridine-1(2H)-carboxylate (5f) 
4-Picoline (2k) (10.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3d (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in MTBE according to the general procedure. The desired 
product x (40.7 mg, 0.094 mmol, 94%) was isolated by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) as slight pale yellow oil. The 
enantiomeric ratio was determined as 76:24 e.r. by chiral HPLC [Chiralpak IC, hexane/iPrOH 
(90:10), 1.0 mL/min, = 300 nm: tr (major): 9.0 min, tr (minor): 10.7 min]. 1H NMR (300 MHz, 
CDCl3): δ 6.71 (t, J = 6.7 Hz, 1H), 5.88 – 5.75 (m, 1H), 5.52 – 5.30 (m, 1H), 5.20 – 5.01 (m, 1H), 
4.81 (d, J = 2.2 Hz, 1H), 4.78 – 4.55 (m, 3H), 1.96 (d, J = 3.6, 3H), 1.34 – 1.25 (m, 12H); 13C NMR 
(75 MHz, CDCl3): δ 150.4, 125.9 (d, J = 4.3 Hz), 122.1, 121.1, 118.9 (d, J = 9.6 Hz), 118.5 (d, J = 
9.7 Hz), 108.2 (d, J = 3.8 Hz), 93.8, 74.6, 70.5 (dd, J = 20.9, 7.4 Hz), 54.7 (d, J = 151.2 Hz), 23.3 
(d, J = 3.0 Hz), 23.2 (d, J = 2.8 Hz), 22.8 – 22.6 (m), 20.5 (d, J = 2.7 Hz); 31P NMR (121 MHz, 
CDCl3) δ 18.23; HRMS (ESI): m/z calculated for [C15H23Cl3NO5P + Na]+: 456.0272; found 
456.0275. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)-6-methylpyridine-1(2H)-carboxylate (5g) 
2-Picoline (2l) (10.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 
eq.), 1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3c (44.4 µL, 0.2 
mmol, 2.0 eq.) were reacted in toluene according to the general 
procedure. The desired product 5g (36.0 mg, 0.078 mmol, 78%) was isolated by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) as a colourless oil. The enantiomeric 
ratio was determined as 85:15 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH (90:10), 1.0 
mL/min, = 300 nm: tr (major): 12.4 min, tr (minor): 31.0 min]. 1H NMR (300 MHz, CDCl3): δ 
6.13 – 5.95 (m, 1H), 5.81 – 5.66 (m, 1H), 5.61 – 5.36 (m, 2H), 5.22 – 4.94 (m, 2H), 4.13 – 3.98 
(m, J = 16.7, 13.7, 6.6, 3.4 Hz, 4H), 2.25 (s, 3H), 1.66 – 1.57 (m, 4H), 1.41 – 1.33 (m, 4H), 0.91 
(t, J = 7.3 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 145.4 (d, J = 154.3 Hz), 144.2 – 143.2 (m), 137.4, 
133.6 – 133.4 (m), 132.9 (d, J = 51.5 Hz), 132.1 (d, J = 44.9 Hz), 127.1 – 125.9 (m), 125.1 (d, J = 
127.3 Hz), 122.4, 122.3 (d, J = 29.7 Hz), 121.9 (dd, J = 78.0, 40.9 Hz), 119.9, 118.7, 116.5, 114.0 
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(d, J = 4.3 Hz), 94.8, 75.9 – 75.3 (m, J = 22.0 Hz), 67.3 – 66.0 (m), 64.3, 51.4 (d, J = 153. Hz), 32.6 
(dd, J = 8.2, 5. Hz), 24.5, 18.6, 13.6 (d, J = 1.7 Hz); 31P NMR (121 MHz, CDCl3): δ 19.40; HRMS 
(ESI): m/z calculated for [C17H28Cl3NO5P]+: 462.0765; found 462.0729. 
 
2,2,2-Trichloroethyl 2-(dibutoxyphosphoryl)pyridine-1(2H)-carboxylate (5h) 
Pyridine (2m) (8.0 µL, 0.1 mmol, 1.0 eq.), TrocCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3c (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure leading to 
a mixture of 11:1 of 5h and regioisomer 5h’. The desired product 5h (42.0 mg, 0.094 mmol, 
94%) was isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as a 
colourless oil. The enantiomeric ratio was determined as 80:20 e.r. by chiral HPLC [Chiralpak 
IA, hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 11.7 min, tr (minor): 12.4 min]. 
1H NMR (300 MHz, CDCl3): δ 6.86 – 6.73 (m, 1H), 6.19 – 5.94 (m, 1H), 5.75 – 5.61 (m, 1H), 5.56 
– 5.24 (m, 2H), 4.98 (dd, J = 58.4, 11.9 Hz, 1H), 4.67 (dd, J = 60.6, 11.9 Hz, 1H), 4.22 – 3.92 (m, 
4H), 1.69 – 1.53 (m, 4H), 1.45 – 1.28 (m, 4H), 0.91 (t, J = 7.3 Hz, 3H), 0.90 (t, J = 6.5 Hz, 3H);  13C 
NMR (75 MHz, CDCl3): δ 150.8 (s, minor), 150.3 (d, J = 1.9 Hz, major), 125.1 – 124.9 (m), 123.9 
(d, J = 1.3 Hz), 123.7 (d, J = 9.7 Hz, minor), 123.1 (d, J = 9.7 Hz, major), 115.7 (d, J = 5.4 Hz, 
major), 115.2 (d, J = 5.4 Hz, minor), 107.6 (d, J = 3.7 Hz, minor), 107.2 (d, J = 3.8 Hz, major),93.8 
(s, major), 93.7 (s, minor), 74.6 (s), 66.3 – 65.3 (m), 50.3 (d, J = 153.5 Hz, minor), 49.8 (d, J = 
153.8 Hz, major), 32.0 – 31.1 (m), 17.6 (s), 12.6 (d, J = 2.3 Hz); 31P NMR (121 MHz, CDCl3): δ 
18.57; HRMS (ESI): m/z calculated for [C16H26Cl3NO5P]+: 448.0609; found 448.0600. 
 
Benzyl 2-(dibutoxyphosphoryl)pyridine-1(2H)-carboxylate (5i) 
Pyridine (2m) (8.0 µL, 0.1 mmol, 1.0 eq.), CbzCl (14.2 µL, 0.1 mmol, 1.0 eq.), 
1a (11.0 mg, 0.01 mmol, 10 mol%) and phosphite 3c (44.4 µL, 0.2 mmol, 2.0 
eq.) were reacted in toluene according to the general procedure leading to a 
mixture of 4:1 of 5i and regioisomer 5i’. The desired product 5i (32.0 mg, 0.079 mmol, 79%) 
was isolated by flash column chromatography (petroleum ether/ethyl acetate, 7:3) as a 
colourless yellow oil. The enantiomeric ratio was determined as 65:35 e.r. by chiral HPLC 
[Chiralpak IA, hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 17.4 min, tr (minor): 
15.7 min]. 1H NMR (300 MHz, CDCl3): δ 7.44 – 7.32 (m, 5H), 6.80 (dd, J = 37.7, 7.6 Hz, 1H), 6.17 
– 5.94 (m, 1H), 5.72 – 5.53 (m, 1H), 5.42 (dd, J = 16.8, 6.4 Hz, 1H), 5.35 – 5.26 (m, 1H), 5.25 – 
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5.12 (m, 2H), 4.10 – 3.83 (m, 4H), 1.63 – 1.53 (m, 4H), 1.31 – 1.22 (m, 4H), 0.94 – 0.87 (m, 6H); 
13C NMR (75 MHz, CDCl3): δ 149.4, 135.7, 128.5, 128.1 (d, J = 1.8 Hz), 127.8, 126.4 (d, J = 2.1 
Hz), 124.8 (d, J = 6.2 Hz), 68.3, 66.3 (d, J = 7.0 Hz), 32.9 – 30.6 (m), 25.3, 22.7, 18.5 (d, J = 10.1 
Hz), 13.5 (d, J = 6.0 Hz); 31P NMR (121 MHz, CDCl3): δ 19.27 
3.3.5 Derivatization of Phosphonates 4/5: 
(1-((2,2,2-Trichloroethoxy)carbonyl)-1,2-dihydroquinolin-2-yl)phosphonic acid (7) 
4a (30 mg, 0.060 mmol, 1.0 eq.; 92:8 e.r.) was dissolved in anhydrous DCM 
(1 mL) and cooled to 0 °C. Bromotrimethylsilane (20 µL, 0.180 mmol, 3.0 
eq.) was added and the reaction mixture was stirred overnight at room 
temperature. After the addition of H2O (1 mL), solvent and water were removed in vacuo to 
obtain the desired product 7 (22 mg, 0.057 mmol, 95%). 1H NMR (300 MHz, CDCl3): δ 7.55 (bs, 
1H), 7.17 (bs, 1H), 7.11 – 6.85 (m, 2H), 6.54 (bs, 1H), 5.97 (bs, 1H), 5.49 (bd, J = 18.0 Hz, 1H), 
5.04 (bs, 1H), 4.56 (bs, 1H); 13C NMR (75 MHz, CDCl3): δ 152.1, 133.5, 128.2, 127.5, 127.4, 
126.7, 126.7, 126.0, 125.0, 124.9, 124.8, 122.3, 94.3, 75.5, 52.9, 50.8; 31P NMR (121 MHz, 
CDCl3): δ 12.37; HRMS (ESI): m/z calculated for [C12H12Cl3NO5P]+: 385.9513; found 385.9513. 
 
To determine the enantiomeric ratio, the acid was again esterified. Therefore, 7 (22 mg, 0.057 
mmol, 95%) was dissolved in CH(OEt)3 (1 mL) and stirred at 145 °C for 3 h. The reaction mixture 
was cooled to r.t. and solvent was evaporated in vacuo. The brown oil was dissolved in EtOAc, 
washed with brine and concentrated in vacuo to obtain the desired product 4a (19 mg, 0.043 
mmol, 75%) as a brown oil. The enantiomeric ratio was determined as 92:8 e.r. by chiral HPLC 
[Chiralpak IA, hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 16.3 min, tr (minor): 
17.3 min]. 
 
Ethyl 2-(dibutoxyphosphoryl)-3,4-dihydroquinoline-1(2H)-carboxylate (8) 
4c (264.0 mg, 0.53 mmol, 1 eq.; 92:8 e.r.) was dissolved in MeOH (5 mL) 
and Pd/C (5.3 mg, 0.05 mmol, 10 mol%) was added. The reaction 
mixture was stirred overnight in an autoclave (10 bar, r.t.) and the 
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product 8 (198.5 mg, 0.5 mmol, 99%) was obtained by filtration through celite. The 
enantiomeric ratio was determined as 92:8 e.r. by chiral HPLC [Chiralpak IA, hexane/iPrOH 
(95:5), 1.0 mL/min, = 300 nm: tr (major): 14.3 min, tr (minor): 15.3 min]. 1H NMR (300 MHz, 
CDCl3): δ 7.50 (dd, J = 13.4 Hz, J = 7.8 Hz, 1H), 7.23 – 6.98 (m, 3H), 5.11 – 4.93 (m, 1H), 4.38 – 
4.08 (m, 2H), 4.06 – 3.79 (m, 4H), 2.90 – 2.76 (m, 1H), 2.72 – 2.55 (m, 1H), 2.53 – 2.35 (m, 1H), 
2.28 – 2.01 (m, 1H), 1.59 – 1.50 (m, 2H), 1.41 – 1.26 (m, 7H), 1.19 – 1.04 (m, 2H), 0.89 (t, J = 
7.3 Hz, 3H), 0.84 – 0.76 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 153.8, 136.1, 126.5, 125.1 (t, J = 
17.3 Hz), 123.8, 68.8, 67.6, 65.1 (d, J = 6.6 Hz), 64.6 (d, J = 7.6 Hz), 61.4, 48.0 (d, J = 158.0 Hz), 
31.4 (dd, J = 13.6, 6.2 Hz), 29.3, 24.5, 17.6 (d, J = 13.4 Hz), 13.4, 12.6 (d, J = 7.7 Hz); 31P NMR 
(121 MHz, CDCl3): δ 24.65, 23.90; HRMS (ESI): m/z calculated for [C20H33NO5P]+: 398.2091; 
found 398.2095. The enantiomeric ratio was detemined as 92:8 e.r. by chiral HPLC [Chiralpak 
IA, hexane/iPrOH (95:5), 1.0 mL/min, = 300 nm: tr (major): 14.3 min, tr (minor): 15.3 min]. 
 
Piperidin-2-ylphosphonic acid (9) [3] 
 
5i (50 mg, 0.12 mmol, 1 eq.) and Pd/C (1.1 mg, 10 mol%) were dissolved in MeOH (1 mL) and 
stirred overnight in an autoclave (10 bar) at room temperature. The reaction mixture was 
filtered through celite to remove the Pd-catalyst, and the crude product was directly dissolved 
in HCl (6 M, 1mL) and stirred at 100 °C for 3 h. After cooling to room temperature, volatiles 
were removed under reduced pressure and the crude product was dissolved again in a small 
amount of MeOH and dropped into Et2O to obtain the desired product as a pale yellow solid 
(5 mg, 0.03 mmol, 25%). Moreover, further 5 mg of 9 were recovered from the MeOH-Et2O 
solution (combined 50% yield/2 steps). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : +2.7 (c 0.1, NaOH 1M); [𝛂]𝟓𝟖𝟗
𝟐𝟎 : +2.6 (c 0.1, 
CD3OD); Lit.[3b] [(-)-(R)-9 [𝛂]𝟓𝟖𝟗
𝟐𝟎 : -4.5 (c 1.0, 1M NaOH)]. 1H NMR (300 MHz, CD3OD): δ 3.98 (dd, 
J = 13.9, 6.8 Hz, 1H), 3.22 (d, J = 13.9 Hz, 1H), 2.99 (t, J = 12.4 Hz, 1H), 2.14 (t, J = 13.3 Hz, 1H), 
1.88 (d, J = 13.1 Hz, 2H), 1.71 – 1.60 (m, 2H), 1.52 – 1.37 (m, 1H); 31P NMR (162 MHz, CD3OD): 
δ 13.69. 
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3.1.4.5 Representative Spectra and HPLC Chromatograms of 4a and 5a 
 
 
 
 
31P-NMR: 
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Chiral-phase HPLC: IA; Hex/iPrOH 95:5, F = 1 mL/min (λ = 300 nm)  
racemic: 
 
 
enantioselective: 
 
 
 
 
Signal 4: DAD1 E, Sig=280,16 Ref=360,100
 
 
Signal 5: DAD1 F, Sig=260,16 Ref=360,100
 
 
Signal 6: DAD1 G, Sig=270,4 Ref=off
 
 
Signal 7: DAD1 H, Sig=300,4 Ref=off
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.324 MF    0.3980  397.84839   16.65875  91.8500
   2  17.334 FM    0.4218   35.30189    1.39503   8.1500
 
Totals :                   433.15028   18.05378
 
 
=====================================================================
                          *** End of Report ***
Data File C:\CHEM32\1\DATA\QD\QD 41 F2 2016-10-11 15-31-23.D
Sample Name: QD 41 F2
LC 1260 10/22/2016 1:35:18 PM SYSTEM Page 3 of 3
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31P-NMR: 
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Chiral-phase HPLC: IC; Hex/iPrOH 80:20 (λ = 300 nm)  
racemic: 
 
 
enantioselective:  
 
 
 
Signal 1: DAD1 A, Sig=300,100 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.889 MM    0.2577  504.70346   32.63961  80.3497
   2  11.601 MM    0.8251  123.42986    2.49325  19.6503
 
Totals :                   628.13332   35.13286
 
 
 
Signal 2: DAD1 B, Sig=254,16 Ref=360,100
 
 
Signal 3: DAD1 C, Sig=210,8 Ref=360,100
 
 
Signal 4: DAD1 D, Sig=230,16 Ref=360,100
 
 
Signal 5: DAD1 E, Sig=280,16 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.889 BB    0.2397  650.58734   42.23640  83.1820
   2  11.724 MM    0.7827  131.53767    2.80100  16.8180
 
Totals :                   782.12502   45.03739
 
 
 
Signal 6: DAD1 F, Sig=260,16 Ref=360,100
 
 
Signal 7: DAD1 G, Sig=270,16 Ref=360,100
 
 
Signal 8: DAD1 H, Sig=300,16 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.889 MM    0.2576 1236.90454   80.01938  82.6916
   2  11.759 MM    0.8110  258.89929    5.32042  17.3084
 
Totals :                  1495.80383   85.33980
 
 
=====================================================================
                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TF\TF-208 OPT 2016-08-16 11-31-04.D
Sample Name: TF-208 opt
LC 1260 1/8/2017 4:55:48 PM SYSTEM Page 3 of 3
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4. Highly Enantioselective Nucleophilic Dearomatization of 
Pyrylium Derivatives 
 
Abstract: A general and highly enantioselective catalytic synthesis of 2-alkyl substituted 
oxygen heterocycles by nucleophilic dearomatization of pyrylium triflate derivatives with silyl 
ketene acetals is described. The use of chiral triazoles as anion-binding catalysts, able to form 
a close ion-pair with the substrates, was crucial to achieve both high conversions and chirality 
transfer. Thus, this method provides a simple access to chiral chromanones and 
dihydropyranones in excellent enantioselectivities from the corresponding 4-
(benzo)pyranones. Kinetic, binding and computational studies were performed, suggesting a 
high order complexation of the catalyst with the triflate anions to form the active catalytic 
species. 
 
Parts of this chapter are reprinted with permission from Julia Bamberger, Melania Gómez Martínez, 
and Olga García Mancheño. Manuscript in preparation. 
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4.1 Introduction 
Oxygen-containing chiral heterocycles are essential moieties commonly found in bioactive 
compounds and natural products.[1] Owing to their synthetic significance, many efforts for the 
development of catalytic asymmetric methodologies have been made.[2] Most of the 
described methods rely however on cyclization reactions from linear compounds[2c] or oxygen-
containing leaving groups alpha to the O-atom in cyclic systems[2e, 2g] to form in situ the 
reactive oxonium species. In 2017, important breakthroughs in this area through cyclic 
oxonium ion intermediates engaging asymmetric organocatalysis have been achieved by List[3] 
and Jacobsen.[4] In both cases, the method relies as well on the employment of a leaving group 
alpha to the oxygen atom to form in situ the active oxonium species from lactols (LG = OAc) 
and sugars (LG = Cl) (Scheme 1).  
 
Scheme 1 Standard LG-approach for asymmetric nucleophilic addition to oxocarbenium ions.  
 
Chapter 4 
110 
List and co-workers introduced an imidodiphosphorimidate (IDPi) catalyst in the 
stereocontrolled nucleophilic substitution reaction with various oxygen heterocycles, 
including tetrahydrofuranes, tetrahydropyranes, oxepanes, chromanes, and 
dihydrobenzofuranes (Scheme 1a). They obtained excellent enantioselectivities by reacting 
the corresponding lactol acetates with silyl ketene acetals. Mechanistic studies confirmed 
pairing between a non-stabilized, aliphatic, cyclic oxocarbenium ion intermediate and the 
chiral counter anion (Scheme 1b).[3] In the same year, Jacobsen reported on a macrocyclic bis-
thiourea derivative that catalyzes α-configured glycosyl electrophiles, which are transformed 
to β-O-glycosidic linkages by means of invertive substitution. (Scheme 1c).[4]  
Alternatively, an interesting approach for the synthesis of chiral oxygen-heterocycles is based 
on catalyzed enantioselective nucleophilic dearomatization reactions[5] of pyrylium-type 
derivatives.[6] However, the targeted electrophilic pyrylium salts present some intrinsic 
reactivity and selectivity challenges (Figure 1). Pyrylium and benzopyrylium salts comprise an 
oxonium ion (–C=O+–), which is stabilized by aromaticity and is therefore less reactive than a 
non-conjugated oxocarbenium ion. Additionally, in most cases the reaction of pyrylium salts 
leads mainly to the ring-opening products, which has been extensively exploited in synthesis 
(e.g. to form the corresponding pyridine derivatives).[7] Moreover, compared to the related N-
heteroarene salts (–C=NR+–), the asymmetric reactions of pyrylium salts are more challenging 
since it is not possible to fine-tune the stereoelectronic properties close to the reactive C2-
site by introducing the appropriate rest “R” at the heteroatom.  
 
Figure 1 Reactivity challenges of electrophilic pyrylium salts. 
Besides the pioneer enantioselective work employing metal catalysis,[8] only few efficient 
organocatalytic approaches for such enantioselective dearomatizations have been reported 
for stereocontrolled nucleophilic substitutions[9] or [5+2]-cyclization[10] reactions on pyrylium 
derivatives (Scheme 2). In this regard, Rueping and his group described a synergistic catalytic 
system for the asymmetric addition of aldehydes to in situ generated prochiral oxocarbenium 
ions yielding the desired products in high enantiomeric ratios and moderate diastereomeric 
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ratios (Scheme 2a).[9a] An example for an intermolecular [5+2] pyrylium cycloaddition was 
given by Jacobsen, who introduced a dual catalyst system consisting of the achiral Schreiner´s 
thiourea catalyst and a chiral primary aminothiourea. Covalent aminocatalysis is responsible 
for the chirality transfer to the desired cyclic products and Schreiner´s thiourea catalyst for the 
anion binding.(Scheme 2b).[10a] 
 
Scheme 2 a) Asymmetric nucleophilic substitutions and b) [5+2]-cyclization of pyrylium derivatives. 
Consequently, divergent approaches towards highly enantioselective methods under mild and 
metal-free conditions from different type of simple cyclic starting materials, such as 
chromones, are still greatly demanded.[11] In this regard, the group of Mattson developed a 
silanediol-catalyzed functionalization of simple chromenones (Scheme 3).[11] Due to moderate 
enantioinductions reached with this kind of catalysts, the development of a general and 
simple method is still needed. 
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Scheme 3 Silanediol-catalyzed chromenone functionalization. 
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4.2 Objectives 
As it is already demonstrated in the chapters before, along with the popular N-H and O-H 
hydrogen bond donors, the less common 1,2,3-triazole-based C-H bond donors have revealed 
enormous potential in dearomatization reactions.[12] For instance, the chiral TetrakisTriazole 
catalysts recently developed by our group have shown excellent results in the dearomatization 
of various demanding heteroarenes such as quinolines,[12b, 12e] isoquinolines,[12d] 
diazarenes[12a] and pyridines[12b, 12c] upon prior N-acylation to the corresponding salt. We 
envisioned to overcome some of the current reactivity and enantioselectivity issues of the 
related O-heteroarenes with our highly active triazole-based H-donor catalysts by forming a 
chiral contact ion-pair between an in situ generated pyrylium ion and the corresponding 
catalyst-counterion complex (Scheme 4). Moreover, the catalyst is anticipated to further 
facilitate the in situ formation of the pyrylium substrates from the corresponding neutral 4-
pyrones by activation of the silylating agent for the enolization step. 
 
Scheme 4 Enantioselective nucleophilic dearomatization of pyrylium derivatives. 
To achieve a highly enantioselective dearomatization reaction of pyrylium derivatives and to 
get a better insight into the anion-binding ability of our triazole catalysts, the following points 
will be carried out in cooperation with Julia Bamberger and Melania Gómez Martínez: 
- Optimization of the reaction conditions: Screening of various chiral H-donor catalysts, solvents 
and silylating agents  
- Study of the scope of the reaction with various silyl ketene acetals, 4-chromone and 4-pyrone 
derivatives 
- Illustration of the synthetic applicability of the catalytic method by further derivatization of 
the obtained chiral products 
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4.3 Results and Discussion 
4.3.1 Optimization Screening 
We started our studies with the one-pot reaction between commercial available 4H-chromen-
4-one (3a) as model substrate and silyl ketene acetal 4a as nucleophile at -78 °C to provide 
enantioenriched 2-substitued chromanone 5a (Table 1). The active benzopyrylium-ion species 
was previously formed in situ by treatment with a silyl derivative (R3SiX) in the presence of 10 
mol% of the H-donor catalyst and catalytic amounts of 2,4,6-collidine at 60 °C. Bulkier 2,6-di-
tert-butyl-4-methylpyridine or less hindered 2-picoline led to no improvement or provided 
lower conversions. The change from chloride to bromide to triflate trimethylsilane led to a 
notable higher conversion (from 32 to 72%) and enantioselectivity (from 64:36 to 87:13 e.r., 
entries 1-3). A screening of various triflate derivatives such as TESOTf, TIPSOTf and TBSOTf 
(entry 3-6) identified TBSOTf as the most active silyl derivative with yields up to 92% and a 
promising enantiomeric ratio of 91:9 (entry 6). Various C-H-based triazole 1,[12] N-H-based 
thiourea[13] and squaramide[14] 2 catalysts were tested (Table 1), leading to the product 5a in 
moderate to excellent yields and a broad range of enantioselectivities from almost racemic to 
high (entries 8-13). Among the tested catalysts, the triazole 1a and 1b showed the highest 
performance, providing 5a in a promising 91:9 e.r. when using TBSOTf as silylating reagent 
(entry 3). Same e.r., but within a lower yield, was observed when adding catalyst 1a in the 
second step. Compared to the N-H-based thiourea and squaramide catalysts 2, all the C-H-
based triazole catalysts 1a-d were superior in terms of enantioselectivitiy. 
  
Highly Enantioselective Nucleophilic Dearomatization of Pyrylium Derivatives 
115 
Table 1 Screening of silylating derivatives and various catalysts with 3a as a model substrate.[a] 
 
entry Catalyst (mol%) R3SiX yield (%)[b] 5a, e.r.[c] 
1 (R,R)-1a (10) TMSCl 32 64:36 
2 (R,R)-1a (10) TMSBr 70 71:29 
3 (R,R)-1a (10) TMSOTf 72 87:13 
4 (R,R)-1a (10) TESOTf 87 84:16 
5 (R,R)-1a (10) TIPSOTf 88 81:19 
6 (R,R)-1a (10) TBSOTf 92 91:9 
7 (R,R)-1a (10) TBSCl 10 72:28 
8 (R,R)-1b (10) TBSOTf 82 91:9 
9 (R,R)-1c (10) TBSOTf 92 78:22 
10 (R,R)-1d (10) TBSOTf 70 85:13 
11 2a (10) TBSOTf 82 57:43 
12 2b (10) TBSOTf 59 51:49 
13 2c (10) TBSOTf 58 50:50 
14 -- TBSOTf 85 50:50 
[a] Conditions: i) 3 (1 eq.) R3SiX (1.1 eq.) and catalyst in toluene (0.25 M) at 60 °C, 1h; ii) at -78 °C, 4a (2 eq.) was 
added and stirred overnight. [b] Isolated yield. [c] Enantiomeric ratios determined by chiral HPLC using a Diacel 
Chiralcel IG column.  
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In a next screening, different solvents, catalyst loadings and additional bulky silylating 
derivatives (R3SiX) were tested (Table 2). 
Table 2 Further optimization of the reaction with 3a as a model substrate.[a] 
 
entry (R,R)-1a (X mol%) solvent R3SiX yield (%)[b] 5a, e.r.[c] 
1 10 cumene TBSOTf 95 80:20 
2 10 ethylbenzene TBSOTf 88 91:9 
3 10 Et2O TBSOTf 82 89:11 
4 10 MTBE TBSOTf 15 73:27 
5 10 toluene TBSOTf 92 76:24[d] 
6 5 toluene TBSOTf 92 98:2 
7 2.5 toluene TBSOTf 88 96:4 
8 1 toluene TBSOTf 90 97:3 
9 1 toluene TBSCl 15 93:7 
10 1 toluene TMSOMs 32 97:3 
11 1 toluene Ph2tBuSiOTf 95 54:46 
12 1 toluene (tBu)2iBuSiOTf 96 82:18 
[a] Conditions: i) 3 (1 eq.) R3SiX (1.1 eq.) and catalyst in the appropriate solvent (0.25 M) at 60 °C, 1h; ii) at -78 
°C, 4a (2 eq.) was added and stirred overnight. [b] Isolated yield. [c] Enantiomeric ratios determined by chiral 
HPLC using a Diacel Chiralcel IG column. [d] Reaction at a 0.10 M concentration. 
First, different etheral and aromatic solvents were tested (entries 1-4), from which toluene 
aroused as the optimal choice. When the reaction was carried out in a more diluted media 
(0.10 M vs. 0.25 M), a drop in enantioselectivity was observed (entry 5). We were pleased to 
see that a decrease of the catalyst loading to 5%, 2.5% and 1% had no crucial influence on the 
yield and provided a notably improved enantioselectivity to 98:2, 96:4 and 97:3 e.r., 
respectively (entries 6-8). For this reason, our following investigations were carried out with a 
1 mol% catalyst loading. Furthermore, the use of other silylating agents than TBSOTf such as 
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TBSCl and TMSOMs or Ph2tBuSiOTf and (tBu)2iBuSiOTf provided 5a in considerable low yields 
(entries 9-10) or enantioselectivities (entries 11-12). 
4.3.2 Screening of the Scope of the Reaction  
With the optimal conditions in hand, [TBSOTf, 2,4,6-collidine and catalyst 1a (1 mol%) in 
toluene], the scope of the reaction was then investigated. Various silyl ketene acetals 4 were 
first tested in the reaction with chromone 3a (Table 3). It is worthy to note that the reaction 
with 4a could be scaled up to 1 mmol without significant detriment on the yield or 
enantioselectivity (5a, 88%, 96:4 e.r.). Moreover, a slightly change on the nucleophile’s 
substitution showed a great influence on the enantioselectivity outcome. Whereas the 
methylester derivative 4b still provided the product 5b with a high enantiopurity (90:10 e.r.), 
the reaction with more sterically hindered nucleophiles such as 4c-e proceeded smoothly but 
showed only a moderate chirality transfer. 
Table 3 Screening of the scope of the reaction with different silyl ketene acetals 4. [a],[b]  
 
[a] Conditions: i) 3 (1.0 eq.), TBSOTf (1.1 eq.), 2,4,6-collidine (0.3 eq.) and 1a (1 mol%) in toluene, 1 h at 60 °C; ii) 
at -78 °C, 4 (2 eq.) was added and stirred overnight. [b] Isolated yields; enantiomeric ratios determined by chiral 
HPLC. [c] Reaction on a 1 mmol scale using 1.2 equiv. of 4a. 
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Different substituted 4-chromones 3 were next examined (Table 4). Electron donating (5f-h) 
and withdrawing groups (5i-l) at the C6-position were well tolerated providing high yields and 
good to excellent enantioselectivities (up to 97:3 e.r.). Substituents at the C7- and C8-position 
led to the products 5o-q in similar high enantioselectivities (up to 94:6 e.r.). One of the best 
results was obtained with the 5,7-dimethyl substituted substrate, obtaining 5m in 98:2 e.r. 
Additionally, thiochromone was effectively enrolled in this reaction too, providing the 
corresponding thiochromane 5m (80:20 e.r.).  
Table 4 Screening of the scope of the reaction of 4-chromones. [a],[b]  
 
[a] Conditions: i) 3 (1.0 eq.), TBSOTf (1.1 eq.), 2,4,6-collidine (0.3 eq.) and 1a (1 mol%) in toluene, 1 h at 60 °C; ii) 
at -78 °C, 4a (2 eq.) was added and stirred overnight. [b] Isolated yields; enantiomeric ratios determined by chiral 
HPLC.  
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Finally, Julia Bamberger and Melania Gómez Martínez could confirm the great feasibility of 
the catalytic system by the effective reaction with the more challenging 4-pyrones (Table 5).  
Table 5 Screening of the scope of the reaction of 4-pyrones. [a]- [b] 
 
[a] Conditions: i) 3 (1.0 eq.), TBSOTf (1.1 eq.), 2,4,6-collidine (0.3 eq.) and 1a (1 mol%) in toluene, 1 h at 60 °C; ii) 
at -78 °C, 4a (2 eq.) was added and stirred overnight. [b] Isolated yields; enantiomeric ratios determined by chiral 
HPLC. [c] Reaction using 1.2 eq. of 4a. [d] Reaction using 5 mol% of 1a.  
Though it was also possible to carry out the reaction with 4-pyrone (3r) in the presence of 1 
mol% of catalyst (5r, 96:4 e.r.), the use of 5 mol% of 1a generally led to the best results with 
this type of substrates in terms of both yield and enantioselectivity. Whereas the reaction of 
electron deficient (2-CO2Me, 3w) and bulky substituted (2-iPr, 3u) pyrones proceeded with 
moderate chirality transfer; good to excellent enantioselectivities were obtained with 2-alkyl 
substituted derivatives, leading to the products 5s-t and 5v with up to 96:4 e.r. 
 
4.3.3 Synthetic Application  
The synthetic applicability of this methodology was next demonstrated by derivatization of 
the chiral products 5 (Scheme 5). Thus, 5a easily transformed to chromane derivative 6 in one 
step by a Clemmensen reduction with Zn in AcOH. The reaction proceeded without loss of 
enantiopurity, which was confirmed by chiral HPLC analysis of 6 (Scheme 5). 
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Scheme 5 Derivatization of products 5a by Clemmensen reduction. 
4.3.4 Absolut Configuration 
After the reaction scope’s study, determining the absolute configuration of the obtained new 
C-stereocenters was of interest. Unfortunately, most of the products resulted as oils, 
hampering obtaining crystals for their X-ray structural analysis. However, alkaline hydrolysis 
of 5a led to the corresponding acid 7, which allowed crystallization followed by X-ray analysis 
of 7 to determine the absolute configuration as (S) at the new stereocenter formed during the 
catalytic reaction (Scheme 6). HPLC-analysis after re-esterification of 7 with iPrOH to 
compound 5a confirmed that the process proceeded without loss of enantiopurity (96:4 e.r.) 
 
Scheme 6 Determination of the absolute configuration. 
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4.4 Conclusion and Outlook 
To sum up, a highly enantioselective catalytic method towards valuable 2-alkyl substituted 
oxygen heterocycles by nucleophilic dearomatization of pyrylium derivatives with silyl ketene 
acetals using chiral triazoles as anion-binding catalysts has been developed. The robustness 
and high activity of the catalyst 1a allows its presence along the different steps in the one-pot 
process without detriment on the reaction outcome, as well as the use of low catalytic 
loadings (1-5 mol%). Moreover, the reaction scope probed to be very broad, providing a 
simple access to the targeted chiral chromanones and dihydropyrones in enantioselectivities 
up to 98:2 e.r and 96:4 e.r, respectively.  
 
The discovery that our TetraTri catalyst can bind not only halide but also triflate anions in its 
cavity and opens new possibilities of transformations. It would be interesting applying this 
catalytic system for example into the stereospecific glycosylation reaction for the synthesis of 
carbohydrates. 
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4.5 Experimental Part 
4.5.1 General Information and Analytical Techniques 
1H-, 13C- and 19F-NMR spectra were recorded in acetone-D6 and CDCl3 (reference signal:[15]  1H 
= 2.05 ppm, 13C = 29.84 ppm, acetone-D6; 1H = 7.26 ppm, 13C = 77.16 ppm, CDCl3) on a Bruker 
Advance 300 or 400 MHz. Chemical shifts (δ) are given in ppm and spin-spin coupling constants 
(J) are given in Hz. Analytical thin layer chromatography was performed using silica gel 60 F254 
and a solution of KMnO4 or phosphomolybdic acid served as staining agent. Column 
chromatography was performed on silica gel 60 (0.040-0.063 mm). Exact masses (HRMS) were 
performed using electrospray ionization techniques (ESI+) and recorded on an Agilent Q-TOF 
6540 UHD or a Bruker Daltonics MicroTof spectrometer. Optical rotations [𝛂]𝟓𝟖𝟗
𝟐𝟎  were 
measured on a Perkin Elmer 241 Polarimeter. Chiral High Pressure Liquid Chromatography 
(HPLC) analyses were performed on a 1200 series Agilent or SFC-LC Agilent using a chiral 
chiralpack IG or AD column. 
Et3N was distilled over CaH2; and MTBE, THF, Et2O, toluene, cumene and ethylbenzene were 
distilled and dried over sodium. The triazole catalysts 1,[12e] NH-catalysts 2,[16] silyl ketene 
acetals 4a-e,[17] (thio)chromenones 3h, and 3n and 3m[11] were prepared following literature 
known procedures. Other solvents and commercially available reagents were used without 
further purification. 
4.5.2 General Procedure for the Organocatalytic Reaction 
 
Derivative 3 (0.10 mmol, 1.0 eq.), 2,4,6-trimethylpyridine (4 L, 0.03 mmol, 0.3 eq.) and 
catalyst 1a (1.1 mg, 0.001 mmol, 1 mol%) were dissolved in dry toluene (0.4 mL, 0.25 M) and 
after the addition of TBSOTf (25 L, 0.11 mmol, 1.1 eq.) the reaction mixture was stirred for 
1 h at 60 °C and cooled to -78 °C afterwards. The silyl ketene acetal 4 (0.20 mmol, 2.0 eq.) was 
added and the reaction mixture was stirred at -78 °C overnight. 3 M HCl (6.0 eq.) was added 
and the mixture was allowed to warm to room temperature for one hour. The solution was 
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diluted with water (5 mL), extracted with ethyl acetate (3 x 10 mL), dried over MgSO4, filtered 
and the solvent was removed under reduced pressure. The crude product was purified by 
column chromatography using petrol ether/EA (5:1) to afford the desired product. 
The racemic versions were prepared without catalyst, following the general procedure 
described above. 
4.5.3 Analytical Data for Compounds 5 
Isopropyl (S)-2-(4-oxochroman-2-yl)acetate (5a) 
According to the general procedure, the reaction of 3a (15.0 mg, 
0.100 mmol, 1.0 eq.) with 4a (51 L, 0.200 mmol, 2.0 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5a (22.8 
mg, 0.092 mmol, 92%) as a pale yellow oil. The enantiomeric ratio was determined as 97:3 e.r. 
(98:2 e.r. when using 5 mol% of 1a catalyst) by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 
1.0 mL/min, = 254 nm): tr (minor): 8.5 min, tr (major): 11.7 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : +38.72 (c 0.9, CHCl3) 
(98:2 e.r.). 1H-NMR (300 MHz, CDCl3) /ppm = 7.89 (dd, J = 7.9, 1.8 Hz, 1H), 7.53 – 7.43 (m, 
1H), 7.07 – 7.00 (m, 1H), 6.96 (d, J = 8.4 Hz, 1H), 5.09 (hept., J = 6.2 Hz, 1H), 4.91 (dtd, J = 8.7, 
7.2, 5.7 Hz, 1H), 2.89 (dd, J = 15.6, 7.4 Hz, 1H), 2.80 (s, 1H), 2.77 (d, J = 2.0 Hz, 1H), 2.69 (dd, J 
= 15.6, 5.7 Hz, 1H), 1.27 (d, J = 6.3 Hz, 3H), 1.26 (d, J = 6.3 Hz, 3H); 13C-NMR (75 MHz, CDCl3) 
/ppm = 191.4, 169.0, 161.1, 136.1, 126.9, 121.6, 120.9, 117.9, 74.3, 68.5, 42.4, 40.3, 21.8, 
21.7; HRMS (EI): m/z calculated for [C14H16O4]+: 248.10431, found 248.10456.  
The scale up reaction of 3a (150.0 mg, 1.0 mmol) using 1 mol% of 1a and 1.2 equiv. of 4a of 
led to the desired product 5a in 88% yield and the enantiomeric ratio of 96:4 e.r. 
 
Methyl (S)-2-(4-oxochroman-2-yl)acetate (5b) 
According to the general procedure, the reaction of 3a (15 mg, 
0.10 mmol, 1.0 eq.) with 4b (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5b (18 
mg, 0.083 mmol, 83%) as a pale yellow oil. The enantiomeric ratio was determined as 90:10 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 
13.6 min, tr (major): 25.6 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 16.31 (c 0.8, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm 
= 7.88 (dd, J = 7.9, 1.7 Hz, 1H), 7.44 - 7.50 (m, 1H), 7.05 – 7.00 (m, 1H), 6.97 (d, J = 8.4 Hz, 1H), 
4.95 – 4.87 (m, 1H), 3.75 (s, 3H), 2.94 (dd, J = 15.9, 7.3 Hz, 1H), 2.80 (s, 1H), 2.78 (d, J = 2.1 Hz, 
1H), 2.74 (dd, J = 15.9, 5.6 Hz, 1H); 13C-NMR (100 MHz, CDCl3) /ppm = 191.4, 170.0, 161.1, 
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136.1, 127.0, 121.7, 120.8, 118.0, 74.1, 74.1, 52.1, 42.5, 39.7; HRMS (EI): m/z calculated for 
[C12H12O4]+: 220.07301, found 220.07261. 
 
tert-Butyl (S)-2-(4-oxochroman-2-yl)acetate (5c)  
According to the general procedure, the reaction of 3a (15 mg, 
0.10 mmol, 1.0 eq.) with 4c (54 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5c (20.2 
mg, 0.077 mmol, 77%) as a pale yellow oil. The enantiomeric ratio was determined as 80:20 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 7.1 
min, tr (major): 10.1 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 12.19 (c 0.5, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm = 
8.12 (dd, J = 7.9, 1.7 Hz, 1H), 7.71 (ddd, J = 8.8, 7.2, 1.8 Hz, 1H), 7.29 – 7.23 (m, 1H), 7.19 (d, J 
= 8.4, 1H), 5.15 – 5.06 (m, 1H), 3.07 (dd, J = 15.5, 7.4 Hz, 1H), 3.02 (s, 1H), 3.00 (d, J = 4.9 Hz, 
1H), 2.88 (dd, J = 15.5, 5.8 Hz, 1H), 1.72 (s, 9H); 13C-NMR (100 MHz, CDCl3) /ppm = 191.6, 
168.8, 161.2, 136.1, 127.0, 121.6, 120.9, 118.0, 81.5, 74.5, 42.5, 41.3, 28.1; HRMS (EI): m/z 
calculated for [C15H18O4]+: 262.11996, found 262.12020. 
 
Methyl (S)-2-methyl-2-(4-oxochroman-2-yl)propanoate (5d)  
According to the general procedure, the reaction of 3a (15 mg, 
0.10 mmol, 1.0 eq.) with 4d (41 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5d (23 
mg, 0.093 mmol, 93%) as a pale yellow oil. The enantiomeric ratio was determined as 74:26 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 8.0 
min, tr (major): 9.2 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 6.48 (c 0.5, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm 7.83 
(dd, J = 7.8, 1.7 Hz, 1H), 7.47 – 7.38 (m, 1H), 7.00 – 6.94 (m, 1H), 6.92 (d, J = 8.4 Hz, 1H), 4.61 
(dd, J = 14.1, 2.6 Hz, 1H), 3.69 (s, 3H), 2.75 (dd, J = 16.5, 14.1 Hz, 1H), 2.56 (dd, J = 16.5, 2.6 Hz, 
1H), 1.33 (s, 3H), 1.24 (s, 3H); 13C-NMR (100 MHz, CDCl3) /ppm = 192.3, 175.5, 161.6, 136.0, 
127.0, 121.5, 120.8, 117.9, 81.7, 52.3, 46.2, 38.4, 20.8, 20.6; HRMS (EI): m/z calculated for 
[C14H16O4]+: 248.10431, found 248.10460. 
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Isopropyl (S)-2-methyl-2-(4-oxochroman-2-yl)propanoate (5e)  
According to the general procedure, the reaction of 3a (15 mg, 
0.10 mmol, 1.0 eq.) with 4e (58 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5e (26.2 
mg, 0.095 mmol, 95%) as a pale yellow oil. The enantiomeric ratio was determined as 70:30 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 5.8 
min, tr (major): 7.4 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 2.04 (c 0.5, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm 7.87 
(dd, J = 7.9, 1.6 Hz, 1H), 7.46 (ddd, J = 8.5, 7.2, 1.8 Hz, 1H), 7.06 – 6.97 (m, 1H), 6.93 (d, J = 8.4 
Hz, 1H), 5.06 (hept, J = 6.3 Hz, 1H), 4.66 (dd, J = 14.1, 2.6 Hz, 1H), 2.78 (dd, J = 16.5, 14.1 Hz, 
1H), 2.60 (dd, J = 16.5, 2.6 Hz, 1H), 1.35 (s, 3H), 1.27 – 1.16 (m, 9H); 13C-NMR (100 MHz, CDCl3) 
/ppm = 192.4, 174.5, 161.7, 136.0, 127.0, 121.4, 120.9, 117.8, 81.9, 68.3, 46.0, 38.3, 21.7, 
20.8, 20.2; HRMS (EI): m/z calculated for [C16H20O4]+: 276.13561, found 276.13505. 
 
Isopropyl (S)-2-(6-methoxy-4-oxochroman-2-yl)acetate (5f)  
According to the general procedure, the reaction of 3f (18 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5f (26 
mg, 0.094 mmol, 94%) as a pale yellow oil. The enantiomeric ratio was determined as 97:3 e.r. 
by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 9.3 min, 
tr (major): 16.2 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 25.57 (c 0.8, CHCl3). 1H-NMR (300 MHz, CDCl3) /ppm = 7.30 
(d, J = 3.2 Hz, 1H), 7.08 (dd, J = 9.0, 3.2 Hz, 1H), 6.89 (d, J = 9.0 Hz, 1H), 5.08 (hept, J = 6.3 Hz, 
1H), 4.93 – 4.78 (m, 1H), 3.80 (s, 3H), 2.87 (dd, J = 15.6, 7.4 Hz, 1H), 2.77 (s, 1H), 2.74 (d, J = 
2.9 Hz, 1H), 2.72 – 2.63 (m, 1H), 1.27 (d, J = 6.3 Hz, 3H), 1.26 (d, J = 6.3 Hz, 3H); 13C-NMR (75 
MHz, CDCl3) /ppm = 191.6, 169.1, 155.9, 154.2, 125.3, 120.7, 119.3, 107.3, 74.4, 68.5, 55.8, 
42.5, 40.4, 21.8, 21.7; HRMS (EI): m/z calculated for [C15H18O5]+: 278.11488, found 278.11498. 
 
Isopropyl (S)-2-(6-methyl-4-oxochroman-2-yl)acetate (5g)  
According to the general procedure, the reaction of 3g (16 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5g (24 
mg, 0.092 mmol, 92%) as a pale yellow oil. The enantiomeric ratio was determined as 95:5 e.r. 
by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 8.4 min, 
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tr (major): 12.0 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 17.10 (c 1.00, CHCl3). 1H-NMR (300 MHz, CDCl3) /ppm = 7.67 
(d, J = 1.8 Hz, 1H), 7.28 (dd, J = 8.7, 2.2 Hz, 1H), 6.86 (d, J = 8.4 Hz, 1H), 5.08 (hept, J = 6.3 Hz, 
1H), 4.93 – 4.79 (m, 1H), 2.87 (dd, J = 15.6, 7.4 Hz, 1H), 2.76 (s, 1H), 2.74 (d, J = 2.1 Hz, 1H), 
2.67 (dd, J = 15.6, 5.7 Hz, 1H), 2.30 (s, 3H), 1.27 (d, J = 6.2 Hz, 3H), 1.26 (d, J = 6.2 Hz, 3H); 13C-
NMR (75 MHz, CDCl3) /ppm = 191.7, 169.1, 159.3, 137.2, 131.1, 126.6, 120.5, 117.7, 74.2, 
68.5, 42.6, 40.4, 29.7, 21.8, 21.7, 20.4; HRMS (EI): m/z calculated for [C15H18O4]+: 262.11996, 
found 262.11925. 
 
Isopropyl (S)-2-(6-benzyl-4-oxochroman-2-yl)acetate (5h)  
According to the general procedure, the reaction of 3h (24 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5h (27 
mg, 0.08 mmol, 80%) as a dark yellow oil. The enantiomeric ratio was determined as 87:13 e.r. 
by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 10.2 
min, tr (major): 13.7 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 11.07 (c 0.75, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm = 
7.74 (d, J = 2.1 Hz, 1H), 7.30 (d, J = 2.1 Hz, 1H), 7.27 (d, J = 8.3 Hz, 2H), 7.20 (d, J = 7.2 Hz, 1H), 
7.16 (d, J = 7.3 Hz, 2H), 6.88 (d, J = 8.5 Hz, 1H), 5.08 (hept, J = 6.2 Hz, 1H), 4.92 – 4.83 (m, 1H), 
3.93 (s, 2H), 2.87 (dd, J = 15.6, 7.4 Hz, 1H), 2.76 (s, 1H), 2.75 (d, J = 2.9 Hz, 1H), 2.67 (dd, J = 
15.6, 5.6 Hz, 1H), 1.27 (d, J = 6.1 Hz, 3H), 1.26 (d, J = 6.1 Hz, 3H); 13C-NMR (100 MHz, CDCl3) 
/ppm = 191.6, 169.1, 159.7, 140.6, 136.9, 134.6, 128.8, 128.6, 126.6, 126.3, 120.6, 118.1, 
74.3, 68.6, 42.5, 41.0, 40.4, 25.3, 21.8, 21.7; HRMS (EI): m/z calculated for [C21H22O4]+: 
338.15126, found 338.15152. 
 
Isopropyl (S)-2-(6-fluoro-4-oxochroman-2-yl)acetate (5i)  
According to the general procedure, the reaction of 3i (16.0 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5i (22.6 
mg, 0.083 mmol, 83%) as a pale yellow oil. The enantiomeric ratio was determined as 96:4 e.r. 
by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 230 nm): tr (minor): 7.4 min, 
tr (major): 10.1 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : +32.95 (c 1.05, CHCl3). 1H-NMR (300 MHz, CDCl3) /ppm = 7.54 
(dd, J = 8.2, 3.2 Hz, 1H), 7.20 (ddd, J = 9.0, 7.8, 3.2 Hz, 1H), 6.95 (dd, J = 9.1, 4.2 Hz, 1H), 5.09 
(hept, J = 6.2 Hz, 1H), 4.93 – 4.83 (m, 1H), 2.88 (dd, J = 15.7, 7.4 Hz, 1H), 2.79 (d, J = 2.0 Hz, 
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1H), 2.77 (d, J = 8.2 Hz, 1H), 2.69 (dd, J = 15.7, 5.7 Hz, 1H), 1.27 (d, J = 6.1 Hz, 3H), 1.26 (d, J = 
6.1 Hz, 3H); 13C-NMR (75 MHz, CDCl3) /ppm = 190.7, 169.0, 157.5 (d, JCF = 242.0 Hz), 157.4, 
123.6 (d, JCF = 24.4 Hz), 121.3, 119.6 (d, JCF = 7.6 Hz), 112.1 - 111.9 (d, JCF = 23.3 Hz), 74.5, 68.7, 
42.2, 40.3, 21.8, 21.8; 19F NMR (376 MHz, CDCl3) δ -121.54; HRMS (EI): m/z calculated for 
[C14H15FO4]+: 266.09375, found 266.09425. The scale up reaction of 3i (160.0 mg, 1.0 mmol) 
of led to the desired product 5i in 76% yield and the same enantiomeric ratio of 96:4 e.r. 
 
Isopropyl (S)-2-(6-chloro-4-oxochroman-2-yl)acetate (5j)  
According to the general procedure, the reaction of 3j (18 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5j 
(23.7 mg, 0.085 mmol, 85%) as a yellow oil. The enantiomeric ratio was determined as 93:7 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 8.0 
min, tr (major): 11.8 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 21.16 (c 0.75, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm = 
7.84 (d, J = 2.6 Hz, 1H), 7.41 (dd, J = 8.8, 2.7 Hz, 1H), 6.92 (d, J = 8.8 Hz, 1H), 5.09 (hept, J = 6.3 
Hz, 1H), 4.96 – 4.81 (m, 1H), 2.88 (dd, J = 15.7, 7.4 Hz, 1H), 2.79 (d, J = 1.9 Hz, 1H), 2.77 (d, J = 
7.9 Hz, 1H), 2.69 (dd, J = 15.8, 5.7 Hz, 1H), 1.27 (d, J = 6.2 Hz, 3H), 1.26 (d, J = 6.2 Hz, 3H); 13C-
NMR (101 MHz, CDCl3) /ppm = 190.3, 168.9, 159.6, 136.0, 127.2, 126.4, 121.7, 119.7, 74.5, 
68.7, 42.2, 40.2, 21.8, 21.7; HRMS (EI): m/z calculated for [C14H15ClO4]+: 282.06534, found 
282.06469. 
 
Isopropyl (S)-2-(6-bromo-4-oxochroman-2-yl)acetate (5k)  
According to the general procedure, the reaction of 3k (22.5 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5k 
(27.3 mg, 0.085 mmol, 85%) as a pale yellow oil. The enantiomeric ratio was determined as 
90:10 e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr 
(minor): 8.7 min, tr (major): 13.8 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 19.36 (c 0.75, CHCl3). 1H-NMR (300 MHz, 
CDCl3) /ppm = 7.99 (d, J = 2.5 Hz, 1H), 7.55 (dd, J = 8.8, 2.6 Hz, 1H), 6.87 (d, J = 8.8 Hz, 1H), 
5.09 (hept, J = 6.3 Hz, 1H), 4.89 (ddt, J = 10.2, 7.4, 5.6 Hz, 1H), 2.88 (dd, J = 15.8, 7.4 Hz, 1H), 
2.79 (s, 1H), 2.77 (d, J = 5.3 Hz, 1H), 2.69 (dd, J = 15.8, 5.7 Hz, 1H), 1.27 (d, J = 6.3 Hz, 3H), 1.26 
(d, J = 6.3 Hz, 3H); 13C-NMR (75 MHz, CDCl3) /ppm = 190.2, 168.9, 160.0, 138.7, 129.5, 122.1, 
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120.0, 114.4, 74.5, 68.7, 42.1, 40.2, 21.8, 21.7; HRMS (EI): m/z calculated for [C14H15BrO4]+: 
326.01482, found 326.01416. 
 
Isopropyl (S)-2-(6-nitro-4-oxochroman-2-yl)acetate (5l)  
According to the general procedure, the reaction of 3l (19.2 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5l 
(22.4 mg, 0.077 mmol, 77%) as a dark yellow oil. The enantiomeric ratio was determined as 
92:8 e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 
18.7 min, tr (major): 24.7 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 46.48 (c 0.5, CHCl3). 1H-NMR (400 MHz, CDCl3) 
/ppm = 8.78 (d, J = 2.8 Hz, 1H), 8.34 (dd, J = 9.1, 2.8 Hz, 1H), 7.10 (d, J = 9.1 Hz, 1H), 5.12 
(hept, J = 6.3 Hz, 1H), 5.06 – 4.96 (m, 1H), 2.95 (dd, J = 10.1, 5.9 Hz, 1H), 2.91 – 2.84 (m, 2H), 
2.75 (dd, J = 16.5, 5.6 Hz, 1H), 1.29 (d, J = 4.0 Hz, 3H), 1.27 (d, J = 4.0 Hz, 3H). 13C-NMR (101 
MHz, CDCl3) /ppm = 189.21, 168.51, 164.92, 142.33, 130.44, 123.64, 120.39, 119.33, 75.25, 
68.96, 41.85, 39.93, 29.71, 21.81, 21.79, 14.13; HRMS (EI): m/z calculated for [C14H15NO6]+: 
293.08939, found 293.08920. 
 
Isopropyl (S)-2-(4-oxothiochroman-2-yl)acetate (5m)  
According to the general procedure, the reaction of 3m (16 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5m (24.7 
mg, 0.093 mmol, 93%) as a pale yellow oil. The enantiomeric ratio was determined as 80:20 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 8.6 
min, tr (major): 11.2 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 32.66 (c 1.0, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm = 
8.09 (dd, J = 7.9, 1.5 Hz, 1H), 7.46 – 7.31 (m, 1H), 7.28 – 7.15 (m, 2H), 5.05 (hept, J = 6.3 Hz, 
1H), 3.99 – 3.87 (m, 1H), 3.13 (dd, J = 16.5, 3.6 Hz, 1H), 2.86 (dd, J = 16.5, 8.9 Hz, 1H), 2.77 – 
2.60 (m, 2H), 1.24 (s, 3H), 1.22 (s, 3H); 13C-NMR (100 MHz, CDCl3) /ppm = 193.5, 169.5, 140.5, 
133.7, 130.4, 129.0, 127.8, 125.2, 68.7, 45.2, 39.3, 37.2, 21.8, 21.7; HRMS (EI): m/z calculated 
for [C14H16O3S]+: 264.08147, found 264.08088. 
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Isopropyl (S)-2-(5,7-dimethyl-4-oxochroman-2-yl)acetate (5n)  
According to the general procedure, the reaction of 3n (17.4 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5n (24.1 
mg, 0.087 mmol, 87%) as a yellow oil. The enantiomeric ratio was determined as 98:2 e.r. by 
chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 7.3 min, 
tr (major): 9.7 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 14.81 (c 0.75, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm = 6.62 
(s, 2H), 5.08 (hept, J = 6.3 Hz, 1H), 4.88 – 4.76 (m, 1H), 2.83 (dd, J = 15.5, 7.5 Hz, 1H), 2.73 (d, J 
= 1.5 Hz, 1H), 2.71 (s, 1H), 2.64 (dd, J = 15.5, 5.6 Hz, 1H), 2.59 (s, 3H), 2.28 (s, 3H), 1.27 (d, J = 
5.3 Hz, 3H), 1.26 (d, J = 5.3 Hz, 3H); 13C-NMR (100 MHz, CDCl3) /ppm = 192.5, 169.2, 162.3, 
146.0, 141.9, 126.1, 117.2, 116.0, 73.5, 68.5, 43.9, 40.4, 22.7, 21.9, 21.8, 21.6; HRMS (EI): m/z 
calculated for [C16H20O4]+: 276.13561, found 276.13617. 
 
Isopropyl (S)-2-(7-methoxy-4-oxochroman-2-yl)acetate (5o)  
According to the general procedure, the reaction of 3o (17.6 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5o 
(25.1 mg, 0.090 mmol, 90%) as a pale yellow oil. The enantiomeric ratio was determined as 
94:6 e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 
16.6 min, tr (major): 23.9 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 14.81 (c 0.75, CHCl3). 1H-NMR (300 MHz, CDCl3) 
/ppm = 7.82 (d, J = 8.8 Hz, 1H), 6.58 (dd, J = 8.8, 2.4 Hz, 1H), 6.40 (d, J = 2.4 Hz, 1H), 5.09 
(hept, J = 6.3 Hz, 1H), 4.96 – 4.80 (m, 1H), 3.82 (s, 3H), 2.87 (dd, J = 15.7, 7.5 Hz, 1H), 2.72 (d, J 
= 7.5 Hz, 2H), 2.71 – 2.63 (dd, J = 15.7, 5.4 Hz, 1H), 1.28 (d, J = 6.2 Hz, 3H), 1.26 (d, J = 6.2 Hz, 
3H); 13C-NMR (100 MHz, CDCl3) /ppm = 190.1, 169.1, 166.1, 163.1, 128.7, 114.8, 110.2, 100.8, 
74.6, 68.6, 55.7, 42.2, 40.4, 21.8, 21.7; HRMS (EI): m/z calculated for [C15H18O5]+: 278.11488, 
found 278.11452. 
 
Isopropyl (S)-2-(8-bromo-4-oxochroman-2-yl)acetate (5p)  
According to the general procedure, the reaction of 3p (22.5 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5p (28.1 
mg, 0.086 mmol, 86%) as a dark yellow oil. The enantiomeric ratio was determined as 92:8 e.r. 
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by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 3.7 min, 
tr (major): 7.9 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 22.08 (c 0.75, CHCl3). 1H-NMR (400 MHz, CDCl3) /ppm = 7.85 
(d, J = 7.8 Hz, 1H), 7.73 (d, J = 7.7 Hz, 1H), 6.92 (t, J = 7.8 Hz, 1H), 5.10 (hept, J = 6.2 Hz, 1H), 
4.99 (dt, J = 11.5, 5.2 Hz, 1H), 2.97 (dd, J = 15.6, 7.6 Hz, 1H), 2.89 – 2.78 (m, 2H), 2.74 (dd, J = 
15.6, 5.6 Hz, 1H), 1.29 (d, J = 6.1 Hz, 3H), 1.27 (d, J = 6.1 Hz, 3H); 13C-NMR (100 MHz, CDCl3) 
/ppm = 190.6, 168.8, 157.6, 139.4, 126.4, 122.3, 122.1, 111.8, 75.2, 68.8, 42.1, 40.3, 21.9, 
21.8; HRMS (EI): m/z calculated for [C14H15BrO4]+: 327.02400, found 327.02430. 
 
Isopropyl (S)-2-(7-bromo-4-oxochroman-2-yl)acetate (5q)  
According to the general procedure, the reaction of 3q (22.5 mg, 
0.10 mmol, 1.0 eq.) with 4a (51 L, 0.20 mmol, 2 eq.) led after flash 
column chromatography (PE/EtOAc 5:1) to the desired product 5q 
(28.7 mg, 0.088 mmol, 88%) as a yellow oil. The enantiomeric ratio was determined as 87:13 
e.r. by chiral HPLC (Chiralcel IG, hexane/iPrOH (80:20) 1.0 mL/min, = 254 nm): tr (minor): 9.3 
min, tr (major): 14.5 min.). [𝛂]𝟓𝟖𝟗
𝟐𝟎 : + 21.82 (c 1.00, CHCl3). 1H-NMR (300 MHz, CDCl3) /ppm = 
7.73 (d, J = 8.8 Hz, 1H), 7.19 – 7.12 (m, 2H), 5.08 (hept, J = 6.3 Hz, 1H), 4.97 – 4.84 (m, 1H), 2.87 
(dd, J = 15.8, 7.4 Hz, 1H), 2.78 (s, 1H), 2.76 (d, J = 3.7 Hz, 1H), 2.68 (dd, J = 15.8, 5.6 Hz, 1H), 
1.28 (d, J = 6.1 Hz, 3H), 1.26 (d, J = 6.1 Hz, 3H); 13C-NMR (100 MHz, CDCl3) /ppm = 190.5, 
168.8, 161.3, 130.5, 128.2, 125.3, 121.2, 119.8, 74.8, 68.7, 42.3, 40.2, 21.8, 21.7; HRMS (EI): 
m/z calculated for [C14H15BrO4]+: 326.01482, found 326.01405. 
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4.5.4 Representative Spectra and HPLC Chromatograms of 5a 
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Chiral-phase HPLC: IG; Hex/iPrOH 80:20, F = 1 mL/min (λ = 254 nm) 
racemic: 
 
 
enantioselective: 
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Chapter 5 
Research stay abroad 
5. Intramolecular α-Alkylation of Aldehydes via Photoredox 
Catalysis 
 
Abstract: This project describes a methodological study carried out to develop a new 
intramolecular photocatalyzed enantioselective α-alkylation of aldehydes. To achieve this goal 
in asymmetric fashion, we have used an organocatalytic approach to create the new 
stereogenic carbons. Different tests have been performed with the corresponding previously-
synthesized alkylbromo-aldehydes. Several variables, such as the aminocatalysts, 
photocatalysts, light sources, solvents or concentrations, have been evaluated aiming at 
achieving high yields and enantiomeric excesses. 
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This project was carried out in the chemistry department Departamento de Química Orgánica de la 
Facultad de Ciencias de la Universidad Autónoma de Madrid under the supervision of Prof. Dr. José 
Alemán Lara during a research stay of 5 months (February 2017 – July 2017). 
Parts of this chapter are reprinted with permission from Delia Álvarez Fernández and José Alemán Lara 
from the Master thesis of Delia Álvarez Fernández in 2017. 
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5.1 Introduction  
5.1.1 Enamine Catalysis 
Although the early examples of amino acid catalyzed enantioselective reactions were known 
since 1971,[1] enamine catalysis was rediscovered in the late 90’s, becoming one of the main 
pillars for the further advance of the field of organocatalysis. Accordingly, in 2000 Barbas III, 
Lerner and List used independently the natural amino acid (S)-proline to catalyze the 
intermolecular aldol reaction between aldehydes and ketones.[2] Since then, enamine catalysis 
and the development of new and more efficient organocatalysts gained huge interest. In this 
mode of activation, an amine-containing catalyst (typically a secondary amine) activates a 
carbonyl-containing substrate that has an α-acidic proton, which permits the iminium-
enamine tautomery (Scheme 1). If the catalyst has an additional functionality, it acts as a 
bifunctional catalyst (e.g. activating the reaction partner through hydrogen bonding or it can 
also bear a photocatalytic moiety, which will be described later in this chapter). This mode of 
activation has been employed in a wide variety of enantioselective α-functionalization 
reactions.[3] 
In general, two different types of catalysts can be differentiated. Type I, a catalyst like (S)-
proline that contains a hydrogen bond donor to orient the attack of the nucleophile. They are 
used for aldol, Mannich, α-amination reactions, etc. 
Type II, a catalyst that contains a bulky group, which pre-orient the attack of the nucleophile 
by blocking one face. Well established catalysts are the MacMillan imidazolidinones of type 4 
and the Hayashi-Jørgensen diarylprolinol silyl ethers of type 5. They can be employed for α-
halogenation as well as some conjugate addition reactions. 
In this work we focused more on the type II catalyst. 
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Scheme 1. Enamine catalysis mechanism. 
5.1.2 Iminium Catalysis  
Depending on the reaction conditions, α,β-unsaturated carbonyl compounds can undergo 
nucleophilic 1,2-additions, 1,4-addition reactions or Diels-Alder reactions. For these 
transformations, a catalyst is used to lower the energy of the LUMO orbitals of the carbonyl 
group and therefore enhancing its electrophilic character. Traditionally a Lewis acid has been 
used to coordinate to the oxygen atom of the carbonyl group. In 2000, MacMillan introduced 
the concept of iminium catalysis, which relies on the use of a chiral secondary amine to form 
an iminium ion that is analogue to a Lewis acid activated carbonyl-containing compound 
(Scheme 2).[4] This approach has widespread use for various reactions such as cycloadditions, 
Friedel-Crafts alkylations and 1,4-addition reactions.[5] The most famous organocatalysts are 
the MacMillan imidazolidinones (4 in Scheme 1) and the Jørgensen-Hayashi diaryl prolinols 
(e.g. 5, R = Ph or 3,5-(CF3)2Ph), which present an orthogonal reactivity. 
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Scheme 2. The fundamentals of iminium catalysis. 
5.1.3 SOMO Catalysis 
Recently, catalysis based on single electron oxidation of transiently produced, electron-rich 
enamines has introduced a new mode of activation termed SOMO (Single Occupied Molecular 
Orbital) organocatalysis. This activation mode was introduced by the MacMillan group, and is 
based on the idea of an electron-rich enamine, which can be oxidized to a reactive radical 
cation with three π-electrons. Thereby, the radical electron occupies the SOMO orbital. This 
reactive substrate can readily react at its α-position with a wide range of soft nucleophiles 
(SOMO-philes), with the subsequent alkylation of the substrate (Scheme 3). The reactivity of 
the activated enamine differs from its typical reactivity, leading to a wide range of possible 
transformations that are complementary to the enamine catalysis. This strategy represents a 
useful methodology for the α-functionalization of carbonyl compounds.[6] 
 
Scheme 3. General mechanism of the SOMO catalysis. 
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5.1.4 Photocatalysis 
In the last years, photocatalysis emerged as a useful tool for achieving transformations that 
were not feasible till date under standard thermal conditions. In the presence of light, certain 
photoactive compounds can accelerate reactions catalytically. The use of visible light could 
hence facilitate the synthesis of valuable molecules, while represents a cheap, clean and 
inexhaustible source of energy.[7] In this field, two different types of photoactivation must be 
differentiated:  
1) the photosensitization, which is the transfer of energy, and  
2) the photoredox induction, which is the transfer of electrons.  
In general, metal complexes are used in photoredox catalysis to perform electron transfer 
processes to organic substrates through the irradiation by visible light. Those catalysts in their 
excited state, reached by the absorption of light, can act as oxidants or reductants, depending 
on substrates and the reaction conditions employed.[8]  
5.1.5 Merging Photoredox Catalysis with Organocatalysis 
In 2008, MacMillan combined for the first time organocatalysis and photocatalysis and solved 
many of the still present issues in the asymmetric alkylation of aldehydes (Scheme 4). He used 
[Ru(bpy)3Cl2] as photocatalyst and a imidazolidinone as organocatalyst. The in situ formed 
chiral enamines could then catch the radicals, which were generated in the photoredox cycle. 
The combination of these two methods presents a perfect technique to activate and react 
molecules via the corresponding generated radicals. It was found that these radical species 
give higher yields and enantiomeric excesses, the greater the electron withdrawing nature of 
α-bromocarbon is.[9]  
 
Scheme 4 Asymmetric α-alkylation of aldehydes by MacMillan. 
Since then, other groups like Melchiorre,[10] Zeitler[11] and Cozzi[12] investigated different 
methods for the α-alkylation of aldehydes with various cooperative systems. In general, those 
are assembled by an aminocatalyst and an organic or inorganic photocatalyst. MacMillan has 
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been very active in this field, publishing various key papers on the topic like the first α-
trifluormethylation and α-perfluoroalkylation of aldehydes.[13] 
In 2015, Melchiorre published two strategies of α-alkylation without employing additional 
photocatalysts.[10b] He found out that the in situ generated enamines were able to form a 
photon-absorbing Electron Donor - Acceptor complex (EDA) with electron-deficient benzyl 
and phenacyl bromides. These EDA complexes could absorb visible light and trigger a 
photocatalytic reaction (Scheme 5a). Nevertheless, the reactions were limited to strong 
deactivated benzylic halides. More recently, Melchiorre described that some nucleophilic 
enamines can photo-reduce species and induce the photo-organocatalytical process (Scheme 
5b). 
 
Scheme 5. Strategies of the α-alkylation of aldehydes carried out by Melchiorre et al. 
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5.2 Objectives 
As mentioned above, several methods for the intermolecular α-alkylation of aldehydes with 
electron-deficient groups such as α-trifluoromethylation,[13] α-benzylation,[14] α-amination[15] 
and α-cyanoalkylation[16] have been described in the literature. Inspired by the work of 
MacMillan and Melchiorre among many others, and in order to combine the knowledge of the 
group of José Alemán on the fields of organo- and photocatalysis, we decided to go one step 
further and investigate the enantioselective intramolecular alkylation of aldehydes. A mild and 
straightforward synthesis of this kind of enantioenriched molecules would open a new way to 
access chiral cyclic compounds of different ring sizes (Scheme 6).  
  
Scheme 6 General reaction scheme of the intramolecular α-alkylation of aldehydes. 
To achieve our goal in an asymmetric fashion, we will make use of an organocatalytic approach 
to create the new stereogenic carbons. Different tests will be performed with previously 
synthesized alkylbromo-containing aldehydes, in which several variables such as the 
aminocatalyst, photocatalyst, light source and wavelength, solvent or concentration will be 
evaluated to achieve optimal yields and high enantiomeric excesses. 
For this type of reaction, a cooperative mechanism with two catalytical cycles is proposed: a 
organocatalytic and a photocatalytic cycle. Nevertheless, Melchiorre published a mechanism 
for the intramolecular α-alkylation of aldehydes, where it seems to be possible that the 
photocatalyst is not required. Therefore, different reactions will be carried out to confirm this 
allegation. 
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5.3 Results and Discussion 
5.3.1. Optimization of the Catalyst 
To get a better insight in the reaction requirements, an optimization of the reaction conditions 
with different organo- and photocatalysts was carried out. These results are presented in 
Table 1. Initially, a blank reaction with aminocatalyst I and without light was performed, which 
did not yield any product (entry 1). Following the work of MacMillan, a cooperative system of 
aminocatalyst I and Ru-photocatalyst A was introduced to the reaction giving a complex 
mixture of decomposition products (entry 2). By changing the Ru-photocatalyst to the 
organophotocatalyst B, the desired product 2 was obtained in a moderate yield and 
enantioselectivity (entry 3). Next, a screening of different aminocatalysts was carried out 
(entries 4 - 8). However, the change from the MacMillan type catalyst (entry 4) to the 
Jørgensen-Hayashi type catalysts (V-VIII) gave no significant change in the yield and 
enantiopurity. This behavior can be traced back to the fact that the reaction already works 
without any aminocatalyst, which was confirmed by the formation of the product 2 in a 18% 
yield in the reaction using exclusively thioxanthene as a photocatalyst (entry 10). Thus, the 
thioxanthene is obviously able to reduce the bromo-species, which then could react with the 
enol present in the reaction medium. Consequently, an aminocatalyst is not needed then for 
obtaining the product and no enantiomeric induction would be seen. The group of José 
Alemán recently developed on a bifunctional photocatalyst (IV), which consists of the 
combination of an aminocatalytic- and a photocatalytic moiety and already proofed to work 
well in alkylation reactions of aldehydes. This bifunctional photocatalyst was next employed 
in the reaction, but unfortunately did not lead to any enantiomeric induction (entry 9). The 
need of an aminocatalyst was indicated in entry 11, where the reaction was carried out 
without any catalyst, yielding the product in only 10% yield. On the other hand, this try 
confirmed our fear of a background reaction, which would lower the enantiomeric excess. 
Thinking about the latest work of Melchiorre in this field, we decided to carry out the reaction 
without an additional photocatalyst and fortunately, we achieved better results. A screening 
of the different aminocatalyst (entries 12-17) showed that the Jørgensen-Hayashi type 
catalysts (entries 14-17) gave the best results in terms of both yield and enantioselectivity. 
Then, a promising enantiomeric ratio up to 75:25 with catalyst VI was obtained (entry 15). 
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Table 1. Optimization of the reaction conditions and screening of various amino- and 
photocatalysts.[a]  
 
Entry Aminocatalyst Photocatalyst Conv.[%] e.r.[b] 
1 rac-I - - - 
2 I A - - 
3 I B 38 40:60 
4 III B 54 55:45 
5 V B 52 40:60 
6 VI B 43 61:39 
7 VII B 54 50:50 
8 VIII B 52 50:50 
9 IV - 42 50:50 
10[c] - B 18 50:50 
11[c] - - 10 - 
12 I - 72 63:37 
13 II - 13 n.d. 
14 V - 100 67:34 
15 VI - 50 75:25 
16 VII - 100 47:53 
17 VIII - 92 70:30 
[a] Conditions: organocatalyst (0.02 mmol, 20 mol %), 1a (0.1 mmol, 1.0 eq.), and/or photocatalyst (0.001 mmol, 
1 mol%), 2,6-lutidine (0.2 mmol, 2 eq.) in 0.2 mL of DMF under visible light irradiation (23 W) at room 
temperature and N2-atmosphere. [b] The enantiomeric ratio of product 2a was determined by chiral HPLC on the 
derivatization product 2Wa from a subsequent Wittig reaction. [c] Reaction carried out in the absence of an 
aminocatalyst.  
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Since the direct determination of the enantiomeric ratio by HPLC or GC analysis was not 
possible with aldehyde 2a, a further derivatization by a Wittig reaction was necessary. 
Therefore, benzyl(triphenylphosphoranylidene)acetate 3 was used as a Wittig reagent, 
forming, together with 2 the derivatized product 2W after two hours in full conversion 
(Scheme 7). 
 
Scheme 7 General reaction scheme of the Wittig derivatization of aldehyde 2. 
5.3.2 Optimization of the Light Source 
In a next step, different light sources were employed to see their influence on the reaction. 
With the optimized reaction conditions in hand (catalyst VI and DMF as a solvent), parallel 
reactions were carried out with four different wavelengths ranging from UV to white light 
(Table 3.2).  
Table 2. Optimization of the light source. [a; b] 
 
Entry Light (λmax, nm) Conversion[%] e.r.[b] 
1 white 50 75:25 
2 green (540) 100 61:39 
3 blue (450) 90 65:35 
4 UV (385) 100 55:45 
[a] Conditions: organocatalyst IV (0.02 mmol, 20 mol %), 1a (0.1 mmol, 1.0 eq.), 2,6-lutidine (0.2 mmol, 2 eq.) in 
0.2 mL of DMF at room temperature and N2-atmosphere using different light sources as indicated. [b] To 
determine the enantiomeric ratio of product 2a a derivatization with a Wittig reagent to 2Wa was necessary. 
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It was observed that other wavelengths than white light improved the conversion to product 
2 (90-100% vs. only 50%), but also a degradation of the enantiomeric induction was 
detected. Using green light (λmax = 540 nm, P = 0.4 W, entry 2), a full conversion but an 
inferior 61:39 enantiomeric ratio was obtained. Employing a minor wavelength (blue light, 
λmax = 450 nm, P = 0.4 W, entry 3), the conversion was also up to 90%, but no increase of the 
enantiomeric excess was achieved. UV light (λmax = 385 nm, P = 0.4 W, entry 4) gave the 
lowest enantiomeric ratio, however full conversion was observed. Finally, we could conclude 
that the white light was the best light source in regard of enantiomeric induction (up to 
75:25 e.r.). 
5.3.3 Solvent Screening 
Next, the solvent and concentration effects on the reaction were studied. First, other polar 
aprotic solvents like acetonitrile and DMSO were tested (entries 2 and 3), leading to a similar 
enantiomeric ratio but higher conversions than DMF (entry 1). In DCM, a higher enantiomeric 
induction and conversion were observed (entry 4), which turned out to be slightly enhanced 
in a more concentrated reaction media (0.25 M; 86:14 e.r., entry 5). Polar protic solvents like 
MeOH gave less satisfactory results (entry 6). Apolar solvents like MTBE (entry 7), hexane 
(entries 8 and 9) or cyclohexane (entries 10 and 11) gave improved results than the polar 
aprotic solvents but were not superior compared to DCM. Finally, aromatic solvents in 
different concentrations were tested (entries 12-19). In respect to the best results obtained 
till now in DCM shown in entry 5 (86:14 e.r.), p-xylene gave a better enantiomeric ratio of 
87:13 (entry 12), whereas trifluorotoluene led to low enantioselectivity (60:40, entry 13). The 
highest enantiomeric ratio of 90:10 was obtained with toluene as a solvent and a 
concentration of 0.5 M (entry 14). To improve the conversion with toluene, the same reaction 
was carried out with a prolonged reaction time of three days. Unfortunately, a high detriment 
on the enantioinduction leading to almost a racemic mixture was observed (entry 15). To 
evaluate the solvent effects within other catalysts, different Jørgensen-Hayashi type catalysts 
were employed in the reaction with toluene as most promising solvent. However, no 
improvement of the enantiomeric excess took placed (entries 18 and 19). 
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Table 3. Optimization of solvent and concentration.[a] 
 
Entry Aminocatalyst Solvent c [M] Conversion [%] e.r.[b] 
1 VI DMF 0.5 50 75:25 
2 VI CH3CN 0.5 100 70:30 
3 VI DMSO 0.5 95 75:25 
4 VI CH2Cl2 0.5 93 83:17 
5 VI CH2Cl2 0.25 100 86:14 
6 VI CH3OH 0.5 85 68:32 
7 VI MTBE 0.5 50 81:19 
8 VI hexane 0.5 60 67:33 
9 VI hexane 0.25 42 n.d 
10 VI cyclohexane 0.5 60 75:25 
11 VI cyclohexane 0.25 20 80:20 
12 VI p-xylene 0.5 50 87:13 
13 VI trifluorotoluene 0.5 100 60:40 
14 VI toluene 0.5 55 90:10 
15[c] VI toluene 0.5 82 55:45c 
16 VI toluene 0.25 43 88:12 
17 VI toluene 1 72 70:30 
18 VIII toluene 0.5 66 70:30 
19 IX toluene 0.5 100 45:55 
[a] Conditions: organocatalyst (0.02 mmol, 20 mol %), 1a (0.1 mmol, 1.0 eq.), 2,6-lutidine (0.2 mmol, 2 eq.) in 0.2 
mL of DMF at room temperature and N2-atmosphere using different light sources as indicated. [b] To determine 
the enantiomeric ratio of product 2a a derivatization with a Wittig reagent to 2Wa was necessary. [c] The reaction 
was stirred for 3 days.  
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5.3.4 Reaction with Aldehydes 1b, 1c and 1d 
With the optimized reaction conditions for aldehyde 1a in hand, we decided to study the 
reaction with different aldehydes. In aldehyde 1b the benzyl group of the esters moieties at 
the malonate unit was changed to a tert-butyl group to enhance the steric hindrance aiming 
at further improve the enantiomeric induction. First, the reaction was carried out with the 
best conditions from aldehyde 1a, but surprisingly no reaction was observed (entry 1). Thus, 
an optimization of the reaction conditions for aldehyde 1b was carried out (Table 4). When 
the reaction was performed for three days, low yield and moderate enantiomeric induction of 
75:25 e.r. was recorded (entry 2). The conversion of the reaction could be improved 
dramatically by changing the catalyst from VI to V, though suffering from a drop in 
enantiomeric induction (25:65 e.r., entry 3). Following experiments changing the solvent or 
catalyst did not give a better result (entries 4-8). 
Table 4. Modification of the electron withdrawing group and optimization of the reaction 
conditions.[a] 
 
Entry Aminocatalyst Solvent Conv.[%] e.r.[b] 
1 VI toluene n.r - 
2 VI toluene 10 75:25c 
3 V toluene 76 35:65 
4 VI CH2Cl2 10 n.d 
5 VI MTBE n.r - 
6 VI DMF 30 50:50 
7 VI DMF 36 50:50 
8 V DMF 73 40:60 
[a] Conditions: organocatalyst (0.02 mmol, 20 mol%), 1b (0.1 mmol, 1.0 eq.), 2,6-lutidine (0.2 mmol, 2 eq.) in 0.2 
mL of solvent at room temperature and N2-atmosphere under visible light irradiation (23W). [b] To determine 
the enantiomeric ratio of product 2b a derivatization with a Wittig reagent to 2Wb was necessary. [c] The reaction 
was stirred for 3 days. 
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Since the enantiomeric ratio was not improved by a greater steric hinderance in the electron-
withdrawing ester group of aldehyde 1b we changed to a methyl substituent for further 
investigations. Therefore, aldehyde 1c was synthesized bearing methyl instead of the tert-
butyl ester groups. To our delight, the reaction worked smoothly with full conversion to the 
desired cyclic product 2c. Unfortunately, we were not able to separate the two enantiomers 
by chiral HPLC to measure the enantiomeric ratio. All attempts with different methods and 
various chiral columns on HPLC, SFC and GC measurements were unsuccessful. 
Table 5. Modification of the electron withdrawing group.[a] 
 
Entry Aminocatalyst Solvent Conv.[%] e.r.[b] 
1 rac-I toluene 100 n.d 
2 VI DMF 100 n.dc 
[a] Conditions: organocatalyst (0.02 mmol, 20 mol%), 1b (0.1 mmol, 1.0 eq.), 2,6-lutidine (0.2 mmol, 2 eq.) in 0.2 
mL of solvent at room temperature and N2-atmosphere under visible light irradiation (23W). [b] The enantiomeric 
ratio of product 2c could not be determined by chiral HPLC or GC. [c] The reaction was stirred for 3 days. 
Since the changes on the ester groups of the malonate unit did not lead to the identification 
of any reactivity or enantioselectivity trend, we decided to vary the length of the alkyl chain 
to create a six-membered ring instead of a five-membered ring. Unfortunately, all our tries to 
achieve the product failed and no conversion was observed (Table 6). 
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Table 6. Modification of the length of the alkyl chain.[a] 
 
Entry Aminocatalyst Solvent Conv.[%] e.r.[b] 
1 rac-I DMF n.r - 
2[b] rac-I DMF n.r - 
3 VI DMF n.r - 
4 V DMF decomposition  
5[c] VI DMF 3 - 
6 VI CH2Cl2 n.r - 
7 VI toluene n.r - 
8[c] VI toluene n.r - 
[a] Conditions: organocatalyst (0.02 mmol, 20 mol%), 1d (0.1 mmol, 1.0 eq.), 2,6-lutidine (0.2 mmol, 2 eq.) in 
0.2 mL of solvent at room temperature and N2-atmosphere under visible light irradiation (23W). [b] The 
reaction was stirred for 6 days. [c] The reaction was stirred for 3 days. 
5.3 Mechanistic Proposal 
Based on the obtained results, we propose a possible mechanism depicted in Scheme 7. We 
supposed that the enamine i is able to absorb light and reach the excited state. In a first step, 
the corresponding aldehyde condensates with the aminocatalyst (a) followed by the 
absorption of visible light of the formed enamine from its ground state (b). The excited state 
enamine ii is then able to form a radical by reductive debromination (c). In this case, the 
excited state enamine ii acts as a photoindicator triggering the formation of the radical iii by 
a single electron transfer (SET). The enamine i is then used as a scarifying species, being 
oxidized (Eº ≃ 2.0 V) to reduce intermediate ii and to form the key C-centered radical iii. Next, 
iii reacts intramolecularly with the enamine group present in the molecule (d), forming a new 
C-C bond. Subsequently, the formed amino-radical iv is oxidized by the enamine ii (e), leading 
to the iminium intermediate v. Finally, hydrolysis of the iminium ion gives the α-alkylated 
aldehyde product and the recycled aminocatalyst (f).  
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2,6-Lutidine was necessary for the neutralization of the formed acid HBr, which would provoke 
the enolization of the aldehyde and the enantioselectivity loss. 
 
Scheme 7 Proposed mechanism. 
5.4 Conclusion 
In conclusion, we have developed a new method for the intramolecular α-alkylation of 
aldehydes without the use of an additional metallic or organic photocatalyst. Despite some 
good results with the enantioselective cyclization of aldehyde 1a, the found reaction 
conditions could not be applied to other substrates. For most of the cases, only low yields or 
enantioselectivities were obtained. Also, the reproducibility of the results was challenging and 
possess a lot of problems. Although a thorough study and various optimizations were carried 
out, until now, no solution for these issues was found. 
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5.5 Experimental Part 
5.5.1 Synthesis of the Starting Material 
Aldehydes 1 were prepared in 5 steps, following a literature known procedure from the 
corresponding malonate.[17] 
General procedure for the synthesis of the starting material: 
 
 
Dibenzyl 2-bromo-2-(5-oxopentyl)malonate (1a) 
1H NMR (300 MHz, CDCl3): δ = 9.63 (d, J = 1.6 Hz, 1H), 7.33 – 7.17 (m, 10H), 
5.11 (d, J = 5.0 Hz, 4H), 2.28 (td, J = 7.4, 1.6 Hz, 2H), 2.25-2.16 (m, 2H), 1.59-
1.46 (m, 2H), 1.33-1.20 (m, 2H). 13C NMR (75 MHz, CDCl3): δ = 201.7, 166.4, 
134.7, 128.6, 128.53, 128.3, 68.5, 67.1, 43.3, 37.9, 24.7, 21.5. HRMS (ESI+): m/z 
calculated for C22H27NO5Br [M+NH4] + 464.1067; found: 464.1092. 
 
Di-tert-butyl 2-bromo-2-(5-oxopentyl)malonate (1b) 
1H NMR (300 MHz, CDCl3): δ = 9.77 (d, J = 1.6 Hz, 1H), 2.47 (t, J = 7.2 Hz, 2H), 
2.24 – 2.14 (m, 2H), 1.75 – 1.62 (m, 2H), 1.60 – 1.54 (m, 2H), 1.48 (s, 18H). 
13C NMR (75 MHz, CDCl3): δ = 201.8, 165.7, 83.5, 65.8, 43.5, 37.8, 27.7, 24.7, 
21.7. HRMS (ESI+): m/z calculated for C16H28BrO5 [M+H] + 379.1115; found: 
379.1092. 
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Dimethyl 2-bromo-2-(5-oxopentyl)malonate (1c) 
 1H NMR (300 MHz, CDCl3) δ 9.72 (t, J = 1.3 Hz, 1H), 3.78 (s, 2H), 2.48 – 2.40 
(m, 1H), 2.28 – 2.20 (m, 1H), 1.71 – 1.57 (m, 1H), 1.46 – 1.35 (m, 1H). 
 
 
 
 
Dibenzyl 2-bromo-2-(6-oxohexyl)malonate (1d) 
1H NMR (300 MHz, CDCl3): δ = 9.72 (d, J = 1.5 Hz, 1H), 7.36 – 7.26 (m, 10H), 
5.18 (d, J = 5.4 Hz, 4H), 2.34 (td, J = 8.6, 4.3 Hz), 2.29 – 2.19 (m, 2H), 1.64 – 
1.44 (m, 2H), 1.41 – 1.20 (m, 6H). 13C NMR (75 MHz, CDCl3): δ = 202.2, 166.5, 
134.7, 128.6, 128.3, 128.2, 68.5, 63.1, 43.5, 37.9, 28.5, 24.9, 21.6. HRMS 
(ESI+): m/z calculated for C23H29BrO5N [M+NH4] + 478.1224; found: 478.1258. 
 
5.5.2 Organocatalytic Cyclization Reaction 
 
In a crimp top vial, the corresponding aldehyde 1a-c (0.05 mmol, 1.0 eq.), the photocatalyst 
(0.0005 mmol, 1 mol%) the aminocatalyst (0.01 mmol, 20 mol%) and 2,6-lutidine (0.1 mmol, 
2.0 eq.) were dissolved in the described solvent. The vial was sealed, and three cycles of Freeze 
Pump Thaw were carried out. The reaction mixture was than irradiated with white light for 
18 h while stirred. The temperature was regulated with a ventilator to avoid heating of the 
reaction by the lamp. The solvent was removed under reduced pressure and the conversion 
was determined by NMR on the crude reaction. Purification by flash column chromatography 
(cyclohexane/EtOAc 10:1) yielded the desired product as yellow oil. 
Dibenzyl 2-formylcyclopentane-1,1-dicarboxylate (2a) 
 1H NMR (300 MHz, CDCl3): δ = 9.70 (d, J = 1.6 Hz, 1H), 7.38 – 7.26 (m, 10H), 
5.24 – 5.12 (s, 4H), 2.41 – 2.24 (t, J = 7.4, 1.6 Hz, 3H), 1.60 (m, 2H), 1.41-1.29 
(m, 2H). 13C NMR (75 MHz, CDCl3): δ = 199.9, 165.3, 128.7, 128.6, 128.5, 128.2, 
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67.8, 57.7, 53.6, 34.8, 29.8, 22.8. HRMS (ESI+): m/z calculated for C22H23O5 [M+H] + 367.1540; 
found: 367.1557. 
 
Di-tert-butyl 2-formylcyclopentane-1,1-dicarboxylate (2b) 
 1H NMR (300 MHz, CDCl3): δ = 9.82 (d, J = 0.9 Hz, 1H), 3.08 (td, J = 8.6, 0.9 Hz, 
1H), 2.35 - 2.09 (m, 2H), 1.96 (td, J = 8.6, 5.7 Hz, 2H), 1.81 – 1.63 (m, 1H), 1.48 
(s, 9H), 1.43 (s, 9H). 13C NMR (75 MHz, CDCl3): δ = 200.7, 170.4, 169.4, 82.6, 
82.2, 64.2, 57.6, 34.7, 29.9, 28.0, 27.9, 22.7. HRMS (ESI+): m/z calculated for C16H27O5 [M+H]+ 
299.1853; found: 299.1861. 
 
Dimethyl 2-formylcyclopentane-1,1-dicarboxylate (2c) 
1H NMR (300 MHz, CDCl3) δ 9.76 (s, 1H), 3.81 (s, J = 3.2 Hz, 5H), 3.75 (s, 1H), 
2.52 – 2.42 (m, 2H), 2.33 – 2.22 (m, J = 10.0, 6.3 Hz, 2H), 1.71 – 1.65 (m, 2H). 
 
5.5.3 Derivatization of the Aldehyde to the Wittig Product 
 
To determine the enantiomeric ratio of the cyclic product, it was necessary to perform a 
derivatization to achieve a separation of the enantiomers in the chiral column of the HPLC. 
Product 2 (0.01 mmol, 1.0 eq.) and the Wittig-ylide 3 (0.02 mmol, 2.0 eq.) were dissolved in 
DCM (1.5 mL) and stirred for 2 h at 40 °C. Purification by flash column chromatography 
(cyclohexane/EtOAc 10:1) yielded the desired product. 
Dibenzyl (E)-2-(3-(benzyloxy)-3-oxoprop-1-en-1-yl)cyclopentane-1,1-dicarboxylate (2Wa) 
 1H NMR (300 MHz, CDCl3): δ = 7.36 (d, J = 5.1 Hz, 5H), 7.33-7.14 (m, 
10H), 7.01 (dd, J = 15.6, 7.99 Hz, 1H), 5.86 (dd, J = 15.6, 1.3 Hz, 1H), 5.12 
(d, J = 9.0 Hz, 4H), 5.09-4.89 (m, 2H), 3.37 (m, 1H), 2.53 (m, 1H), 2.23-
2.07 (m, 1H), 1.84-2.02 (m, 2H), 1.77-1.64 (m, 2H). 13C NMR (75 MHz, CDCl3): δ = 171.4, 170.1, 
166.0, 147.9, 136.2, 135.5, 128.7, 128.7, 128.6, 128.4, 128.3, 128.2, 122.3, 67.4, 66.2, 64.3, 
48.8, 34.4, 30.6, 29.8, 23.3. HRMS (ESI+): m/z calculated for C31H34NO6 [M+NH4]+ 516.2381; 
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found: 516.2379. The enantiomeric ratio was determined as 90:10 e.r. by chiral SFC [Chiralpak 
IA, CO2/MeOH (90:10), 2.0 mL/min, = 300 nm: tr (major): 7.7 min, tr (minor): 8.1 min]. 
 
Di-tert-butyl (E)-2-(3-(benzyloxy)-3-oxoprop-1-en-1-yl)cyclopentane-1,1-dicarboxylate 
(2Wb). 
1H NMR (300 MHz, CDCl3): δ = 7.39 – 7.31 (m, 5H), 7.04 (dd, J = 15.7, 7.8 
Hz, 1H), 5.89 (dd, J = 15.7, 1.4 Hz, 1H), 5.17 (s, 2H), 3.21 – 3.31 (m, 1H), 
2.48 – 2.36 (m, 1H), 2.02 – 1.91 (m, 2H), 1.90 – 1.81 (m, 1H), 1.60 – 1.51 
(m, 2H), 1.44 (s, 9H), 1.35 (s, 9H). 13C NMR (75 MHz, CDCl3): δ = 170.9, 170.6, 166.4, 149.4, 
136.2, 128.6, 128.5, 128.3, 121.4, 81.9, 81.4, 66.2, 65.1, 48.1, 30.4, 29.9, 28.0, 27.9, 23.3. 
HRMS (ESI+): m/z calculated for C25H38O6N [M+NH4]+ 448.2694; found: 498.2740. The 
enantiomeric ratio was determined as 75:25 e.r. by chiral SFC [Chiralpak IG, CO2/MeOH 
(90:10), 2.0 mL/min, = 300 nm: tr (major): 2.4 min, tr (minor): 2.3 min]. 
  
Intramolecular α-alkylation of aldehydes via photoredox catalysis 
155 
5.5.4 Representative Spectra of 2a 
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Chiral heterocycles are ubiquitous structures in natural and synthetic molecules, but chemists 
are still struggling to develop general, convenient and mild methods for a direct synthesis of 
these products. Therefore, important work has been done in the field of anion-binding 
thiourea-catalyzed dearomatization reactions of heteroarenes by applying chiral thiourea 
catalysts. In this regard, the group of Olga García Mancheño developed a new class of triazole 
based C-H bond anion-binding catalysts. These catalysts were successfully applied into 
asymmetric dearomatization reactions of quinolines, isoquinolines and pyridines. 
The main aim of this PhD was the development of novel asymmetric dearomatization 
reactions with the TetraTri catalysts showing their broad synthetic application spectrum. 
In Chapter 2, the first anion-binding organocatalyzed enantioselective Reissert-type 
dearomatization of diazarenes has been developed. Due to various reactive sites in the 
diazarene structures, the reaction presents regioselectivity issues and is therefore highly 
challenging. Fortunately, the use of a chiral tetrakistriazole as a C–H-based hydrogen-donor 
catalyst allowed the straightforward highly regio- and enantioselective synthesis of a variety 
of chiral diazaheterocycles. 
In Chapter 3, phosphorous nucleophiles were further explored. We could describe the first 
enantioselective synthesis of chiral heterocyclic α-amino phosphonates by nucleophilic 
dearomatization of quinolines and pyridines using an anion-binding organocatalysis approach. 
Chiral tetrakistriazoles were employed as efficient hydrogen-bond donor catalysts. The 
corresponding products were obtained in complete or high regioselectivities and up to 97:3 
e.r. for quinolines or up to 87:13 e.r. for the more demanding pyridine substrates. This method 
allows the rapid access to substituted chiral cyclic α-amino phosphonates, which can easily 
further be transformed into phosphonic acid derivatives. Introducing boron-nucleophiles in 
the same reaction was not successful and did not lead to any new discovery. 
In Chapter 4, we changed from the nitrogen-containing heteroarenes to the more challenging 
oxygen-containing heterocycles. A general and highly enantioselective catalytic synthesis of 2-
alkyl substituted oxygen heterocycles by nucleophilic dearomatization of pyrylium triflate 
derivatives with silyl ketene acetals has been developed. The use of chiral triazoles as anion-
binding catalysts, able to form a close ion-pair with the substrates, was crucial to achieve both 
high conversions and chirality transfer. Thus, this method provides a simple access to chiral 
chromanones and dihydropyranones in excellent enantioselectivities from the corresponding 
4-(benzo)pyranones. 
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Besides the main theme of my thesis, in chapter 5 the project of my stay abroad at the 
Universidad Autonoma de Madrid was described. A novel intramolecular photocatalyzed 
enantioselective α-alkylation of aldehydes was developed, yielding the desired product in 
good yield and enantioselectivity. Due to reproducibility issues and a limited applicability of 
the substrate scope, no further investigations were done.  
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Asymmetrische, dearomatisierte Heteroarene sind weitverbreitete Strukturmotive in 
natürlich vorkommenden oder synthetisch hergestellten Molekülen. Trotz ihrer großen 
Bedeutung, wird immer noch nach allgemein geeigneten und milden Methoden gesucht, diese 
Produkte direkt herzustellen. In diesem Zusammenhang entwickelten sich wichtige 
Dearomatisierungsreaktionen, die durch Anionbindungskatalyse mit 
Thioharnstoffkatalysatoren Chiralität in das finale Produkt einbringen können. Die Gruppe von 
Olga García Mancheño entwickelte eine neue Klasse von Anionbindungskatalysatoren, die 
Triazole basierten C-H Bindungskatalysatoren. Diese Katalysatorsysteme wurden erfolgreich 
in asymmetrische Dearomatisierungsreaktionen von Chinolinen, Isochinolinen und Pyridinen 
eingesetzt. 
In dieser Arbeit wird ein breites Anwendungsgebiet dieser TetraTri Katalysatoren in 
verschiedenen Dearomatisierungsreaktionen präsentiert. 
In Kapitel 2 wurde die erste enantioselektive, anionbindungskatalysierte Reissert-artige 
Dearomatisierungsreaktion mit Diazarenen dargestellt. Auf Grund mehrerer reaktiver Zentren 
in der Diazarenstruktur, bringt die Reaktion einige Regioselektivitätsprobleme mit sich und ist 
somit sehr anspruchsvoll. Glücklicherweise konnten wir durch den Einsatz unseres chiralen C-
H basierender Wasserstoffbrückenbindungskatalysator TetraTri die direkte Synthese von hoch 
regio- und enantioselektiven chiralen Diazaheterozyklen erreichen. 
In Kapitel 3 wurden Phosphornukleophile untersucht. Wir konnten die erste enantioselektive 
Synthese von chiralen heterozyklischen α-Aminophosphonaten durch nukleophile 
Dearomatisierung von Chinolinen und Pyridinen mit einem Anionbindungsansatz beschreiben. 
Chirale Tetrakistriazole wurden als effiziente Wasserstoffbindungskatalysatoren eingesetzt. 
Die entstandenen Produkte zeigten komplette oder hohe Regioselektivitäten und bis zu 97:3 
e.r. für Chinoline und bis zu 87:13 e.r. für die schwierigeren Pyridine. Die Methode stellt einen 
schnellen Zugang zu chiralen, substituierten, zyklischen α-Aminophosphonaten dar, welche 
weiter zu ihren Phosphorsäurederivaten umgewandelt werden können. In die gleiche 
Reaktion sollten Bornukleophile eingesetzt werden. Es konnten jedoch keine Ergebnisse 
erzielt werden. 
In Kapitel 4, wurden anstatt der Stickstoffheterozyklen Sauerstoffheterozyklen als Substrate 
verwendet. Eine allgemeingültige, hoch enantioselektive, katalytische Synthese von 2-
alkylsubstituierten Sauerstoffheterozyklen durch nukleophile Dearomatisierung von 
Pyryliumtriflatderivativen mit Silylketenacetalen wurde dargestellt. Ausschlaggebend für den 
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hohen Umsatz und Chiralitätstransfer war die Bildung eines engen Ionenpaars zwischen dem 
chiralen Triazolkatalysator und dem Substrat. Folglich stellt diese Methode einen einfachen 
Zugang zu chiralen Chromanonen und Dihydropyranone mit exzellenten Enantioselektivitäten 
dar. 
Neben dem Hauptthema meiner Doktorarbeit, wurde in Kapitel 5 das Projekt meines 
Forschungsaufenthaltes an der Universidad Autonoma de Madrid beschrieben. Eine neue 
intramolekulare fotokatalysierte enantioselektive α-Alkylierung von Aldehyden wurde 
entwickelt. Obwohl eines der gewünschten Produkte in guten Ausbeuten und 
Enantioselekivitäten erhalten wurde, konnten auf Grund von Reproduzierbarkeitsproblemen, 
und einer stark limitierten Anwendbarkeit auf andere Substrate keine weiteren 
Forschungsergebnisse erreicht werden. 
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6.1 List of Abbreviations  
 
[α] specific rotation 
aq. aqueous 
Ar aryl 
BINOL 1,1′-Bi-2-naphthol 
Bn benzyl 
B(OH)3 boric acid 
B2pin2 Bis(pinacolato)diboron  
Bu butyl 
CbzCl Carboxybenzylchlorid 
CD Circular Dichroism 
CDCl3 Chloroform-d  
CETP  Cholesteryl ester transfer 
protein 
CI chemical ionization 
Conv. Conversion 
CuAAC copper(I)-catalyzed alkyne-
azide cycloaddition 
Cy cyclohexyl 
d doublet (NMR) 
δ chemical shift 
DCM dichloromthene 
DMAP 4-(dimethylamino)pyridine 
DMF N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
ee enantiomeric excess 
EI electron impact ionization 
(MS) 
eq.  equivalent 
e.r. enantiomeric ratio 
ESI electrospray ionization (MS) 
Et ethyl 
Et2O diethyl ether 
Et3N triethyl amine 
Et3SiH triethylsilane 
EtOAc ethyl acetate 
FID flame ionization detector 
(GC) 
GC gas chromatography 
h hour(s) 
hept heptet (NMR)  
HPLC High-performance liquid 
chromatography 
HR high resolution (MS) 
Hz hertz (NMR) 
i iso 
iPrOH iso-propanol 
J coupling constant 
K2CO3 potassium carbonate 
KMNO4 potassium permanganate 
[M] mol per liter 
M metal 
m multiplet (NMR); medium 
(IR) 
Me methyl 
MeOH methanol 
MeOTf methyl triflate 
min.  minute(s) 
mL milliliter 
MS  mass spectrometry 
MTBE  Methyl tert-butyl ether 
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m/z  mass to charge ratio (MS) 
NBSA  nitrobenzene sulfonic acid 
NMR  nuclear magnetic resonance 
Nu  nucleophile 
Pd/C  palladium on active carbon 
Ph  phenyl 
ppm  parts per million 
Pr  propyl 
q quartet (1H-NMR); 
quaternary carbon (13C-
NMR) 
quin  quintet (NMR) 
rac  racemic  
r.t.  room temperature 
s  singlet (NMR) 
sat.  saturated   
sext  sextet (NMR) 
t  triplet (NMR) 
t  tert 
tR  retention time 
TBACl Tetramethylammonium 
chloride 
Temp.  temperature 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
Xantphos 4,5-bis(diphenylphosphino)- 
9,9-dimethylxanthene
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